Vitamin D, Autoimmune Disease and Rheumatoid Arthritis
Identifieur interne : 000220 ( Pmc/Corpus ); précédent : 000219; suivant : 000221Vitamin D, Autoimmune Disease and Rheumatoid Arthritis
Auteurs : Stephanie R. Harrison ; Danyang Li ; Louisa E. Jeffery ; Karim Raza ; Martin HewisonSource :
- Calcified Tissue International [ 0171-967X ] ; 2019.
Abstract
Vitamin D has been reported to influence physiological systems that extend far beyond its established functions in calcium and bone homeostasis. Prominent amongst these are the potent immunomodulatory effects of the active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). The nuclear vitamin D receptor (VDR) for 1,25-(OH)2D3 is expressed by many cells within the immune system and resulting effects include modulation of T cell phenotype to suppress pro-inflammatory Th1 and Th17 CD4+ T cells and promote tolerogenic regulatory T cells. In addition, antigen-presenting cells have been shown to express the enzyme 1α-hydroxylase that converts precursor 25-hydroxyvitamin D3 (25-OHD3) to 1,25-(OH)2D3, so that immune microenvironments are able to both activate and respond to vitamin D. As a consequence of this local, intracrine, system, immune responses may vary according to the availability of 25-OHD3, and vitamin D deficiency has been linked to various autoimmune disorders including rheumatoid arthritis (RA). The aim of this review is to explore the immune activities of vitamin D that impact autoimmune disease, with specific reference to RA. As well as outlining the mechanisms linking vitamin D with autoimmune disease, the review will also describe the different studies that have linked vitamin D status to RA, and the current supplementation studies that have explored the potential benefits of vitamin D for prevention or treatment of RA. The overall aim of the review is to provide a fresh perspective on the potential role of vitamin D in RA pathogenesis and treatment.
The online version of this article (10.1007/s00223-019-00577-2) contains supplementary material, which is available to authorized users.
Url:
DOI: 10.1007/s00223-019-00577-2
PubMed: 31286174
PubMed Central: 6960236
Links to Exploration step
PMC:6960236Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vitamin D, Autoimmune Disease and Rheumatoid Arthritis</title><author><name sortKey="Harrison, Stephanie R" sort="Harrison, Stephanie R" uniqKey="Harrison S" first="Stephanie R." last="Harrison">Stephanie R. Harrison</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.412919.6</institution-id><institution>Department of Rheumatology, Sandwell and West,</institution><institution>Birmingham Hospitals NHS Trust,</institution></institution-wrap>Birmingham, B18 7QH UK</nlm:aff></affiliation></author><author><name sortKey="Li, Danyang" sort="Li, Danyang" uniqKey="Li D" first="Danyang" last="Li">Danyang Li</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Jeffery, Louisa E" sort="Jeffery, Louisa E" uniqKey="Jeffery L" first="Louisa E." last="Jeffery">Louisa E. Jeffery</name><affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Translation Medicine,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Raza, Karim" sort="Raza, Karim" uniqKey="Raza K" first="Karim" last="Raza">Karim Raza</name><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.412919.6</institution-id><institution>Department of Rheumatology, Sandwell and West,</institution><institution>Birmingham Hospitals NHS Trust,</institution></institution-wrap>Birmingham, B18 7QH UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff4"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Inflammation and Ageing, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence and MRC Arthritis Research UK Centre for Musculoskeletal Ageing Research,</institution><institution>University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Hewison, Martin" sort="Hewison, Martin" uniqKey="Hewison M" first="Martin" last="Hewison">Martin Hewison</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff5">Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TT UK</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">31286174</idno><idno type="pmc">6960236</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960236</idno><idno type="RBID">PMC:6960236</idno><idno type="doi">10.1007/s00223-019-00577-2</idno><date when="2019">2019</date><idno type="wicri:Area/Pmc/Corpus">000220</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000220</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Vitamin D, Autoimmune Disease and Rheumatoid Arthritis</title><author><name sortKey="Harrison, Stephanie R" sort="Harrison, Stephanie R" uniqKey="Harrison S" first="Stephanie R." last="Harrison">Stephanie R. Harrison</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.412919.6</institution-id><institution>Department of Rheumatology, Sandwell and West,</institution><institution>Birmingham Hospitals NHS Trust,</institution></institution-wrap>Birmingham, B18 7QH UK</nlm:aff></affiliation></author><author><name sortKey="Li, Danyang" sort="Li, Danyang" uniqKey="Li D" first="Danyang" last="Li">Danyang Li</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Jeffery, Louisa E" sort="Jeffery, Louisa E" uniqKey="Jeffery L" first="Louisa E." last="Jeffery">Louisa E. Jeffery</name><affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Translation Medicine,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Raza, Karim" sort="Raza, Karim" uniqKey="Raza K" first="Karim" last="Raza">Karim Raza</name><affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.412919.6</institution-id><institution>Department of Rheumatology, Sandwell and West,</institution><institution>Birmingham Hospitals NHS Trust,</institution></institution-wrap>Birmingham, B18 7QH UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff4"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Inflammation and Ageing, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence and MRC Arthritis Research UK Centre for Musculoskeletal Ageing Research,</institution><institution>University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation></author><author><name sortKey="Hewison, Martin" sort="Hewison, Martin" uniqKey="Hewison M" first="Martin" last="Hewison">Martin Hewison</name><affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</nlm:aff></affiliation><affiliation><nlm:aff id="Aff5">Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TT UK</nlm:aff></affiliation></author></analytic><series><title level="j">Calcified Tissue International</title><idno type="ISSN">0171-967X</idno><idno type="eISSN">1432-0827</idno><imprint><date when="2019">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p id="Par1">Vitamin D has been reported to influence physiological systems that extend far beyond its established functions in calcium and bone homeostasis. Prominent amongst these are the potent immunomodulatory effects of the active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25-(OH)<sub>2</sub>D3). The nuclear vitamin D receptor (VDR) for 1,25-(OH)<sub>2</sub>D3 is expressed by many cells within the immune system and resulting effects include modulation of T cell phenotype to suppress pro-inflammatory Th1 and Th17 CD4+ T cells and promote tolerogenic regulatory T cells. In addition, antigen-presenting cells have been shown to express the enzyme 1α-hydroxylase that converts precursor 25-hydroxyvitamin D3 (25-OHD3) to 1,25-(OH)<sub>2</sub>D3, so that immune microenvironments are able to both activate and respond to vitamin D. As a consequence of this local, intracrine, system, immune responses may vary according to the availability of 25-OHD3, and vitamin D deficiency has been linked to various autoimmune disorders including rheumatoid arthritis (RA). The aim of this review is to explore the immune activities of vitamin D that impact autoimmune disease, with specific reference to RA. As well as outlining the mechanisms linking vitamin D with autoimmune disease, the review will also describe the different studies that have linked vitamin D status to RA, and the current supplementation studies that have explored the potential benefits of vitamin D for prevention or treatment of RA. The overall aim of the review is to provide a fresh perspective on the potential role of vitamin D in RA pathogenesis and treatment.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1007/s00223-019-00577-2) contains supplementary material, which is available to authorized users.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Christakos, S" uniqKey="Christakos S">S Christakos</name></author><author><name sortKey="Ajibade, D" uniqKey="Ajibade D">D Ajibade</name></author><author><name sortKey="Dhawan, P" uniqKey="Dhawan P">P Dhawan</name></author><author><name sortKey="Fechner, A" uniqKey="Fechner A">A Fechner</name></author><author><name sortKey="Mady, L" uniqKey="Mady L">L Mady</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Deluca, Hf" uniqKey="Deluca H">HF DeLuca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Christakos, S" uniqKey="Christakos S">S Christakos</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Gardner, Dg" uniqKey="Gardner D">DG Gardner</name></author><author><name sortKey="Wagner, Cl" uniqKey="Wagner C">CL Wagner</name></author><author><name sortKey="Sergeev, In" uniqKey="Sergeev I">IN Sergeev</name></author><author><name sortKey="Rutten, E" uniqKey="Rutten E">E Rutten</name></author><author><name sortKey="Pittas, Ag" uniqKey="Pittas A">AG Pittas</name></author><author><name sortKey="Boland, R" uniqKey="Boland R">R Boland</name></author><author><name sortKey="Ferrucci, L" uniqKey="Ferrucci L">L Ferrucci</name></author><author><name sortKey="Bikle, Dd" uniqKey="Bikle D">DD Bikle</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bizzaro, G" uniqKey="Bizzaro G">G Bizzaro</name></author><author><name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kivity, S" uniqKey="Kivity S">S Kivity</name></author><author><name sortKey="Agmon Levin, N" uniqKey="Agmon Levin N">N Agmon-Levin</name></author><author><name sortKey="Zisappl, M" uniqKey="Zisappl M">M Zisappl</name></author><author><name sortKey="Shapira, Y" uniqKey="Shapira Y">Y Shapira</name></author><author><name sortKey="Nagy, Ev" uniqKey="Nagy E">EV Nagy</name></author><author><name sortKey="Danko, K" uniqKey="Danko K">K Danko</name></author><author><name sortKey="Szekanecz, Z" uniqKey="Szekanecz Z">Z Szekanecz</name></author><author><name sortKey="Langevitz, P" uniqKey="Langevitz P">P Langevitz</name></author><author><name sortKey="Shoenfeld, Y" uniqKey="Shoenfeld Y">Y Shoenfeld</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cantorna, Mt" uniqKey="Cantorna M">MT Cantorna</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cutolo, M" uniqKey="Cutolo M">M Cutolo</name></author><author><name sortKey="Otsa, K" uniqKey="Otsa K">K Otsa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhu, Jg" uniqKey="Zhu J">JG Zhu</name></author><author><name sortKey="Ochalek, Jt" uniqKey="Ochalek J">JT Ochalek</name></author><author><name sortKey="Kaufmann, M" uniqKey="Kaufmann M">M Kaufmann</name></author><author><name sortKey="Jones, G" uniqKey="Jones G">G Jones</name></author><author><name sortKey="Deluca, Hf" uniqKey="Deluca H">HF Deluca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Zehnder, D" uniqKey="Zehnder D">D Zehnder</name></author><author><name sortKey="Bland, R" uniqKey="Bland R">R Bland</name></author><author><name sortKey="Stewart, Pm" uniqKey="Stewart P">PM Stewart</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zehnder, D" uniqKey="Zehnder D">D Zehnder</name></author><author><name sortKey="Bland, R" uniqKey="Bland R">R Bland</name></author><author><name sortKey="Williams, Mc" uniqKey="Williams M">MC Williams</name></author><author><name sortKey="Mcninch, Rw" uniqKey="Mcninch R">RW McNinch</name></author><author><name sortKey="Howie, Aj" uniqKey="Howie A">AJ Howie</name></author><author><name sortKey="Stewart, Pm" uniqKey="Stewart P">PM Stewart</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Freeman, L" uniqKey="Freeman L">L Freeman</name></author><author><name sortKey="Hughes, Sv" uniqKey="Hughes S">SV Hughes</name></author><author><name sortKey="Evans, Kn" uniqKey="Evans K">KN Evans</name></author><author><name sortKey="Bland, R" uniqKey="Bland R">R Bland</name></author><author><name sortKey="Eliopoulos, Ag" uniqKey="Eliopoulos A">AG Eliopoulos</name></author><author><name sortKey="Kilby, Md" uniqKey="Kilby M">MD Kilby</name></author><author><name sortKey="Moss, Pa" uniqKey="Moss P">PA Moss</name></author><author><name sortKey="Chakraverty, R" uniqKey="Chakraverty R">R Chakraverty</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kreutz, M" uniqKey="Kreutz M">M Kreutz</name></author><author><name sortKey="Andreesen, R" uniqKey="Andreesen R">R Andreesen</name></author><author><name sortKey="Krause, Sw" uniqKey="Krause S">SW Krause</name></author><author><name sortKey="Szabo, A" uniqKey="Szabo A">A Szabo</name></author><author><name sortKey="Ritz, E" uniqKey="Ritz E">E Ritz</name></author><author><name sortKey="Reichel, H" uniqKey="Reichel H">H Reichel</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Wood, Am" uniqKey="Wood A">AM Wood</name></author><author><name sortKey="Qureshi, Os" uniqKey="Qureshi O">OS Qureshi</name></author><author><name sortKey="Hou, Tz" uniqKey="Hou T">TZ Hou</name></author><author><name sortKey="Gardner, D" uniqKey="Gardner D">D Gardner</name></author><author><name sortKey="Briggs, Z" uniqKey="Briggs Z">Z Briggs</name></author><author><name sortKey="Kaur, S" uniqKey="Kaur S">S Kaur</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Burke, F" uniqKey="Burke F">F Burke</name></author><author><name sortKey="Evans, Kn" uniqKey="Evans K">KN Evans</name></author><author><name sortKey="Lammas, Da" uniqKey="Lammas D">DA Lammas</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author><author><name sortKey="Liu, P" uniqKey="Liu P">P Liu</name></author><author><name sortKey="Modlin, Rl" uniqKey="Modlin R">RL Modlin</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Rafison, B" uniqKey="Rafison B">B Rafison</name></author><author><name sortKey="Witzel, S" uniqKey="Witzel S">S Witzel</name></author><author><name sortKey="Reyes, Re" uniqKey="Reyes R">RE Reyes</name></author><author><name sortKey="Shieh, A" uniqKey="Shieh A">A Shieh</name></author><author><name sortKey="Chun, R" uniqKey="Chun R">R Chun</name></author><author><name sortKey="Zavala, K" uniqKey="Zavala K">K Zavala</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Liu, Pt" uniqKey="Liu P">PT Liu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Peercy, Be" uniqKey="Peercy B">BE Peercy</name></author><author><name sortKey="Orwoll, Es" uniqKey="Orwoll E">ES Orwoll</name></author><author><name sortKey="Nielson, Cm" uniqKey="Nielson C">CM Nielson</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Lauridsen, Al" uniqKey="Lauridsen A">AL Lauridsen</name></author><author><name sortKey="Suon, L" uniqKey="Suon L">L Suon</name></author><author><name sortKey="Zella, La" uniqKey="Zella L">LA Zella</name></author><author><name sortKey="Pike, Jw" uniqKey="Pike J">JW Pike</name></author><author><name sortKey="Modlin, Rl" uniqKey="Modlin R">RL Modlin</name></author><author><name sortKey="Martineau, Ar" uniqKey="Martineau A">AR Martineau</name></author><author><name sortKey="Wilkinson, Rj" uniqKey="Wilkinson R">RJ Wilkinson</name></author><author><name sortKey="Adams, J" uniqKey="Adams J">J Adams</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jones, G" uniqKey="Jones G">G Jones</name></author><author><name sortKey="Prosser, De" uniqKey="Prosser D">DE Prosser</name></author><author><name sortKey="Kaufmann, M" uniqKey="Kaufmann M">M Kaufmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schlingmann, Kp" uniqKey="Schlingmann K">KP Schlingmann</name></author><author><name sortKey="Kaufmann, M" uniqKey="Kaufmann M">M Kaufmann</name></author><author><name sortKey="Weber, S" uniqKey="Weber S">S Weber</name></author><author><name sortKey="Irwin, A" uniqKey="Irwin A">A Irwin</name></author><author><name sortKey="Goos, C" uniqKey="Goos C">C Goos</name></author><author><name sortKey="John, U" uniqKey="John U">U John</name></author><author><name sortKey="Misselwitz, J" uniqKey="Misselwitz J">J Misselwitz</name></author><author><name sortKey="Klaus, G" uniqKey="Klaus G">G Klaus</name></author><author><name sortKey="Kuwertz Broking, E" uniqKey="Kuwertz Broking E">E Kuwertz-Broking</name></author><author><name sortKey="Fehrenbach, H" uniqKey="Fehrenbach H">H Fehrenbach</name></author><author><name sortKey="Wingen, Am" uniqKey="Wingen A">AM Wingen</name></author><author><name sortKey="Guran, T" uniqKey="Guran T">T Guran</name></author><author><name sortKey="Hoenderop, Jg" uniqKey="Hoenderop J">JG Hoenderop</name></author><author><name sortKey="Bindels, Rj" uniqKey="Bindels R">RJ Bindels</name></author><author><name sortKey="Prosser, De" uniqKey="Prosser D">DE Prosser</name></author><author><name sortKey="Jones, G" uniqKey="Jones G">G Jones</name></author><author><name sortKey="Konrad, M" uniqKey="Konrad M">M Konrad</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Y" uniqKey="Wang Y">Y Wang</name></author><author><name sortKey="Zhu, J" uniqKey="Zhu J">J Zhu</name></author><author><name sortKey="Deluca, Hf" uniqKey="Deluca H">HF DeLuca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bouillon, R" uniqKey="Bouillon R">R Bouillon</name></author><author><name sortKey="Carmeliet, G" uniqKey="Carmeliet G">G Carmeliet</name></author><author><name sortKey="Verlinden, L" uniqKey="Verlinden L">L Verlinden</name></author><author><name sortKey="Van Etten, E" uniqKey="Van Etten E">E van Etten</name></author><author><name sortKey="Verstuyf, A" uniqKey="Verstuyf A">A Verstuyf</name></author><author><name sortKey="Luderer, Hf" uniqKey="Luderer H">HF Luderer</name></author><author><name sortKey="Lieben, L" uniqKey="Lieben L">L Lieben</name></author><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author><author><name sortKey="Demay, M" uniqKey="Demay M">M Demay</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhang, Y G" uniqKey="Zhang Y">Y-G Zhang</name></author><author><name sortKey="Wu, S" uniqKey="Wu S">S Wu</name></author><author><name sortKey="Lu, R" uniqKey="Lu R">R Lu</name></author><author><name sortKey="Zhou, D" uniqKey="Zhou D">D Zhou</name></author><author><name sortKey="Zhou, J" uniqKey="Zhou J">J Zhou</name></author><author><name sortKey="Carmeliet, G" uniqKey="Carmeliet G">G Carmeliet</name></author><author><name sortKey="Petrof, E" uniqKey="Petrof E">E Petrof</name></author><author><name sortKey="Claud, Ec" uniqKey="Claud E">EC Claud</name></author><author><name sortKey="Sun, J" uniqKey="Sun J">J Sun</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="He, L" uniqKey="He L">L He</name></author><author><name sortKey="Liu, T" uniqKey="Liu T">T Liu</name></author><author><name sortKey="Shi, Y" uniqKey="Shi Y">Y Shi</name></author><author><name sortKey="Tian, F" uniqKey="Tian F">F Tian</name></author><author><name sortKey="Hu, H" uniqKey="Hu H">H Hu</name></author><author><name sortKey="Deb, Dk" uniqKey="Deb D">DK Deb</name></author><author><name sortKey="Chen, Y" uniqKey="Chen Y">Y Chen</name></author><author><name sortKey="Bissonnette, M" uniqKey="Bissonnette M">M Bissonnette</name></author><author><name sortKey="Li, Yc" uniqKey="Li Y">YC Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, Tt" uniqKey="Wang T">TT Wang</name></author><author><name sortKey="Dabbas, B" uniqKey="Dabbas B">B Dabbas</name></author><author><name sortKey="Laperriere, D" uniqKey="Laperriere D">D Laperriere</name></author><author><name sortKey="Bitton, Aj" uniqKey="Bitton A">AJ Bitton</name></author><author><name sortKey="Soualhine, H" uniqKey="Soualhine H">H Soualhine</name></author><author><name sortKey="Tavera Mendoza, Le" uniqKey="Tavera Mendoza L">LE Tavera-Mendoza</name></author><author><name sortKey="Dionne, S" uniqKey="Dionne S">S Dionne</name></author><author><name sortKey="Servant, Mj" uniqKey="Servant M">MJ Servant</name></author><author><name sortKey="Bitton, A" uniqKey="Bitton A">A Bitton</name></author><author><name sortKey="Seidman, Eg" uniqKey="Seidman E">EG Seidman</name></author><author><name sortKey="Mader, S" uniqKey="Mader S">S Mader</name></author><author><name sortKey="Behr, Ma" uniqKey="Behr M">MA Behr</name></author><author><name sortKey="White, Jh" uniqKey="White J">JH White</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bacchetta, J" uniqKey="Bacchetta J">J Bacchetta</name></author><author><name sortKey="Zaritsky, Jj" uniqKey="Zaritsky J">JJ Zaritsky</name></author><author><name sortKey="Sea, Jl" uniqKey="Sea J">JL Sea</name></author><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Lisse, Ts" uniqKey="Lisse T">TS Lisse</name></author><author><name sortKey="Zavala, K" uniqKey="Zavala K">K Zavala</name></author><author><name sortKey="Nayak, A" uniqKey="Nayak A">A Nayak</name></author><author><name sortKey="Wesseling Perry, K" uniqKey="Wesseling Perry K">K Wesseling-Perry</name></author><author><name sortKey="Westerman, M" uniqKey="Westerman M">M Westerman</name></author><author><name sortKey="Hollis, Bw" uniqKey="Hollis B">BW Hollis</name></author><author><name sortKey="Salusky, Ib" uniqKey="Salusky I">IB Salusky</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Pt" uniqKey="Liu P">PT Liu</name></author><author><name sortKey="Stenger, S" uniqKey="Stenger S">S Stenger</name></author><author><name sortKey="Li, H" uniqKey="Li H">H Li</name></author><author><name sortKey="Wenzel, L" uniqKey="Wenzel L">L Wenzel</name></author><author><name sortKey="Tan, Bh" uniqKey="Tan B">BH Tan</name></author><author><name sortKey="Krutzik, Sr" uniqKey="Krutzik S">SR Krutzik</name></author><author><name sortKey="Ochoa, Mt" uniqKey="Ochoa M">MT Ochoa</name></author><author><name sortKey="Schauber, J" uniqKey="Schauber J">J Schauber</name></author><author><name sortKey="Wu, K" uniqKey="Wu K">K Wu</name></author><author><name sortKey="Meinken, C" uniqKey="Meinken C">C Meinken</name></author><author><name sortKey="Kamen, Dl" uniqKey="Kamen D">DL Kamen</name></author><author><name sortKey="Wagner, M" uniqKey="Wagner M">M Wagner</name></author><author><name sortKey="Bals, R" uniqKey="Bals R">R Bals</name></author><author><name sortKey="Steinmeyer, A" uniqKey="Steinmeyer A">A Steinmeyer</name></author><author><name sortKey="Zugel, U" uniqKey="Zugel U">U Zugel</name></author><author><name sortKey="Gallo, Rl" uniqKey="Gallo R">RL Gallo</name></author><author><name sortKey="Eisenberg, D" uniqKey="Eisenberg D">D Eisenberg</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Hollis, Bw" uniqKey="Hollis B">BW Hollis</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Bloom, Br" uniqKey="Bloom B">BR Bloom</name></author><author><name sortKey="Modlin, Rl" uniqKey="Modlin R">RL Modlin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, Pt" uniqKey="Liu P">PT Liu</name></author><author><name sortKey="Schenk, M" uniqKey="Schenk M">M Schenk</name></author><author><name sortKey="Walker, Vp" uniqKey="Walker V">VP Walker</name></author><author><name sortKey="Dempsey, Pw" uniqKey="Dempsey P">PW Dempsey</name></author><author><name sortKey="Kanchanapoomi, M" uniqKey="Kanchanapoomi M">M Kanchanapoomi</name></author><author><name sortKey="Wheelwright, M" uniqKey="Wheelwright M">M Wheelwright</name></author><author><name sortKey="Vazirnia, A" uniqKey="Vazirnia A">A Vazirnia</name></author><author><name sortKey="Zhang, X" uniqKey="Zhang X">X Zhang</name></author><author><name sortKey="Steinmeyer, A" uniqKey="Steinmeyer A">A Steinmeyer</name></author><author><name sortKey="Zugel, U" uniqKey="Zugel U">U Zugel</name></author><author><name sortKey="Hollis, Bw" uniqKey="Hollis B">BW Hollis</name></author><author><name sortKey="Cheng, G" uniqKey="Cheng G">G Cheng</name></author><author><name sortKey="Modlin, Rl" uniqKey="Modlin R">RL Modlin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, Th" uniqKey="Kim T">TH Kim</name></author><author><name sortKey="Lee, B" uniqKey="Lee B">B Lee</name></author><author><name sortKey="Kwon, E" uniqKey="Kwon E">E Kwon</name></author><author><name sortKey="Choi, Sj" uniqKey="Choi S">SJ Choi</name></author><author><name sortKey="Lee, Yh" uniqKey="Lee Y">YH Lee</name></author><author><name sortKey="Song, Gg" uniqKey="Song G">GG Song</name></author><author><name sortKey="Sohn, J" uniqKey="Sohn J">J Sohn</name></author><author><name sortKey="Ji, Jd" uniqKey="Ji J">JD Ji</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sadeghi, K" uniqKey="Sadeghi K">K Sadeghi</name></author><author><name sortKey="Wessner, B" uniqKey="Wessner B">B Wessner</name></author><author><name sortKey="Laggner, U" uniqKey="Laggner U">U Laggner</name></author><author><name sortKey="Ploder, M" uniqKey="Ploder M">M Ploder</name></author><author><name sortKey="Tamandl, D" uniqKey="Tamandl D">D Tamandl</name></author><author><name sortKey="Friedl, J" uniqKey="Friedl J">J Friedl</name></author><author><name sortKey="Zugel, U" uniqKey="Zugel U">U Zugel</name></author><author><name sortKey="Steinmeyer, A" uniqKey="Steinmeyer A">A Steinmeyer</name></author><author><name sortKey="Pollak, A" uniqKey="Pollak A">A Pollak</name></author><author><name sortKey="Roth, E" uniqKey="Roth E">E Roth</name></author><author><name sortKey="Boltz Nitulescu, G" uniqKey="Boltz Nitulescu G">G Boltz-Nitulescu</name></author><author><name sortKey="Spittler, A" uniqKey="Spittler A">A Spittler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Meyer, V" uniqKey="Meyer V">V Meyer</name></author><author><name sortKey="Saccone, Ds" uniqKey="Saccone D">DS Saccone</name></author><author><name sortKey="Tugizimana, F" uniqKey="Tugizimana F">F Tugizimana</name></author><author><name sortKey="Asani, Ff" uniqKey="Asani F">FF Asani</name></author><author><name sortKey="Jeffery, Tj" uniqKey="Jeffery T">TJ Jeffery</name></author><author><name sortKey="Bornman, L" uniqKey="Bornman L">L Bornman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fritsche, J" uniqKey="Fritsche J">J Fritsche</name></author><author><name sortKey="Mondal, K" uniqKey="Mondal K">K Mondal</name></author><author><name sortKey="Ehrnsperger, A" uniqKey="Ehrnsperger A">A Ehrnsperger</name></author><author><name sortKey="Andreesen, R" uniqKey="Andreesen R">R Andreesen</name></author><author><name sortKey="Kreutz, M" uniqKey="Kreutz M">M Kreutz</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dionne, S" uniqKey="Dionne S">S Dionne</name></author><author><name sortKey="Duchatelier, Cf" uniqKey="Duchatelier C">CF Duchatelier</name></author><author><name sortKey="Seidman, Eg" uniqKey="Seidman E">EG Seidman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Zehnder, D" uniqKey="Zehnder D">D Zehnder</name></author><author><name sortKey="Chakraverty, R" uniqKey="Chakraverty R">R Chakraverty</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Penna, G" uniqKey="Penna G">G Penna</name></author><author><name sortKey="Adorini, L" uniqKey="Adorini L">L Adorini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Halteren, Ag" uniqKey="Van Halteren A">AG van Halteren</name></author><author><name sortKey="Tysma, Om" uniqKey="Tysma O">OM Tysma</name></author><author><name sortKey="Van Etten, E" uniqKey="Van Etten E">E van Etten</name></author><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author><author><name sortKey="Roep, Bo" uniqKey="Roep B">BO Roep</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pedersen, Aw" uniqKey="Pedersen A">AW Pedersen</name></author><author><name sortKey="Holmstr M, K" uniqKey="Holmstr M K">K Holmstrøm</name></author><author><name sortKey="Jensen, Ss" uniqKey="Jensen S">SS Jensen</name></author><author><name sortKey="Fuchs, D" uniqKey="Fuchs D">D Fuchs</name></author><author><name sortKey="Rasmussen, S" uniqKey="Rasmussen S">S Rasmussen</name></author><author><name sortKey="Kvistborg, P" uniqKey="Kvistborg P">P Kvistborg</name></author><author><name sortKey="Claesson, Mh" uniqKey="Claesson M">MH Claesson</name></author><author><name sortKey="Zocca, Mb" uniqKey="Zocca M">MB Zocca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Griffin, Md" uniqKey="Griffin M">MD Griffin</name></author><author><name sortKey="Lutz, W" uniqKey="Lutz W">W Lutz</name></author><author><name sortKey="Phan, Va" uniqKey="Phan V">VA Phan</name></author><author><name sortKey="Bachman, La" uniqKey="Bachman L">LA Bachman</name></author><author><name sortKey="Mckean, Dj" uniqKey="Mckean D">DJ McKean</name></author><author><name sortKey="Kumar, R" uniqKey="Kumar R">R Kumar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Willheim, M" uniqKey="Willheim M">M Willheim</name></author><author><name sortKey="Thien, R" uniqKey="Thien R">R Thien</name></author><author><name sortKey="Schrattbauer, K" uniqKey="Schrattbauer K">K Schrattbauer</name></author><author><name sortKey="Bajna, E" uniqKey="Bajna E">E Bajna</name></author><author><name sortKey="Holub, M" uniqKey="Holub M">M Holub</name></author><author><name sortKey="Gruber, R" uniqKey="Gruber R">R Gruber</name></author><author><name sortKey="Baier, K" uniqKey="Baier K">K Baier</name></author><author><name sortKey="Pietschmann, P" uniqKey="Pietschmann P">P Pietschmann</name></author><author><name sortKey="Reinisch, W" uniqKey="Reinisch W">W Reinisch</name></author><author><name sortKey="Scheiner, O" uniqKey="Scheiner O">O Scheiner</name></author><author><name sortKey="Peterlik, M" uniqKey="Peterlik M">M Peterlik</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bartels, Le" uniqKey="Bartels L">LE Bartels</name></author><author><name sortKey="J Rgensen, Sp" uniqKey="J Rgensen S">SP Jørgensen</name></author><author><name sortKey="Agnholt, J" uniqKey="Agnholt J">J Agnholt</name></author><author><name sortKey="Kelsen, J" uniqKey="Kelsen J">J Kelsen</name></author><author><name sortKey="Hvas, Cl" uniqKey="Hvas C">CL Hvas</name></author><author><name sortKey="Dahlerup, Jf" uniqKey="Dahlerup J">JF Dahlerup</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Penna, G" uniqKey="Penna G">G Penna</name></author><author><name sortKey="Adorini, L" uniqKey="Adorini L">L Adorini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Piemonti, L" uniqKey="Piemonti L">L Piemonti</name></author><author><name sortKey="Monti, P" uniqKey="Monti P">P Monti</name></author><author><name sortKey="Sironi, M" uniqKey="Sironi M">M Sironi</name></author><author><name sortKey="Fraticelli, P" uniqKey="Fraticelli P">P Fraticelli</name></author><author><name sortKey="Leone, Be" uniqKey="Leone B">BE Leone</name></author><author><name sortKey="Dal Cin, E" uniqKey="Dal Cin E">E Dal Cin</name></author><author><name sortKey="Allavena, P" uniqKey="Allavena P">P Allavena</name></author><author><name sortKey="Di Carlo, V" uniqKey="Di Carlo V">V Di Carlo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Szeles, L" uniqKey="Szeles L">L Szeles</name></author><author><name sortKey="Keresztes, G" uniqKey="Keresztes G">G Keresztes</name></author><author><name sortKey="Torocsik, D" uniqKey="Torocsik D">D Torocsik</name></author><author><name sortKey="Balajthy, Z" uniqKey="Balajthy Z">Z Balajthy</name></author><author><name sortKey="Krenacs, L" uniqKey="Krenacs L">L Krenacs</name></author><author><name sortKey="Poliska, S" uniqKey="Poliska S">S Poliska</name></author><author><name sortKey="Steinmeyer, A" uniqKey="Steinmeyer A">A Steinmeyer</name></author><author><name sortKey="Zuegel, U" uniqKey="Zuegel U">U Zuegel</name></author><author><name sortKey="Pruenster, M" uniqKey="Pruenster M">M Pruenster</name></author><author><name sortKey="Rot, A" uniqKey="Rot A">A Rot</name></author><author><name sortKey="Nagy, L" uniqKey="Nagy L">L Nagy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bhalla, Ak" uniqKey="Bhalla A">AK Bhalla</name></author><author><name sortKey="Amento, Ep" uniqKey="Amento E">EP Amento</name></author><author><name sortKey="Clemens, Tl" uniqKey="Clemens T">TL Clemens</name></author><author><name sortKey="Holick, Mf" uniqKey="Holick M">MF Holick</name></author><author><name sortKey="Krane, Sm" uniqKey="Krane S">SM Krane</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Provvedini, Dm" uniqKey="Provvedini D">DM Provvedini</name></author><author><name sortKey="Tsoukas, Cd" uniqKey="Tsoukas C">CD Tsoukas</name></author><author><name sortKey="Deftos, Lj" uniqKey="Deftos L">LJ Deftos</name></author><author><name sortKey="Manolagas, Sc" uniqKey="Manolagas S">SC Manolagas</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sarkar, S" uniqKey="Sarkar S">S Sarkar</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Studzinski, Gp" uniqKey="Studzinski G">GP Studzinski</name></author><author><name sortKey="Li, Yc" uniqKey="Li Y">YC Li</name></author><author><name sortKey="Kalia, V" uniqKey="Kalia V">V Kalia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cantorna, Mt" uniqKey="Cantorna M">MT Cantorna</name></author><author><name sortKey="Snyder, L" uniqKey="Snyder L">L Snyder</name></author><author><name sortKey="Lin, Y D" uniqKey="Lin Y">Y-D Lin</name></author><author><name sortKey="Yang, L" uniqKey="Yang L">L Yang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Joshi, S" uniqKey="Joshi S">S Joshi</name></author><author><name sortKey="Pantalena, Lc" uniqKey="Pantalena L">LC Pantalena</name></author><author><name sortKey="Liu, Xk" uniqKey="Liu X">XK Liu</name></author><author><name sortKey="Gaffen, Sl" uniqKey="Gaffen S">SL Gaffen</name></author><author><name sortKey="Liu, H" uniqKey="Liu H">H Liu</name></author><author><name sortKey="Rohowsky Kochan, C" uniqKey="Rohowsky Kochan C">C Rohowsky-Kochan</name></author><author><name sortKey="Ichiyama, K" uniqKey="Ichiyama K">K Ichiyama</name></author><author><name sortKey="Yoshimura, A" uniqKey="Yoshimura A">A Yoshimura</name></author><author><name sortKey="Steinman, L" uniqKey="Steinman L">L Steinman</name></author><author><name sortKey="Christakos, S" uniqKey="Christakos S">S Christakos</name></author><author><name sortKey="Youssef, S" uniqKey="Youssef S">S Youssef</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cantorna, Mt" uniqKey="Cantorna M">MT Cantorna</name></author><author><name sortKey="Nashold, Fe" uniqKey="Nashold F">FE Nashold</name></author><author><name sortKey="Chun, Ty" uniqKey="Chun T">TY Chun</name></author><author><name sortKey="Hayes, Ce" uniqKey="Hayes C">CE Hayes</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Boonstra, A" uniqKey="Boonstra A">A Boonstra</name></author><author><name sortKey="Barrat, Fj" uniqKey="Barrat F">FJ Barrat</name></author><author><name sortKey="Crain, C" uniqKey="Crain C">C Crain</name></author><author><name sortKey="Heath, Vl" uniqKey="Heath V">VL Heath</name></author><author><name sortKey="Savelkoul, Hf" uniqKey="Savelkoul H">HF Savelkoul</name></author><author><name sortKey="O Arra, A" uniqKey="O Arra A">A O’Garra</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Barrat, Fj" uniqKey="Barrat F">FJ Barrat</name></author><author><name sortKey="Cua, Dj" uniqKey="Cua D">DJ Cua</name></author><author><name sortKey="Boonstra, A" uniqKey="Boonstra A">A Boonstra</name></author><author><name sortKey="Richards, Df" uniqKey="Richards D">DF Richards</name></author><author><name sortKey="Crain, C" uniqKey="Crain C">C Crain</name></author><author><name sortKey="Savelkoul, Hf" uniqKey="Savelkoul H">HF Savelkoul</name></author><author><name sortKey="De Waal Malefyt, R" uniqKey="De Waal Malefyt R">R de Waal-Malefyt</name></author><author><name sortKey="Coffman, Rl" uniqKey="Coffman R">RL Coffman</name></author><author><name sortKey="Hawrylowicz, Cm" uniqKey="Hawrylowicz C">CM Hawrylowicz</name></author><author><name sortKey="O Arra, A" uniqKey="O Arra A">A O’Garra</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Burke, F" uniqKey="Burke F">F Burke</name></author><author><name sortKey="Mura, M" uniqKey="Mura M">M Mura</name></author><author><name sortKey="Zheng, Y" uniqKey="Zheng Y">Y Zheng</name></author><author><name sortKey="Qureshi, Os" uniqKey="Qureshi O">OS Qureshi</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Walker, Ls" uniqKey="Walker L">LS Walker</name></author><author><name sortKey="Lammas, Da" uniqKey="Lammas D">DA Lammas</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Von Essen, Mr" uniqKey="Von Essen M">MR von Essen</name></author><author><name sortKey="Kongsbak, M" uniqKey="Kongsbak M">M Kongsbak</name></author><author><name sortKey="Schjerling, P" uniqKey="Schjerling P">P Schjerling</name></author><author><name sortKey="Olgaard, K" uniqKey="Olgaard K">K Olgaard</name></author><author><name sortKey="Odum, N" uniqKey="Odum N">N Odum</name></author><author><name sortKey="Geisler, C" uniqKey="Geisler C">C Geisler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Merino, F" uniqKey="Merino F">F Merino</name></author><author><name sortKey="Alvarez Mon, M" uniqKey="Alvarez Mon M">M Alvarez-Mon</name></author><author><name sortKey="De La Hera, A" uniqKey="De La Hera A">A de la Hera</name></author><author><name sortKey="Ales, Je" uniqKey="Ales J">JE Ales</name></author><author><name sortKey="Bonilla, F" uniqKey="Bonilla F">F Bonilla</name></author><author><name sortKey="Durantez, A" uniqKey="Durantez A">A Durantez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yu, S" uniqKey="Yu S">S Yu</name></author><author><name sortKey="Cantorna, Mt" uniqKey="Cantorna M">MT Cantorna</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Muller, K" uniqKey="Muller K">K Muller</name></author><author><name sortKey="Heilmann, C" uniqKey="Heilmann C">C Heilmann</name></author><author><name sortKey="Poulsen, Lk" uniqKey="Poulsen L">LK Poulsen</name></author><author><name sortKey="Barington, T" uniqKey="Barington T">T Barington</name></author><author><name sortKey="Bendtzen, K" uniqKey="Bendtzen K">K Bendtzen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Chen, S" uniqKey="Chen S">S Chen</name></author><author><name sortKey="Sims, Gp" uniqKey="Sims G">GP Sims</name></author><author><name sortKey="Chen, Xx" uniqKey="Chen X">XX Chen</name></author><author><name sortKey="Gu, Yy" uniqKey="Gu Y">YY Gu</name></author><author><name sortKey="Chen, S" uniqKey="Chen S">S Chen</name></author><author><name sortKey="Lipsky, Pe" uniqKey="Lipsky P">PE Lipsky</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Heine, G" uniqKey="Heine G">G Heine</name></author><author><name sortKey="Niesner, U" uniqKey="Niesner U">U Niesner</name></author><author><name sortKey="Chang, Hd" uniqKey="Chang H">HD Chang</name></author><author><name sortKey="Steinmeyer, A" uniqKey="Steinmeyer A">A Steinmeyer</name></author><author><name sortKey="Zugel, U" uniqKey="Zugel U">U Zugel</name></author><author><name sortKey="Zuberbier, T" uniqKey="Zuberbier T">T Zuberbier</name></author><author><name sortKey="Radbruch, A" uniqKey="Radbruch A">A Radbruch</name></author><author><name sortKey="Worm, M" uniqKey="Worm M">M Worm</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shirakawa, Ak" uniqKey="Shirakawa A">AK Shirakawa</name></author><author><name sortKey="Nagakubo, D" uniqKey="Nagakubo D">D Nagakubo</name></author><author><name sortKey="Hieshima, K" uniqKey="Hieshima K">K Hieshima</name></author><author><name sortKey="Nakayama, T" uniqKey="Nakayama T">T Nakayama</name></author><author><name sortKey="Jin, Z" uniqKey="Jin Z">Z Jin</name></author><author><name sortKey="Yoshie, O" uniqKey="Yoshie O">O Yoshie</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hufnaql, K" uniqKey="Hufnaql K">K Hufnaql</name></author><author><name sortKey="Jensen Jarolim, E" uniqKey="Jensen Jarolim E">E Jensen-Jarolim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Anaya, Jm" uniqKey="Anaya J">JM Anaya</name></author><author><name sortKey="Restrepo Jimenez, P" uniqKey="Restrepo Jimenez P">P Restrepo-Jiménez</name></author><author><name sortKey="Ramirez Santana, C" uniqKey="Ramirez Santana C">C Ramírez-Santana</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nikiphorou, E" uniqKey="Nikiphorou E">E Nikiphorou</name></author><author><name sortKey="Uksila, J" uniqKey="Uksila J">J Uksila</name></author><author><name sortKey="Sokka, T" uniqKey="Sokka T">T Sokka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lucas, R" uniqKey="Lucas R">R Lucas</name></author><author><name sortKey="Rodney Harris, R" uniqKey="Rodney Harris R">R Rodney Harris</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Disanto, G" uniqKey="Disanto G">G Disanto</name></author><author><name sortKey="Chaplin, G" uniqKey="Chaplin G">G Chaplin</name></author><author><name sortKey="Morahan, Jm" uniqKey="Morahan J">JM Morahan</name></author><author><name sortKey="Giovannoni, G" uniqKey="Giovannoni G">G Giovannoni</name></author><author><name sortKey="Hypponen, E" uniqKey="Hypponen E">E Hypponen</name></author><author><name sortKey="Ebers, Gc" uniqKey="Ebers G">GC Ebers</name></author><author><name sortKey="Ramagopalan, Sv" uniqKey="Ramagopalan S">SV Ramagopalan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Harroud, A" uniqKey="Harroud A">A Harroud</name></author><author><name sortKey="Richards, Jb" uniqKey="Richards J">JB Richards</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mokry, Le" uniqKey="Mokry L">LE Mokry</name></author><author><name sortKey="Ross, S" uniqKey="Ross S">S Ross</name></author><author><name sortKey="Ahmad, Os" uniqKey="Ahmad O">OS Ahmad</name></author><author><name sortKey="Forgetta, V" uniqKey="Forgetta V">V Forgetta</name></author><author><name sortKey="Smith, Gd" uniqKey="Smith G">GD Smith</name></author><author><name sortKey="Goltzman, D" uniqKey="Goltzman D">D Goltzman</name></author><author><name sortKey="Leong, A" uniqKey="Leong A">A Leong</name></author><author><name sortKey="Greenwood, Cm" uniqKey="Greenwood C">CM Greenwood</name></author><author><name sortKey="Thanassoulis, G" uniqKey="Thanassoulis G">G Thanassoulis</name></author><author><name sortKey="Richards, Jb" uniqKey="Richards J">JB Richards</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Krementsov, Dn" uniqKey="Krementsov D">DN Krementsov</name></author><author><name sortKey="Asarian, L" uniqKey="Asarian L">L Asarian</name></author><author><name sortKey="Fang, Q" uniqKey="Fang Q">Q Fang</name></author><author><name sortKey="Mcgill, Mm" uniqKey="Mcgill M">MM McGill</name></author><author><name sortKey="Teuscher, C" uniqKey="Teuscher C">C Teuscher</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kamisli, O" uniqKey="Kamisli O">O Kamisli</name></author><author><name sortKey="Acar, C" uniqKey="Acar C">C Acar</name></author><author><name sortKey="Sozen, M" uniqKey="Sozen M">M Sozen</name></author><author><name sortKey="Tecellioglu, M" uniqKey="Tecellioglu M">M Tecellioglu</name></author><author><name sortKey="Yucel, Fe" uniqKey="Yucel F">FE Yücel</name></author><author><name sortKey="Vaizoglu, D" uniqKey="Vaizoglu D">D Vaizoglu</name></author><author><name sortKey="Ozcan, C" uniqKey="Ozcan C">C Özcan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="K Enek, P" uniqKey="K Enek P">P Křenek</name></author><author><name sortKey="Benesova, Y" uniqKey="Benesova Y">Y Benešová</name></author><author><name sortKey="Bienertova Vasku, J" uniqKey="Bienertova Vasku J">J Bienertová-Vašků</name></author><author><name sortKey="Vasku, A" uniqKey="Vasku A">A Vašků</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kouchaki, E" uniqKey="Kouchaki E">E Kouchaki</name></author><author><name sortKey="Afarini, M" uniqKey="Afarini M">M Afarini</name></author><author><name sortKey="Abolhassani, J" uniqKey="Abolhassani J">J Abolhassani</name></author><author><name sortKey="Mirhosseini, N" uniqKey="Mirhosseini N">N Mirhosseini</name></author><author><name sortKey="Bahmani, F" uniqKey="Bahmani F">F Bahmani</name></author><author><name sortKey="Masoud, Sa" uniqKey="Masoud S">SA Masoud</name></author><author><name sortKey="Asemi, Z" uniqKey="Asemi Z">Z Asemi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rolf, L" uniqKey="Rolf L">L Rolf</name></author><author><name sortKey="Muris, Ag" uniqKey="Muris A">AG Muris</name></author><author><name sortKey="Theunissen, R" uniqKey="Theunissen R">R Theunissen</name></author><author><name sortKey="Hupperts, R" uniqKey="Hupperts R">R Hupperts</name></author><author><name sortKey="Damoiseaux, J" uniqKey="Damoiseaux J">J Damoiseaux</name></author><author><name sortKey="Smolders, J" uniqKey="Smolders J">J Smolders</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Miclea, A" uniqKey="Miclea A">A Miclea</name></author><author><name sortKey="Miclea, M" uniqKey="Miclea M">M Miclea</name></author><author><name sortKey="Pistor, M" uniqKey="Pistor M">M Pistor</name></author><author><name sortKey="Hoepner, A" uniqKey="Hoepner A">A Hoepner</name></author><author><name sortKey="Chan, A" uniqKey="Chan A">A Chan</name></author><author><name sortKey="Hoepner, R" uniqKey="Hoepner R">R Hoepner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rosjo, E" uniqKey="Rosjo E">E Rosjo</name></author><author><name sortKey="Lossius, A" uniqKey="Lossius A">A Lossius</name></author><author><name sortKey="Abdelmagid, N" uniqKey="Abdelmagid N">N Abdelmagid</name></author><author><name sortKey="Lindstrom, Jc" uniqKey="Lindstrom J">JC Lindstrom</name></author><author><name sortKey="Kampman, Mt" uniqKey="Kampman M">MT Kampman</name></author><author><name sortKey="Jorgensen, L" uniqKey="Jorgensen L">L Jorgensen</name></author><author><name sortKey="Sundstrom, P" uniqKey="Sundstrom P">P Sundstrom</name></author><author><name sortKey="Olsson, T" uniqKey="Olsson T">T Olsson</name></author><author><name sortKey="Steffensen, Lh" uniqKey="Steffensen L">LH Steffensen</name></author><author><name sortKey="Torkildsen, O" uniqKey="Torkildsen O">O Torkildsen</name></author><author><name sortKey="Holmoy, T" uniqKey="Holmoy T">T Holmoy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rosjo, E" uniqKey="Rosjo E">E Rosjo</name></author><author><name sortKey="Steffensen, Lh" uniqKey="Steffensen L">LH Steffensen</name></author><author><name sortKey="Jorgensen, L" uniqKey="Jorgensen L">L Jorgensen</name></author><author><name sortKey="Lindstrom, Jc" uniqKey="Lindstrom J">JC Lindstrom</name></author><author><name sortKey="Saltyte Benth, J" uniqKey="Saltyte Benth J">J Saltyte Benth</name></author><author><name sortKey="Michelsen, Ae" uniqKey="Michelsen A">AE Michelsen</name></author><author><name sortKey="Aukrust, P" uniqKey="Aukrust P">P Aukrust</name></author><author><name sortKey="Ueland, T" uniqKey="Ueland T">T Ueland</name></author><author><name sortKey="Kampman, Mt" uniqKey="Kampman M">MT Kampman</name></author><author><name sortKey="Torkildsen, O" uniqKey="Torkildsen O">O Torkildsen</name></author><author><name sortKey="Holmoy, T" uniqKey="Holmoy T">T Holmoy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bae, Sc" uniqKey="Bae S">SC Bae</name></author><author><name sortKey="Lee, Yh" uniqKey="Lee Y">YH Lee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zhao, M" uniqKey="Zhao M">M Zhao</name></author><author><name sortKey="Duan, X H" uniqKey="Duan X">X-H Duan</name></author><author><name sortKey="Wu, Z Z" uniqKey="Wu Z">Z-Z Wu</name></author><author><name sortKey="Gao, C C" uniqKey="Gao C">C-C Gao</name></author><author><name sortKey="Wang, N" uniqKey="Wang N">N Wang</name></author><author><name sortKey="Zheng, Z H" uniqKey="Zheng Z">Z-H Zheng</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abdel Galil, Sm" uniqKey="Abdel Galil S">SM Abdel Galil</name></author><author><name sortKey="El Shafey, Am" uniqKey="El Shafey A">AM El-Shafey</name></author><author><name sortKey="Abdul Makoud, Rs" uniqKey="Abdul Makoud R">RS Abdul-Makoud</name></author><author><name sortKey="El Boshy, M" uniqKey="El Boshy M">M El-Boshy</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Shahin, D" uniqKey="Shahin D">D Shahin</name></author><author><name sortKey="El Farahaty, Rm" uniqKey="El Farahaty R">RM El-Farahaty</name></author><author><name sortKey="Houssen, Me" uniqKey="Houssen M">ME Houssen</name></author><author><name sortKey="Machaly, Sa" uniqKey="Machaly S">SA Machaly</name></author><author><name sortKey="Sallam, M" uniqKey="Sallam M">M Sallam</name></author><author><name sortKey="Elsaid, To" uniqKey="Elsaid T">TO ElSaid</name></author><author><name sortKey="Neseem, No" uniqKey="Neseem N">NO Neseem</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Aranow, C" uniqKey="Aranow C">C Aranow</name></author><author><name sortKey="Kamen, Dl" uniqKey="Kamen D">DL Kamen</name></author><author><name sortKey="Dall Ra, M" uniqKey="Dall Ra M">M Dall’Era</name></author><author><name sortKey="Massarotti, Em" uniqKey="Massarotti E">EM Massarotti</name></author><author><name sortKey="Mackay, Mc" uniqKey="Mackay M">MC Mackay</name></author><author><name sortKey="Koumpouras, F" uniqKey="Koumpouras F">F Koumpouras</name></author><author><name sortKey="Coca, A" uniqKey="Coca A">A Coca</name></author><author><name sortKey="Chatham, Ww" uniqKey="Chatham W">WW Chatham</name></author><author><name sortKey="Clowse, Me" uniqKey="Clowse M">ME Clowse</name></author><author><name sortKey="Criscione Schreiber, Lg" uniqKey="Criscione Schreiber L">LG Criscione-Schreiber</name></author><author><name sortKey="Callahan, S" uniqKey="Callahan S">S Callahan</name></author><author><name sortKey="Goldmuntz, Ea" uniqKey="Goldmuntz E">EA Goldmuntz</name></author><author><name sortKey="Keyes Elstein, L" uniqKey="Keyes Elstein L">L Keyes-Elstein</name></author><author><name sortKey="Oswald, M" uniqKey="Oswald M">M Oswald</name></author><author><name sortKey="Gregersen, Pk" uniqKey="Gregersen P">PK Gregersen</name></author><author><name sortKey="Diamond, B" uniqKey="Diamond B">B Diamond</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Karimzadeh, H" uniqKey="Karimzadeh H">H Karimzadeh</name></author><author><name sortKey="Shirzadi, M" uniqKey="Shirzadi M">M Shirzadi</name></author><author><name sortKey="Karimifar, M" uniqKey="Karimifar M">M Karimifar</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Costenbader, Kh" uniqKey="Costenbader K">KH Costenbader</name></author><author><name sortKey="Feskanich, D" uniqKey="Feskanich D">D Feskanich</name></author><author><name sortKey="Holmes, M" uniqKey="Holmes M">M Holmes</name></author><author><name sortKey="Karlson, Ew" uniqKey="Karlson E">EW Karlson</name></author><author><name sortKey="Benito Garcia, E" uniqKey="Benito Garcia E">E Benito-Garcia</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lima, Gl" uniqKey="Lima G">GL Lima</name></author><author><name sortKey="Paupitz, J" uniqKey="Paupitz J">J Paupitz</name></author><author><name sortKey="Aikawa, Ne" uniqKey="Aikawa N">NE Aikawa</name></author><author><name sortKey="Takayama, L" uniqKey="Takayama L">L Takayama</name></author><author><name sortKey="Bonfa, E" uniqKey="Bonfa E">E Bonfa</name></author><author><name sortKey="Pereira, Rm" uniqKey="Pereira R">RM Pereira</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Zella, Jb" uniqKey="Zella J">JB Zella</name></author><author><name sortKey="Deluca, Hf" uniqKey="Deluca H">HF DeLuca</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author><author><name sortKey="Badenhoop, K" uniqKey="Badenhoop K">K Badenhoop</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Aljabri, Ks" uniqKey="Aljabri K">KS Aljabri</name></author><author><name sortKey="Bokhari, Sa" uniqKey="Bokhari S">SA Bokhari</name></author><author><name sortKey="Khan, Mj" uniqKey="Khan M">MJ Khan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bailey, R" uniqKey="Bailey R">R Bailey</name></author><author><name sortKey="Cooper, Jd" uniqKey="Cooper J">JD Cooper</name></author><author><name sortKey="Zeitels, L" uniqKey="Zeitels L">L Zeitels</name></author><author><name sortKey="Smyth, Dj" uniqKey="Smyth D">DJ Smyth</name></author><author><name sortKey="Yang, Jh" uniqKey="Yang J">JH Yang</name></author><author><name sortKey="Walker, Nm" uniqKey="Walker N">NM Walker</name></author><author><name sortKey="Hypponen, E" uniqKey="Hypponen E">E Hypponen</name></author><author><name sortKey="Dunger, Db" uniqKey="Dunger D">DB Dunger</name></author><author><name sortKey="Ramos Lopez, E" uniqKey="Ramos Lopez E">E Ramos-Lopez</name></author><author><name sortKey="Badenhoop, K" uniqKey="Badenhoop K">K Badenhoop</name></author><author><name sortKey="Nejentsev, S" uniqKey="Nejentsev S">S Nejentsev</name></author><author><name sortKey="Todd, Ja" uniqKey="Todd J">JA Todd</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cooper, Jd" uniqKey="Cooper J">JD Cooper</name></author><author><name sortKey="Smyth, Dj" uniqKey="Smyth D">DJ Smyth</name></author><author><name sortKey="Walker, Nm" uniqKey="Walker N">NM Walker</name></author><author><name sortKey="Stevens, H" uniqKey="Stevens H">H Stevens</name></author><author><name sortKey="Burren, Os" uniqKey="Burren O">OS Burren</name></author><author><name sortKey="Wallace, C" uniqKey="Wallace C">C Wallace</name></author><author><name sortKey="Greissl, C" uniqKey="Greissl C">C Greissl</name></author><author><name sortKey="Ramos Lopez, E" uniqKey="Ramos Lopez E">E Ramos-Lopez</name></author><author><name sortKey="Hypponen, E" uniqKey="Hypponen E">E Hypponen</name></author><author><name sortKey="Dunger, Db" uniqKey="Dunger D">DB Dunger</name></author><author><name sortKey="Spector, Td" uniqKey="Spector T">TD Spector</name></author><author><name sortKey="Ouwehand, Wh" uniqKey="Ouwehand W">WH Ouwehand</name></author><author><name sortKey="Wang, Tj" uniqKey="Wang T">TJ Wang</name></author><author><name sortKey="Badenhoop, K" uniqKey="Badenhoop K">K Badenhoop</name></author><author><name sortKey="Todd, Ja" uniqKey="Todd J">JA Todd</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lopez, Er" uniqKey="Lopez E">ER Lopez</name></author><author><name sortKey="Regulla, K" uniqKey="Regulla K">K Regulla</name></author><author><name sortKey="Pani, Ma" uniqKey="Pani M">MA Pani</name></author><author><name sortKey="Krause, M" uniqKey="Krause M">M Krause</name></author><author><name sortKey="Usadel, Kh" uniqKey="Usadel K">KH Usadel</name></author><author><name sortKey="Badenhoop, K" uniqKey="Badenhoop K">K Badenhoop</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ramos Lopez, E" uniqKey="Ramos Lopez E">E Ramos-Lopez</name></author><author><name sortKey="Jansen, T" uniqKey="Jansen T">T Jansen</name></author><author><name sortKey="Ivaskevicius, V" uniqKey="Ivaskevicius V">V Ivaskevicius</name></author><author><name sortKey="Kahles, H" uniqKey="Kahles H">H Kahles</name></author><author><name sortKey="Klepzig, C" uniqKey="Klepzig C">C Klepzig</name></author><author><name sortKey="Oldenburg, J" uniqKey="Oldenburg J">J Oldenburg</name></author><author><name sortKey="Badenhoop, K" uniqKey="Badenhoop K">K Badenhoop</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ramagopalan, Sv" uniqKey="Ramagopalan S">SV Ramagopalan</name></author><author><name sortKey="Heger, A" uniqKey="Heger A">A Heger</name></author><author><name sortKey="Berlanga, Aj" uniqKey="Berlanga A">AJ Berlanga</name></author><author><name sortKey="Maugeri, Nj" uniqKey="Maugeri N">NJ Maugeri</name></author><author><name sortKey="Lincoln, Mr" uniqKey="Lincoln M">MR Lincoln</name></author><author><name sortKey="Burrell, A" uniqKey="Burrell A">A Burrell</name></author><author><name sortKey="Handunnetthi, L" uniqKey="Handunnetthi L">L Handunnetthi</name></author><author><name sortKey="Handel, Ae" uniqKey="Handel A">AE Handel</name></author><author><name sortKey="Disanto, G" uniqKey="Disanto G">G Disanto</name></author><author><name sortKey="Orton, Sm" uniqKey="Orton S">SM Orton</name></author><author><name sortKey="Watson, Ct" uniqKey="Watson C">CT Watson</name></author><author><name sortKey="Morahan, Jm" uniqKey="Morahan J">JM Morahan</name></author><author><name sortKey="Giovannoni, G" uniqKey="Giovannoni G">G Giovannoni</name></author><author><name sortKey="Ponting, Cp" uniqKey="Ponting C">CP Ponting</name></author><author><name sortKey="Ebers, Gc" uniqKey="Ebers G">GC Ebers</name></author><author><name sortKey="Knight, Jc" uniqKey="Knight J">JC Knight</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author><author><name sortKey="Waer, M" uniqKey="Waer M">M Waer</name></author><author><name sortKey="Laureys, J" uniqKey="Laureys J">J Laureys</name></author><author><name sortKey="Rutgeerts, O" uniqKey="Rutgeerts O">O Rutgeerts</name></author><author><name sortKey="Bouillon, R" uniqKey="Bouillon R">R Bouillon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, X" uniqKey="Li X">X Li</name></author><author><name sortKey="Liao, L" uniqKey="Liao L">L Liao</name></author><author><name sortKey="Yan, X" uniqKey="Yan X">X Yan</name></author><author><name sortKey="Huang, G" uniqKey="Huang G">G Huang</name></author><author><name sortKey="Lin, J" uniqKey="Lin J">J Lin</name></author><author><name sortKey="Lei, M" uniqKey="Lei M">M Lei</name></author><author><name sortKey="Wang, X" uniqKey="Wang X">X Wang</name></author><author><name sortKey="Zhou, Z" uniqKey="Zhou Z">Z Zhou</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gabbay, Ma" uniqKey="Gabbay M">MA Gabbay</name></author><author><name sortKey="Sato, Mn" uniqKey="Sato M">MN Sato</name></author><author><name sortKey="Finazzo, C" uniqKey="Finazzo C">C Finazzo</name></author><author><name sortKey="Duarte, Aj" uniqKey="Duarte A">AJ Duarte</name></author><author><name sortKey="Dib, Sa" uniqKey="Dib S">SA Dib</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ataie Jafari, A" uniqKey="Ataie Jafari A">A Ataie-Jafari</name></author><author><name sortKey="Loke, Sc" uniqKey="Loke S">SC Loke</name></author><author><name sortKey="Rahmat, Ab" uniqKey="Rahmat A">AB Rahmat</name></author><author><name sortKey="Larijani, B" uniqKey="Larijani B">B Larijani</name></author><author><name sortKey="Abbasi, F" uniqKey="Abbasi F">F Abbasi</name></author><author><name sortKey="Leow, Mk" uniqKey="Leow M">MK Leow</name></author><author><name sortKey="Yassin, Z" uniqKey="Yassin Z">Z Yassin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bizzarri, C" uniqKey="Bizzarri C">C Bizzarri</name></author><author><name sortKey="Pitocco, D" uniqKey="Pitocco D">D Pitocco</name></author><author><name sortKey="Napoli, N" uniqKey="Napoli N">N Napoli</name></author><author><name sortKey="Di Stasio, E" uniqKey="Di Stasio E">E Di Stasio</name></author><author><name sortKey="Maggi, D" uniqKey="Maggi D">D Maggi</name></author><author><name sortKey="Manfrini, S" uniqKey="Manfrini S">S Manfrini</name></author><author><name sortKey="Suraci, C" uniqKey="Suraci C">C Suraci</name></author><author><name sortKey="Cavallo, Mg" uniqKey="Cavallo M">MG Cavallo</name></author><author><name sortKey="Cappa, M" uniqKey="Cappa M">M Cappa</name></author><author><name sortKey="Ghirlanda, G" uniqKey="Ghirlanda G">G Ghirlanda</name></author><author><name sortKey="Pozzilli, P" uniqKey="Pozzilli P">P Pozzilli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Walter, M" uniqKey="Walter M">M Walter</name></author><author><name sortKey="Kaupper, T" uniqKey="Kaupper T">T Kaupper</name></author><author><name sortKey="Adler, K" uniqKey="Adler K">K Adler</name></author><author><name sortKey="Foersch, J" uniqKey="Foersch J">J Foersch</name></author><author><name sortKey="Bonifacio, E" uniqKey="Bonifacio E">E Bonifacio</name></author><author><name sortKey="Ziegler, Ag" uniqKey="Ziegler A">AG Ziegler</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ananthakrishnan, An" uniqKey="Ananthakrishnan A">AN Ananthakrishnan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ham, M" uniqKey="Ham M">M Ham</name></author><author><name sortKey="Longhi, Ms" uniqKey="Longhi M">MS Longhi</name></author><author><name sortKey="Lahiff, C" uniqKey="Lahiff C">C Lahiff</name></author><author><name sortKey="Cheifetz, A" uniqKey="Cheifetz A">A Cheifetz</name></author><author><name sortKey="Robson, S" uniqKey="Robson S">S Robson</name></author><author><name sortKey="Moss, Ac" uniqKey="Moss A">AC Moss</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="J Rgensen, Sp" uniqKey="J Rgensen S">SP Jørgensen</name></author><author><name sortKey="Hvas, Cl" uniqKey="Hvas C">CL Hvas</name></author><author><name sortKey="Agnholt, J" uniqKey="Agnholt J">J Agnholt</name></author><author><name sortKey="Christensen, La" uniqKey="Christensen L">LA Christensen</name></author><author><name sortKey="Heickendorff, L" uniqKey="Heickendorff L">L Heickendorff</name></author><author><name sortKey="Dahlerup, Jf" uniqKey="Dahlerup J">JF Dahlerup</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mohammad, Ms" uniqKey="Mohammad M">MS Mohammad</name></author><author><name sortKey="Mayberry, J" uniqKey="Mayberry J">J Mayberry</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Froicu, M" uniqKey="Froicu M">M Froicu</name></author><author><name sortKey="Weaver, V" uniqKey="Weaver V">V Weaver</name></author><author><name sortKey="Wynn, Ta" uniqKey="Wynn T">TA Wynn</name></author><author><name sortKey="Mcdowell, Ma" uniqKey="Mcdowell M">MA McDowell</name></author><author><name sortKey="Welsh, Je" uniqKey="Welsh J">JE Welsh</name></author><author><name sortKey="Cantorna, Mt" uniqKey="Cantorna M">MT Cantorna</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, N" uniqKey="Liu N">N Liu</name></author><author><name sortKey="Nguyen, L" uniqKey="Nguyen L">L Nguyen</name></author><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Lagishetty, V" uniqKey="Lagishetty V">V Lagishetty</name></author><author><name sortKey="Ren, S" uniqKey="Ren S">S Ren</name></author><author><name sortKey="Wu, S" uniqKey="Wu S">S Wu</name></author><author><name sortKey="Hollis, B" uniqKey="Hollis B">B Hollis</name></author><author><name sortKey="Deluca, Hf" uniqKey="Deluca H">HF DeLuca</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lagishetty, V" uniqKey="Lagishetty V">V Lagishetty</name></author><author><name sortKey="Misharin, Av" uniqKey="Misharin A">AV Misharin</name></author><author><name sortKey="Liu, Nq" uniqKey="Liu N">NQ Liu</name></author><author><name sortKey="Lisse, Ts" uniqKey="Lisse T">TS Lisse</name></author><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Ouyang, Y" uniqKey="Ouyang Y">Y Ouyang</name></author><author><name sortKey="Mclachlan, Sm" uniqKey="Mclachlan S">SM McLachlan</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Liu, W" uniqKey="Liu W">W Liu</name></author><author><name sortKey="Chen, Y" uniqKey="Chen Y">Y Chen</name></author><author><name sortKey="Golan, Ma" uniqKey="Golan M">MA Golan</name></author><author><name sortKey="Annunziata, Ml" uniqKey="Annunziata M">ML Annunziata</name></author><author><name sortKey="Du, J" uniqKey="Du J">J Du</name></author><author><name sortKey="Dougherty, U" uniqKey="Dougherty U">U Dougherty</name></author><author><name sortKey="Kong, J" uniqKey="Kong J">J Kong</name></author><author><name sortKey="Musch, M" uniqKey="Musch M">M Musch</name></author><author><name sortKey="Huang, Y" uniqKey="Huang Y">Y Huang</name></author><author><name sortKey="Pekow, J" uniqKey="Pekow J">J Pekow</name></author><author><name sortKey="Zheng, C" uniqKey="Zheng C">C Zheng</name></author><author><name sortKey="Bissonnette, M" uniqKey="Bissonnette M">M Bissonnette</name></author><author><name sortKey="Hanauer, Sb" uniqKey="Hanauer S">SB Hanauer</name></author><author><name sortKey="Li, Yc" uniqKey="Li Y">YC Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="England, Br" uniqKey="England B">BR England</name></author><author><name sortKey="Thiele, Gm" uniqKey="Thiele G">GM Thiele</name></author><author><name sortKey="Anderson, Dr" uniqKey="Anderson D">DR Anderson</name></author><author><name sortKey="Mikuls, Tr" uniqKey="Mikuls T">TR Mikuls</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tobon, Gj" uniqKey="Tobon G">GJ Tobon</name></author><author><name sortKey="Youinou, P" uniqKey="Youinou P">P Youinou</name></author><author><name sortKey="Saraux, A" uniqKey="Saraux A">A Saraux</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kim, K" uniqKey="Kim K">K Kim</name></author><author><name sortKey="Bang, Sy" uniqKey="Bang S">SY Bang</name></author><author><name sortKey="Lee, Hs" uniqKey="Lee H">HS Lee</name></author><author><name sortKey="Cho, Sk" uniqKey="Cho S">SK Cho</name></author><author><name sortKey="Choi, Cb" uniqKey="Choi C">CB Choi</name></author><author><name sortKey="Sung, Yk" uniqKey="Sung Y">YK Sung</name></author><author><name sortKey="Kim, Th" uniqKey="Kim T">TH Kim</name></author><author><name sortKey="Jun, Jb" uniqKey="Jun J">JB Jun</name></author><author><name sortKey="Yoo, Dh" uniqKey="Yoo D">DH Yoo</name></author><author><name sortKey="Kang, Ym" uniqKey="Kang Y">YM Kang</name></author><author><name sortKey="Kim, Sk" uniqKey="Kim S">SK Kim</name></author><author><name sortKey="Suh, Ch" uniqKey="Suh C">CH Suh</name></author><author><name sortKey="Shim, Sc" uniqKey="Shim S">SC Shim</name></author><author><name sortKey="Lee, Ss" uniqKey="Lee S">SS Lee</name></author><author><name sortKey="Lee, J" uniqKey="Lee J">J Lee</name></author><author><name sortKey="Chung, Wt" uniqKey="Chung W">WT Chung</name></author><author><name sortKey="Choe, Jy" uniqKey="Choe J">JY Choe</name></author><author><name sortKey="Shin, Hd" uniqKey="Shin H">HD Shin</name></author><author><name sortKey="Lee, Jy" uniqKey="Lee J">JY Lee</name></author><author><name sortKey="Han, Bg" uniqKey="Han B">BG Han</name></author><author><name sortKey="Nath, Sk" uniqKey="Nath S">SK Nath</name></author><author><name sortKey="Eyre, S" uniqKey="Eyre S">S Eyre</name></author><author><name sortKey="Bowes, J" uniqKey="Bowes J">J Bowes</name></author><author><name sortKey="Pappas, Da" uniqKey="Pappas D">DA Pappas</name></author><author><name sortKey="Kremer, Jm" uniqKey="Kremer J">JM Kremer</name></author><author><name sortKey="Gonzalez Gay, Ma" uniqKey="Gonzalez Gay M">MA Gonzalez-Gay</name></author><author><name sortKey="Rodriguez Rodriguez, L" uniqKey="Rodriguez Rodriguez L">L Rodriguez-Rodriguez</name></author><author><name sortKey="Arlestig, L" uniqKey="Arlestig L">L Arlestig</name></author><author><name sortKey="Okada, Y" uniqKey="Okada Y">Y Okada</name></author><author><name sortKey="Diogo, D" uniqKey="Diogo D">D Diogo</name></author><author><name sortKey="Liao, Kp" uniqKey="Liao K">KP Liao</name></author><author><name sortKey="Karlson, Ew" uniqKey="Karlson E">EW Karlson</name></author><author><name sortKey="Raychaudhuri, S" uniqKey="Raychaudhuri S">S Raychaudhuri</name></author><author><name sortKey="Rantapaa Dahlqvist, S" uniqKey="Rantapaa Dahlqvist S">S Rantapaa-Dahlqvist</name></author><author><name sortKey="Martin, J" uniqKey="Martin J">J Martin</name></author><author><name sortKey="Klareskog, L" uniqKey="Klareskog L">L Klareskog</name></author><author><name sortKey="Padyukov, L" uniqKey="Padyukov L">L Padyukov</name></author><author><name sortKey="Gregersen, Pk" uniqKey="Gregersen P">PK Gregersen</name></author><author><name sortKey="Worthington, J" uniqKey="Worthington J">J Worthington</name></author><author><name sortKey="Greenberg, Jd" uniqKey="Greenberg J">JD Greenberg</name></author><author><name sortKey="Plenge, Rm" uniqKey="Plenge R">RM Plenge</name></author><author><name sortKey="Bae, Sc" uniqKey="Bae S">SC Bae</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Yarwood, A" uniqKey="Yarwood A">A Yarwood</name></author><author><name sortKey="Huizinga, Tw" uniqKey="Huizinga T">TW Huizinga</name></author><author><name sortKey="Worthington, J" uniqKey="Worthington J">J Worthington</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tracy, A" uniqKey="Tracy A">A Tracy</name></author><author><name sortKey="Buckley, Cd" uniqKey="Buckley C">CD Buckley</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lin, J" uniqKey="Lin J">J Lin</name></author><author><name sortKey="Liu, J" uniqKey="Liu J">J Liu</name></author><author><name sortKey="Davies, Ml" uniqKey="Davies M">ML Davies</name></author><author><name sortKey="Chen, W" uniqKey="Chen W">W Chen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Higgins, Mk" uniqKey="Higgins M">MK Higgins</name></author><author><name sortKey="Mackie, Sl" uniqKey="Mackie S">SL Mackie</name></author><author><name sortKey="Thalayasingam, N" uniqKey="Thalayasingam N">N Thalayasingam</name></author><author><name sortKey="Bingham, Sj" uniqKey="Bingham S">SJ Bingham</name></author><author><name sortKey="Hamilton, J" uniqKey="Hamilton J">J Hamilton</name></author><author><name sortKey="Kelly, Ca" uniqKey="Kelly C">CA Kelly</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cooles, Fa" uniqKey="Cooles F">FA Cooles</name></author><author><name sortKey="Pratt, Ag" uniqKey="Pratt A">AG Pratt</name></author><author><name sortKey="Lendrem, Dw" uniqKey="Lendrem D">DW Lendrem</name></author><author><name sortKey="Ng, Wf" uniqKey="Ng W">WF Ng</name></author><author><name sortKey="Aspray, Tj" uniqKey="Aspray T">TJ Aspray</name></author><author><name sortKey="Isaacs, Jd" uniqKey="Isaacs J">JD Isaacs</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Di Franco, M" uniqKey="Di Franco M">M Di Franco</name></author><author><name sortKey="Barchetta, I" uniqKey="Barchetta I">I Barchetta</name></author><author><name sortKey="Iannuccelli, C" uniqKey="Iannuccelli C">C Iannuccelli</name></author><author><name sortKey="Gerardi, Mc" uniqKey="Gerardi M">MC Gerardi</name></author><author><name sortKey="Frisenda, S" uniqKey="Frisenda S">S Frisenda</name></author><author><name sortKey="Ceccarelli, F" uniqKey="Ceccarelli F">F Ceccarelli</name></author><author><name sortKey="Valesini, G" uniqKey="Valesini G">G Valesini</name></author><author><name sortKey="Cavallo, Mg" uniqKey="Cavallo M">MG Cavallo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Furuya, T" uniqKey="Furuya T">T Furuya</name></author><author><name sortKey="Hosoi, T" uniqKey="Hosoi T">T Hosoi</name></author><author><name sortKey="Tanaka, E" uniqKey="Tanaka E">E Tanaka</name></author><author><name sortKey="Nakajima, A" uniqKey="Nakajima A">A Nakajima</name></author><author><name sortKey="Taniguchi, A" uniqKey="Taniguchi A">A Taniguchi</name></author><author><name sortKey="Momohara, S" uniqKey="Momohara S">S Momohara</name></author><author><name sortKey="Yamanaka, H" uniqKey="Yamanaka H">H Yamanaka</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Haga, Hj" uniqKey="Haga H">HJ Haga</name></author><author><name sortKey="Schmedes, A" uniqKey="Schmedes A">A Schmedes</name></author><author><name sortKey="Naderi, Y" uniqKey="Naderi Y">Y Naderi</name></author><author><name sortKey="Moreno, Am" uniqKey="Moreno A">AM Moreno</name></author><author><name sortKey="Peen, E" uniqKey="Peen E">E Peen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Emery, P" uniqKey="Emery P">P Emery</name></author><author><name sortKey="Salmon, M" uniqKey="Salmon M">M Salmon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jr, Gd" uniqKey="Jr G">GD Jr</name></author><author><name sortKey="Holweg, Ctj" uniqKey="Holweg C">CTJ Holweg</name></author><author><name sortKey="Kummerfeld, Sk" uniqKey="Kummerfeld S">SK Kummerfeld</name></author><author><name sortKey="Choy, Df" uniqKey="Choy D">DF Choy</name></author><author><name sortKey="Setiadi, Af" uniqKey="Setiadi A">AF Setiadi</name></author><author><name sortKey="Hackney, Ja" uniqKey="Hackney J">JA Hackney</name></author><author><name sortKey="Haverty, Pm" uniqKey="Haverty P">PM Haverty</name></author><author><name sortKey="Gilbert, H" uniqKey="Gilbert H">H Gilbert</name></author><author><name sortKey="Lin, Wy" uniqKey="Lin W">WY Lin</name></author><author><name sortKey="Diehl, L" uniqKey="Diehl L">L Diehl</name></author><author><name sortKey="Fischer, S" uniqKey="Fischer S">S Fischer</name></author><author><name sortKey="Song, A" uniqKey="Song A">A Song</name></author><author><name sortKey="Musselman, D" uniqKey="Musselman D">D Musselman</name></author><author><name sortKey="Klearman, M" uniqKey="Klearman M">M Klearman</name></author><author><name sortKey="Gabay, C" uniqKey="Gabay C">C Gabay</name></author><author><name sortKey="Kavanaugh, A" uniqKey="Kavanaugh A">A Kavanaugh</name></author><author><name sortKey="Endres, J" uniqKey="Endres J">J Endres</name></author><author><name sortKey="Fox, Da" uniqKey="Fox D">DA Fox</name></author><author><name sortKey="Martin, F" uniqKey="Martin F">F Martin</name></author><author><name sortKey="Townsend, Mj" uniqKey="Townsend M">MJ Townsend</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hayes, Me" uniqKey="Hayes M">ME Hayes</name></author><author><name sortKey="Denton, J" uniqKey="Denton J">J Denton</name></author><author><name sortKey="Freemont, Aj" uniqKey="Freemont A">AJ Freemont</name></author><author><name sortKey="Mawer, Eb" uniqKey="Mawer E">EB Mawer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mawer, Eb" uniqKey="Mawer E">EB Mawer</name></author><author><name sortKey="Hayes, Me" uniqKey="Hayes M">ME Hayes</name></author><author><name sortKey="Still, Pe" uniqKey="Still P">PE Still</name></author><author><name sortKey="Davies, M" uniqKey="Davies M">M Davies</name></author><author><name sortKey="Lumb, Ga" uniqKey="Lumb G">GA Lumb</name></author><author><name sortKey="Holt, Pj" uniqKey="Holt P">PJ Holt</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hayes, Me" uniqKey="Hayes M">ME Hayes</name></author><author><name sortKey="Bayley, D" uniqKey="Bayley D">D Bayley</name></author><author><name sortKey="Still, P" uniqKey="Still P">P Still</name></author><author><name sortKey="Palit, J" uniqKey="Palit J">J Palit</name></author><author><name sortKey="Denton, J" uniqKey="Denton J">J Denton</name></author><author><name sortKey="Freemont, Aj" uniqKey="Freemont A">AJ Freemont</name></author><author><name sortKey="Cooper, Rg" uniqKey="Cooper R">RG Cooper</name></author><author><name sortKey="Mawer, Eb" uniqKey="Mawer E">EB Mawer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, D" uniqKey="Li D">D Li</name></author><author><name sortKey="Jeffery, L" uniqKey="Jeffery L">L Jeffery</name></author><author><name sortKey="Jenkinson, C" uniqKey="Jenkinson C">C Jenkinson</name></author><author><name sortKey="Harrison, Sr" uniqKey="Harrison S">SR Harrison</name></author><author><name sortKey="Chun, Rf" uniqKey="Chun R">RF Chun</name></author><author><name sortKey="Adams, Js" uniqKey="Adams J">JS Adams</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="Varenna, M" uniqKey="Varenna M">M Varenna</name></author><author><name sortKey="Manara, M" uniqKey="Manara M">M Manara</name></author><author><name sortKey="Cantatore, Fp" uniqKey="Cantatore F">FP Cantatore</name></author><author><name sortKey="Del Puente, A" uniqKey="Del Puente A">A Del Puente</name></author><author><name sortKey="Di Munno, O" uniqKey="Di Munno O">O Di Munno</name></author><author><name sortKey="Malavolta, N" uniqKey="Malavolta N">N Malavolta</name></author><author><name sortKey="Minisola, G" uniqKey="Minisola G">G Minisola</name></author><author><name sortKey="Adami, S" uniqKey="Adami S">S Adami</name></author><author><name sortKey="Sinigaglia, L" uniqKey="Sinigaglia L">L Sinigaglia</name></author><author><name sortKey="Rossini, M" uniqKey="Rossini M">M Rossini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Franco, As" uniqKey="Franco A">AS Franco</name></author><author><name sortKey="Freitas, Tq" uniqKey="Freitas T">TQ Freitas</name></author><author><name sortKey="Bernardo, Wm" uniqKey="Bernardo W">WM Bernardo</name></author><author><name sortKey="Pereira, Rmr" uniqKey="Pereira R">RMR Pereira</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Allan, Gm" uniqKey="Allan G">GM Allan</name></author><author><name sortKey="Cranston, L" uniqKey="Cranston L">L Cranston</name></author><author><name sortKey="Lindblad, A" uniqKey="Lindblad A">A Lindblad</name></author><author><name sortKey="Mccormack, J" uniqKey="Mccormack J">J McCormack</name></author><author><name sortKey="Kolber, Mr" uniqKey="Kolber M">MR Kolber</name></author><author><name sortKey="Garrison, S" uniqKey="Garrison S">S Garrison</name></author><author><name sortKey="Korownyk, C" uniqKey="Korownyk C">C Korownyk</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Song, Gg" uniqKey="Song G">GG Song</name></author><author><name sortKey="Bae, Sc" uniqKey="Bae S">SC Bae</name></author><author><name sortKey="Lee, Yh" uniqKey="Lee Y">YH Lee</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Barry, El" uniqKey="Barry E">EL Barry</name></author><author><name sortKey="Rees, Jr" uniqKey="Rees J">JR Rees</name></author><author><name sortKey="Peacock, Jl" uniqKey="Peacock J">JL Peacock</name></author><author><name sortKey="Mott, La" uniqKey="Mott L">LA Mott</name></author><author><name sortKey="Amos, Ci" uniqKey="Amos C">CI Amos</name></author><author><name sortKey="Bostick, Rm" uniqKey="Bostick R">RM Bostick</name></author><author><name sortKey="Figueiredo, Jc" uniqKey="Figueiredo J">JC Figueiredo</name></author><author><name sortKey="Ahnen, Dj" uniqKey="Ahnen D">DJ Ahnen</name></author><author><name sortKey="Bresalier, Rs" uniqKey="Bresalier R">RS Bresalier</name></author><author><name sortKey="Burke, Ca" uniqKey="Burke C">CA Burke</name></author><author><name sortKey="Baron, Ja" uniqKey="Baron J">JA Baron</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Qureshi, Os" uniqKey="Qureshi O">OS Qureshi</name></author><author><name sortKey="Gardner, D" uniqKey="Gardner D">D Gardner</name></author><author><name sortKey="Hou, Tz" uniqKey="Hou T">TZ Hou</name></author><author><name sortKey="Briggs, Z" uniqKey="Briggs Z">Z Briggs</name></author><author><name sortKey="Soskic, B" uniqKey="Soskic B">B Soskic</name></author><author><name sortKey="Baker, J" uniqKey="Baker J">J Baker</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Danks, L" uniqKey="Danks L">L Danks</name></author><author><name sortKey="Komatsu, N" uniqKey="Komatsu N">N Komatsu</name></author><author><name sortKey="Guerrini, Mm" uniqKey="Guerrini M">MM Guerrini</name></author><author><name sortKey="Sawa, S" uniqKey="Sawa S">S Sawa</name></author><author><name sortKey="Armaka, M" uniqKey="Armaka M">M Armaka</name></author><author><name sortKey="Kollias, G" uniqKey="Kollias G">G Kollias</name></author><author><name sortKey="Nakashima, T" uniqKey="Nakashima T">T Nakashima</name></author><author><name sortKey="Takayanagi, H" uniqKey="Takayanagi H">H Takayanagi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rodriguez Fernandez, Jl" uniqKey="Rodriguez Fernandez J">JL Rodriguez-Fernandez</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Klareskog, L" uniqKey="Klareskog L">L Klareskog</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nistala, K" uniqKey="Nistala K">K Nistala</name></author><author><name sortKey="Adams, S" uniqKey="Adams S">S Adams</name></author><author><name sortKey="Cambrook, H" uniqKey="Cambrook H">H Cambrook</name></author><author><name sortKey="Ursu, S" uniqKey="Ursu S">S Ursu</name></author><author><name sortKey="Olivito, B" uniqKey="Olivito B">B Olivito</name></author><author><name sortKey="De Jager, W" uniqKey="De Jager W">W de Jager</name></author><author><name sortKey="Evans, Jg" uniqKey="Evans J">JG Evans</name></author><author><name sortKey="Cimaz, R" uniqKey="Cimaz R">R Cimaz</name></author><author><name sortKey="Bajaj Elliott, M" uniqKey="Bajaj Elliott M">M Bajaj-Elliott</name></author><author><name sortKey="Wedderburn, Lr" uniqKey="Wedderburn L">LR Wedderburn</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Hamburg, Jp" uniqKey="Van Hamburg J">JP van Hamburg</name></author><author><name sortKey="Asmawidjaja, Ps" uniqKey="Asmawidjaja P">PS Asmawidjaja</name></author><author><name sortKey="Davelaar, N" uniqKey="Davelaar N">N Davelaar</name></author><author><name sortKey="Mus, Am" uniqKey="Mus A">AM Mus</name></author><author><name sortKey="Colin, Em" uniqKey="Colin E">EM Colin</name></author><author><name sortKey="Hazes, Jm" uniqKey="Hazes J">JM Hazes</name></author><author><name sortKey="Dolhain, Rj" uniqKey="Dolhain R">RJ Dolhain</name></author><author><name sortKey="Lubberts, E" uniqKey="Lubberts E">E Lubberts</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Stoop, Jn" uniqKey="Stoop J">JN Stoop</name></author><author><name sortKey="Harry, Ra" uniqKey="Harry R">RA Harry</name></author><author><name sortKey="Von Delwig, A" uniqKey="Von Delwig A">A von Delwig</name></author><author><name sortKey="Isaacs, Jd" uniqKey="Isaacs J">JD Isaacs</name></author><author><name sortKey="Robinson, Jh" uniqKey="Robinson J">JH Robinson</name></author><author><name sortKey="Hilkens, Cmu" uniqKey="Hilkens C">CMU Hilkens</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bscheider, M" uniqKey="Bscheider M">M Bscheider</name></author><author><name sortKey="Butcher, Ec" uniqKey="Butcher E">EC Butcher</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Anderson, Ae" uniqKey="Anderson A">AE Anderson</name></author><author><name sortKey="Swan, Dj" uniqKey="Swan D">DJ Swan</name></author><author><name sortKey="Wong, Oy" uniqKey="Wong O">OY Wong</name></author><author><name sortKey="Buck, M" uniqKey="Buck M">M Buck</name></author><author><name sortKey="Eltherington, O" uniqKey="Eltherington O">O Eltherington</name></author><author><name sortKey="Harry, Ra" uniqKey="Harry R">RA Harry</name></author><author><name sortKey="Patterson, Am" uniqKey="Patterson A">AM Patterson</name></author><author><name sortKey="Pratt, Ag" uniqKey="Pratt A">AG Pratt</name></author><author><name sortKey="Reynolds, G" uniqKey="Reynolds G">G Reynolds</name></author><author><name sortKey="Doran, Jp" uniqKey="Doran J">JP Doran</name></author><author><name sortKey="Kirby, Ja" uniqKey="Kirby J">JA Kirby</name></author><author><name sortKey="Isaacs, Jd" uniqKey="Isaacs J">JD Isaacs</name></author><author><name sortKey="Hilkens, Cm" uniqKey="Hilkens C">CM Hilkens</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ponchel, F" uniqKey="Ponchel F">F Ponchel</name></author><author><name sortKey="Goeb, V" uniqKey="Goeb V">V Goëb</name></author><author><name sortKey="Parmar, R" uniqKey="Parmar R">R Parmar</name></author><author><name sortKey="El Sherbiny, Y" uniqKey="El Sherbiny Y">Y El-Sherbiny</name></author><author><name sortKey="Boissinot, M" uniqKey="Boissinot M">M Boissinot</name></author><author><name sortKey="El Jawhari, J" uniqKey="El Jawhari J">J El Jawhari</name></author><author><name sortKey="Burska, A" uniqKey="Burska A">A Burska</name></author><author><name sortKey="Vital, Em" uniqKey="Vital E">EM Vital</name></author><author><name sortKey="Harrison, S" uniqKey="Harrison S">S Harrison</name></author><author><name sortKey="Conaghan, Pg" uniqKey="Conaghan P">PG Conaghan</name></author><author><name sortKey="Hensor, E" uniqKey="Hensor E">E Hensor</name></author><author><name sortKey="Emery, P" uniqKey="Emery P">P Emery</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Langdon, K" uniqKey="Langdon K">K Langdon</name></author><author><name sortKey="Haleagrahara, N" uniqKey="Haleagrahara N">N Haleagrahara</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Li, N" uniqKey="Li N">N Li</name></author><author><name sortKey="Wei, W" uniqKey="Wei W">W Wei</name></author><author><name sortKey="Yin, F" uniqKey="Yin F">F Yin</name></author><author><name sortKey="Chen, M" uniqKey="Chen M">M Chen</name></author><author><name sortKey="Ma, Tr" uniqKey="Ma T">TR Ma</name></author><author><name sortKey="Wu, Q" uniqKey="Wu Q">Q Wu</name></author><author><name sortKey="Zhou, Jr" uniqKey="Zhou J">JR Zhou</name></author><author><name sortKey="Zheng, S G" uniqKey="Zheng S">S-G Zheng</name></author><author><name sortKey="Han, J" uniqKey="Han J">J Han</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wang, T" uniqKey="Wang T">T Wang</name></author><author><name sortKey="Sun, X" uniqKey="Sun X">X Sun</name></author><author><name sortKey="Zhao, J" uniqKey="Zhao J">J Zhao</name></author><author><name sortKey="Zhang, J" uniqKey="Zhang J">J Zhang</name></author><author><name sortKey="Zhu, H" uniqKey="Zhu H">H Zhu</name></author><author><name sortKey="Li, C" uniqKey="Li C">C Li</name></author><author><name sortKey="Gao, N" uniqKey="Gao N">N Gao</name></author><author><name sortKey="Jia, Y" uniqKey="Jia Y">Y Jia</name></author><author><name sortKey="Xu, D" uniqKey="Xu D">D Xu</name></author><author><name sortKey="Huang, F P" uniqKey="Huang F">F-P Huang</name></author><author><name sortKey="Li, N" uniqKey="Li N">N Li</name></author><author><name sortKey="Lu, L" uniqKey="Lu L">L Lu</name></author><author><name sortKey="Li, Z G" uniqKey="Li Z">Z-G Li</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Cooles, Fah" uniqKey="Cooles F">FAH Cooles</name></author><author><name sortKey="Isaacs, Jd" uniqKey="Isaacs J">JD Isaacs</name></author><author><name sortKey="Anderson, Ae" uniqKey="Anderson A">AE Anderson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moradi, B" uniqKey="Moradi B">B Moradi</name></author><author><name sortKey="Schnatzer, P" uniqKey="Schnatzer P">P Schnatzer</name></author><author><name sortKey="Hagmann, S" uniqKey="Hagmann S">S Hagmann</name></author><author><name sortKey="Rosshirt, N" uniqKey="Rosshirt N">N Rosshirt</name></author><author><name sortKey="Gotterbarm, T" uniqKey="Gotterbarm T">T Gotterbarm</name></author><author><name sortKey="Kretzer, Jp" uniqKey="Kretzer J">JP Kretzer</name></author><author><name sortKey="Thomsen, M" uniqKey="Thomsen M">M Thomsen</name></author><author><name sortKey="Lorenz, H M" uniqKey="Lorenz H">H-M Lorenz</name></author><author><name sortKey="Zeifang, F" uniqKey="Zeifang F">F Zeifang</name></author><author><name sortKey="Tretter, T" uniqKey="Tretter T">T Tretter</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Baeke, F" uniqKey="Baeke F">F Baeke</name></author><author><name sortKey="Korf, H" uniqKey="Korf H">H Korf</name></author><author><name sortKey="Overbergh, L" uniqKey="Overbergh L">L Overbergh</name></author><author><name sortKey="Verstuyf, A" uniqKey="Verstuyf A">A Verstuyf</name></author><author><name sortKey="Thorrez, L" uniqKey="Thorrez L">L Thorrez</name></author><author><name sortKey="Van Lommel, L" uniqKey="Van Lommel L">L Van Lommel</name></author><author><name sortKey="Waer, M" uniqKey="Waer M">M Waer</name></author><author><name sortKey="Schuit, F" uniqKey="Schuit F">F Schuit</name></author><author><name sortKey="Gysemans, C" uniqKey="Gysemans C">C Gysemans</name></author><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Belle, Tl" uniqKey="Van Belle T">TL Van Belle</name></author><author><name sortKey="Vanherwegen, A S" uniqKey="Vanherwegen A">A-S Vanherwegen</name></author><author><name sortKey="Feyaerts, D" uniqKey="Feyaerts D">D Feyaerts</name></author><author><name sortKey="De Clercq, P" uniqKey="De Clercq P">P De Clercq</name></author><author><name sortKey="Verstuyf, A" uniqKey="Verstuyf A">A Verstuyf</name></author><author><name sortKey="Korf, H" uniqKey="Korf H">H Korf</name></author><author><name sortKey="Gysemans, C" uniqKey="Gysemans C">C Gysemans</name></author><author><name sortKey="Mathieu, C" uniqKey="Mathieu C">C Mathieu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Henley, P" uniqKey="Henley P">P Henley</name></author><author><name sortKey="Marium, N" uniqKey="Marium N">N Marium</name></author><author><name sortKey="Filer, A" uniqKey="Filer A">A Filer</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author><author><name sortKey="Hewison, M" uniqKey="Hewison M">M Hewison</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gardner, Dh" uniqKey="Gardner D">DH Gardner</name></author><author><name sortKey="Jeffery, Le" uniqKey="Jeffery L">LE Jeffery</name></author><author><name sortKey="Soskic, B" uniqKey="Soskic B">B Soskic</name></author><author><name sortKey="Briggs, Z" uniqKey="Briggs Z">Z Briggs</name></author><author><name sortKey="Hou, Tz" uniqKey="Hou T">TZ Hou</name></author><author><name sortKey="Raza, K" uniqKey="Raza K">K Raza</name></author><author><name sortKey="Sansom, Dm" uniqKey="Sansom D">DM Sansom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gu, X" uniqKey="Gu X">X Gu</name></author><author><name sortKey="Gu, B" uniqKey="Gu B">B Gu</name></author><author><name sortKey="Lv, X" uniqKey="Lv X">X Lv</name></author><author><name sortKey="Yu, Z" uniqKey="Yu Z">Z Yu</name></author><author><name sortKey="Wang, R" uniqKey="Wang R">R Wang</name></author><author><name sortKey="Zhou, X" uniqKey="Zhou X">X Zhou</name></author><author><name sortKey="Qiao, W" uniqKey="Qiao W">W Qiao</name></author><author><name sortKey="Mao, Z" uniqKey="Mao Z">Z Mao</name></author><author><name sortKey="Zuo, G" uniqKey="Zuo G">G Zuo</name></author><author><name sortKey="Li, Q" uniqKey="Li Q">Q Li</name></author><author><name sortKey="Miao, D" uniqKey="Miao D">D Miao</name></author><author><name sortKey="Jin, J" uniqKey="Jin J">J Jin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Van Hamburg, Jp" uniqKey="Van Hamburg J">JP van Hamburg</name></author><author><name sortKey="Asmawidjaja, Ps" uniqKey="Asmawidjaja P">PS Asmawidjaja</name></author><author><name sortKey="Davelaar, N" uniqKey="Davelaar N">N Davelaar</name></author><author><name sortKey="Mus, Amc" uniqKey="Mus A">AMC Mus</name></author><author><name sortKey="Cornelissen, F" uniqKey="Cornelissen F">F Cornelissen</name></author><author><name sortKey="Van Leeuwen, Jptm" uniqKey="Van Leeuwen J">JPTM van Leeuwen</name></author><author><name sortKey="Hazes, Jmw" uniqKey="Hazes J">JMW Hazes</name></author><author><name sortKey="Dolhain, Rjem" uniqKey="Dolhain R">RJEM Dolhain</name></author><author><name sortKey="Bakx, Pagm" uniqKey="Bakx P">PAGM Bakx</name></author><author><name sortKey="Colin, Em" uniqKey="Colin E">EM Colin</name></author><author><name sortKey="Lubberts, E" uniqKey="Lubberts E">E Lubberts</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Feng, X" uniqKey="Feng X">X Feng</name></author><author><name sortKey="Lv, C" uniqKey="Lv C">C Lv</name></author><author><name sortKey="Wang, F" uniqKey="Wang F">F Wang</name></author><author><name sortKey="Gan, K" uniqKey="Gan K">K Gan</name></author><author><name sortKey="Zhang, M" uniqKey="Zhang M">M Zhang</name></author><author><name sortKey="Tan, W" uniqKey="Tan W">W Tan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tetlow, Lc" uniqKey="Tetlow L">LC Tetlow</name></author><author><name sortKey="Woolley, De" uniqKey="Woolley D">DE Woolley</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Martineau, Ar" uniqKey="Martineau A">AR Martineau</name></author><author><name sortKey="Jolliffe, Da" uniqKey="Jolliffe D">DA Jolliffe</name></author><author><name sortKey="Hooper, Rl" uniqKey="Hooper R">RL Hooper</name></author><author><name sortKey="Greenberg, L" uniqKey="Greenberg L">L Greenberg</name></author><author><name sortKey="Aloia, Jf" uniqKey="Aloia J">JF Aloia</name></author><author><name sortKey="Bergman, P" uniqKey="Bergman P">P Bergman</name></author><author><name sortKey="Dubnov Raz, G" uniqKey="Dubnov Raz G">G Dubnov-Raz</name></author><author><name sortKey="Esposito, S" uniqKey="Esposito S">S Esposito</name></author><author><name sortKey="Ganmaa, D" uniqKey="Ganmaa D">D Ganmaa</name></author><author><name sortKey="Ginde, Aa" uniqKey="Ginde A">AA Ginde</name></author><author><name sortKey="Goodall, Ec" uniqKey="Goodall E">EC Goodall</name></author><author><name sortKey="Grant, Cc" uniqKey="Grant C">CC Grant</name></author><author><name sortKey="Griffiths, Cj" uniqKey="Griffiths C">CJ Griffiths</name></author><author><name sortKey="Janssens, W" uniqKey="Janssens W">W Janssens</name></author><author><name sortKey="Laaksi, I" uniqKey="Laaksi I">I Laaksi</name></author><author><name sortKey="Manaseki Holland, S" uniqKey="Manaseki Holland S">S Manaseki-Holland</name></author><author><name sortKey="Mauger, D" uniqKey="Mauger D">D Mauger</name></author><author><name sortKey="Murdoch, Dr" uniqKey="Murdoch D">DR Murdoch</name></author><author><name sortKey="Neale, R" uniqKey="Neale R">R Neale</name></author><author><name sortKey="Rees, Jr" uniqKey="Rees J">JR Rees</name></author><author><name sortKey="Simpson, S" uniqKey="Simpson S">S Simpson</name></author><author><name sortKey="Stelmach, I" uniqKey="Stelmach I">I Stelmach</name></author><author><name sortKey="Kumar, Gt" uniqKey="Kumar G">GT Kumar</name></author><author><name sortKey="Urashima, M" uniqKey="Urashima M">M Urashima</name></author><author><name sortKey="Camargo, Ca" uniqKey="Camargo C">CA Camargo</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Sanders, Km" uniqKey="Sanders K">KM Sanders</name></author><author><name sortKey="Stuart, Al" uniqKey="Stuart A">AL Stuart</name></author><author><name sortKey="Williamson, Ej" uniqKey="Williamson E">EJ Williamson</name></author><author><name sortKey="Simpson, Ja" uniqKey="Simpson J">JA Simpson</name></author><author><name sortKey="Kotowicz, Ma" uniqKey="Kotowicz M">MA Kotowicz</name></author><author><name sortKey="Young, D" uniqKey="Young D">D Young</name></author><author><name sortKey="Nicholson, Gc" uniqKey="Nicholson G">GC Nicholson</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Calcif Tissue Int</journal-id><journal-id journal-id-type="iso-abbrev">Calcif. Tissue Int</journal-id><journal-title-group><journal-title>Calcified Tissue International</journal-title></journal-title-group><issn pub-type="ppub">0171-967X</issn><issn pub-type="epub">1432-0827</issn><publisher><publisher-name>Springer US</publisher-name><publisher-loc>New York</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31286174</article-id><article-id pub-id-type="pmc">6960236</article-id><article-id pub-id-type="publisher-id">577</article-id><article-id pub-id-type="doi">10.1007/s00223-019-00577-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Vitamin D, Autoimmune Disease and Rheumatoid Arthritis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Harrison</surname><given-names>Stephanie R.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Danyang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jeffery</surname><given-names>Louisa E.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Raza</surname><given-names>Karim</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5806-9690</contrib-id><name><surname>Hewison</surname><given-names>Martin</given-names></name><address><email>m.hewison@bham.ac.uk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Metabolism and Systems Research,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412919.6</institution-id><institution>Department of Rheumatology, Sandwell and West,</institution><institution>Birmingham Hospitals NHS Trust,</institution></institution-wrap>Birmingham, B18 7QH UK</aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Translation Medicine,</institution><institution>The University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.6572.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7486</institution-id><institution>Institute of Inflammation and Ageing, Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence and MRC Arthritis Research UK Centre for Musculoskeletal Ageing Research,</institution><institution>University of Birmingham,</institution></institution-wrap>Birmingham, B15 2TT UK</aff><aff id="Aff5"><label>5</label>Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, B15 2TT UK</aff></contrib-group><pub-date pub-type="epub"><day>8</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>8</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="ppub"><year>2020</year></pub-date><volume>106</volume><issue>1</issue><fpage>58</fpage><lpage>75</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2018</year></date><date date-type="accepted"><day>18</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Vitamin D has been reported to influence physiological systems that extend far beyond its established functions in calcium and bone homeostasis. Prominent amongst these are the potent immunomodulatory effects of the active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25-(OH)<sub>2</sub>D3). The nuclear vitamin D receptor (VDR) for 1,25-(OH)<sub>2</sub>D3 is expressed by many cells within the immune system and resulting effects include modulation of T cell phenotype to suppress pro-inflammatory Th1 and Th17 CD4+ T cells and promote tolerogenic regulatory T cells. In addition, antigen-presenting cells have been shown to express the enzyme 1α-hydroxylase that converts precursor 25-hydroxyvitamin D3 (25-OHD3) to 1,25-(OH)<sub>2</sub>D3, so that immune microenvironments are able to both activate and respond to vitamin D. As a consequence of this local, intracrine, system, immune responses may vary according to the availability of 25-OHD3, and vitamin D deficiency has been linked to various autoimmune disorders including rheumatoid arthritis (RA). The aim of this review is to explore the immune activities of vitamin D that impact autoimmune disease, with specific reference to RA. As well as outlining the mechanisms linking vitamin D with autoimmune disease, the review will also describe the different studies that have linked vitamin D status to RA, and the current supplementation studies that have explored the potential benefits of vitamin D for prevention or treatment of RA. The overall aim of the review is to provide a fresh perspective on the potential role of vitamin D in RA pathogenesis and treatment.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1007/s00223-019-00577-2) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Vitamin D</kwd><kwd>Vitamin D receptor</kwd><kwd>Autoimmune disease</kwd><kwd>Rheumatoid arthritis</kwd><kwd>Inflammation</kwd><kwd>T cell</kwd></kwd-group><funding-group><award-group><funding-source><institution>Royal Society</institution></funding-source><award-id>WM130118</award-id><principal-award-recipient><name><surname>Hewison</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>National Institutes of Health Research</institution></funding-source><award-id>Birmingham Biomedical Research Centre</award-id><principal-award-recipient><name><surname>Raza</surname><given-names>Karim</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Medical Research Council</institution></funding-source><award-id>PhD Studentship</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Danyang</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Vitamin D is a secosteroid which can be obtained from the diet (in particular from oily fish, eggs, dairy products and fortified foods). However, in humans, the majority of vitamin D is synthesised in the skin from the precursor molecule 7-dehydrocholesterol, which undergoes a series of UV light-mediated modifications to generate parental vitamin D3 [<xref ref-type="bibr" rid="CR1">1</xref>]. Vitamin D was first recognised for its role in bone mineralisation and calcium regulation, with vitamin D deficiency associated with the bone disease rickets [<xref ref-type="bibr" rid="CR2">2</xref>]. More recently, vitamin D has been reported to exert many extra-skeletal effects [<xref ref-type="bibr" rid="CR3">3</xref>] with association studies linking vitamin D status to a broad range of human health issues. Prominent amongst these is the proposed role of vitamin D in the pathophysiology of autoimmune disease, including insulin-dependent type 1 diabetes mellitus (T1D) [<xref ref-type="bibr" rid="CR4">4</xref>], autoimmune thyroid disease [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], multiple sclerosis (MS), inflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="CR7">7</xref>], systemic lupus erythematosus (SLE) [<xref ref-type="bibr" rid="CR8">8</xref>] and rheumatoid arthritis (RA) [<xref ref-type="bibr" rid="CR9">9</xref>]. The underlying mechanisms by which vitamin D impacts autoimmune disease remain elusive, and it is still not clear whether vitamin D deficiency contributes to autoimmune disease pathogenesis or whether it is marker of disease progression and severity. In this article, we address these issues with specific reference to the role of vitamin D in RA. We discuss the potential clinical significance, and the mechanisms of action of vitamin D in RA, and suggest areas where future research is needed.</p></sec><sec id="Sec2"><title>Vitamin D in Health</title><p id="Par3">Humans obtain vitamin D in two forms; vitamin D2 (ergocalciferol, derived from plant ergosterols) and vitamin D3 (cholecalciferol), which differ in the number/location of double carbon–carbon bonds. Vitamin D2 has only two C=C bonds, whilst vitamin D3 has three, affording D2 a lower affinity for vitamin D-binding protein (DBP), increasing clearance and reduced bioavailability; thus, vitamin D3 is the main form of vitamin D used by humans. Generation of active, hormonal, vitamin D3 involves a series of non-enzymatic and enzymatic processes. Firstly, 7-dehydrocholesterol is converted to vitamin D3 when exposed to UVB light in the dermis. Vitamin D3 is then converted to 25-hydroxycholecalciferol (25-OHD3) by the enzyme 25-hydroxylase (CYP2R1) located predominantly in the liver [<xref ref-type="bibr" rid="CR10">10</xref>]. The final step in generating active 1,25-dihydroxycholecalciferol (1,25-(OH)<sub>2</sub>D3) is mediated by the enzyme 25-hydroxyvitamin D-1α-hydroxylase (CYP27B1), which is abundant in the proximal tubule cells of the kidney [<xref ref-type="bibr" rid="CR11">11</xref>]. This step is responsible for the majority of circulating 1,25-(OH)<sub>2</sub>D3, but CYP27B1 is also expressed by a variety of non-renal tissues [<xref ref-type="bibr" rid="CR12">12</xref>], including several immune cell subsets [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR15">15</xref>], suggesting that these cells also have significant capacity to generate 1,25-(OH)<sub>2</sub>D3, with this process being instrumental in various autocrine and paracrine cell responses to vitamin D [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Moreover, whilst renal CYP27B1 is tightly regulated by parathyroid hormone, fibroblast growth factor 23 and 1,25-(OH)<sub>2</sub>D3 itself, extra-renal CYP27B1 does not appear to be subject to the same regulatory constraints [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Instead extra-renal synthesis of 1,25-(OH)<sub>2</sub>D3 appears to be more dependent on the availability of 25-OHD3. In view of the fact that 25-OHD3 is the main determinant of serum vitamin D status, it is highly likely that extra-renal synthesis of 1,25-(OH)<sub>2</sub>D3 will therefore be strongly influenced by vitamin D deficiency/sufficiency. The availability of 25-OHD3 is also affected by circulating serum carrier proteins for vitamin D: Vitamin D-Binding Protein (VBP), and to a lesser extent albumin [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Levels of 1,25-(OH)<sub>2</sub>D3 in either renal or extra-renal settings are also influenced by catabolism of 1,25-(OH)<sub>2</sub>D3 to inactive metabolites which is primarily controlled by the enzyme 24-hydroxylase (CYP24A1) [<xref ref-type="bibr" rid="CR22">22</xref>], with mutations in the <italic>CYP24A1</italic> gene being associated with dysregulated catabolism of 1,25-(OH)<sub>2</sub>D3 [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par4">Active 1,25-(OH)<sub>2</sub>D3 has an established role in regulating bone metabolism and calcium homeostasis, but it has also been shown to modulate key mechanisms in innate and adaptive immunity [<xref ref-type="bibr" rid="CR24">24</xref>–<xref ref-type="bibr" rid="CR26">26</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The nuclear receptor for 1,25-(OH)<sub>2</sub>D3 (the vitamin D receptor (VDR)) is expressed by a plethora of immune cells, including monocytes/macrophage, dendritic cells (DC), neutrophils and B and T cells [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. This, coupled with the capacity for localised CYP27B1-mediated synthesis of 1,25-(OH)<sub>2</sub>D3 by monocytes, macrophages and DC [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], supports a role for vitamin D as an important contributor to normal immune function. The remainder of the review will focus on this activity of vitamin D and the impact that this may have on the chronic inflammatory/autoimmune disease RA.<fig id="Fig1"><label>Fig. 1</label><caption><p>Role of vitamin D in the immune system. Schematic representation of cells from the innate and adaptive immune systems. Monocyte/macrophages from the innate immune system expression pattern recognition receptors (PRR) such as toll-like receptors (TLR), and response to pathogen-associated molecular patterns (PAMPs) such as lipopolysaccharide (LPS). PAMP–PRR responses include induction of transcription to increased expression of the vitamin D receptor (VDR) and the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) via STAT 1 or 5, AP-1, NF-κB or CEBP response elements. This increases monocyte/macrophage capacity to metabolise 25-hydroxyvitamin D3 (25-OHD3) to 1,25-dihydroxyvitamin D3 (1,25-(OH)<sub>2</sub>D3), which then interacts with VDR to regulate gene expression via DNA vitamin D response elements (VDRE). Prominent target genes for regulation by 1,25-(OH)<sub>2</sub>D3 include Nucleotide-binding oligomerization domain-containing protein 2 (NOD2), hepcidin antimicrobial protein (HAMP), cathelicidin (CAMP) and β-defensin 2 (DEFB4). 1,25-(OH)<sub>2</sub>D3 also enhances pathogen killing by inducing autophagy and reactive oxygen species (ROS), but acts to inhibit inflammation by suppressing inflammatory cytokines and expression of TLR2/4. Monocytes/macrophages may contribute to local levels of 1,25-(OH)<sub>2</sub>D3 which may then act on non-immune cells such as local tissue fibroblasts, chondrocytes or epithelial cells. For other innate immunity cells such as dendritic cells (DC), differentiation of these cells from immature (iDC) to mature (mDC) phenotypes is associated with increased expression of CYP27B1 but decreased expression of VDR, suggesting local conversion of 25-OHD3 to 1,25-(OH)2D3, which results in a paracrine effect to generate tolerogenic DC. Synthesis of 1,25-(OH)<sub>2</sub>D3 by mDC may also have paracrine effects on cells from the adaptive immune system such as T cells which, when activated, express VDR and respond to 1,25-(OH)<sub>2</sub>D3 by inducing Th2 and Treg phenotypes whilst suppressing Th1 and Th17 inflammatory phenotypes. 1,25-(OH)<sub>2</sub>D3 can also act on B cells to decrease CD40 expression and enhance class switching</p></caption><graphic xlink:href="223_2019_577_Fig1_HTML" id="MO1"></graphic></fig></p></sec><sec id="Sec3"><title>Vitamin D and Immunity</title><p id="Par5">The multi-modal innate immune system is the body’s first line of defence against pathogens, comprising physical barriers (e.g. epithelium), chemical barriers (e.g. stomach acid), complement proteins and cellular responses such as those mediated by macrophage, DC and neutrophils. Vitamin D participates in several of these processes, including the maintenance of barrier function in the intestine, by regulating tight junctions [<xref ref-type="bibr" rid="CR29">29</xref>] and intestinal epithelial cell apoptosis [<xref ref-type="bibr" rid="CR30">30</xref>]. However, to date, studies of vitamin D and innate immunity have predominantly explored its impact on antigen-presenting cells, such as macrophages and DC, which participate in the recognition of and response to pathogen-associated molecular patterns (PAMPs) via pattern recognition receptors (PRR) [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>). DNA target sequences for 1,25-(OH)<sub>2</sub>D3-bound to VDR, referred to as vitamin D response elements (VDRE) have been found in multiple genes associated with PRR responses, including the antibacterial proteins NOD2 [<xref ref-type="bibr" rid="CR31">31</xref>], hepcidin antimicrobial protein (HAMP) [<xref ref-type="bibr" rid="CR32">32</xref>], cathelicidin (CAMP) [<xref ref-type="bibr" rid="CR33">33</xref>], B-defensin 2 (DEFB4) [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] and TREM-1 [<xref ref-type="bibr" rid="CR35">35</xref>]. Toll-Like Receptors (TLRs) are an important group of PRR, and 1,25-(OH)<sub>2</sub>D3 has been shown to downregulate TLR2 and TLR4 in monocytes [<xref ref-type="bibr" rid="CR36">36</xref>], abrogating over-elaboration of TLR immune responses to PAMPs and damage-associated molecular patterns (DAMPs). In a separate study, methylation of the Vitamin D Receptor (VDR) gene and single-nucleotide polymorphisms in the VDR were also found to alter VDR-mediated TLR1/2 signalling in monocytes [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par6">Vitamin D is also known to differentially regulate innate immune cell subsets, influencing cell maturation, metabolism and antigen presentation, alongside response to and production of cytokines and chemokines [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Notably, mature DC express CYP27B1 but little VDR, whereas the converse is true for immature DC [<xref ref-type="bibr" rid="CR13">13</xref>]. This has led to the hypothesis that mature DC may in fact produce vitamin D locally on activation, which then acts on immature DC to modulate immune responses [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. The principal effect of 1,25-(OH)<sub>2</sub>D3 on DC is to suppress maturation markers such as CD80/CD86 [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR43">43</xref>] and CD83 [<xref ref-type="bibr" rid="CR44">44</xref>], increase IL-10 production and decrease pro-inflammatory cytokines [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. In this way, 1,25(OH)<sub>2</sub>D3 promotes an immature, tolerogenic DC phenotype [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>], thereby reducing antigen presentation to T cells.</p><p id="Par7">Adaptive immune cells are also modulated directly by 1,25-(OH)<sub>2</sub>D3, with VDR being transiently expressed by developing thymocytes, and re-activation of VDR expression in peripheral T and B cells following immune challenge [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. 1,25-(OH)<sub>2</sub>D3 was initially thought to act primarily as a regulator of T and B cell proliferation, but is now known to play a more important role in regulating T cell phenotype [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR54">54</xref>]. In particular, 1,25-(OH)<sub>2</sub>D3 has been shown to suppress inflammatory interleukin-17 expressing CD4+ T-helper (Th) cells (Th17) [<xref ref-type="bibr" rid="CR55">55</xref>] and Th1 cells [<xref ref-type="bibr" rid="CR56">56</xref>], whilst promoting differentiation of Th2 cells [<xref ref-type="bibr" rid="CR57">57</xref>] and regulatory T cells (Treg) [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>). However, vitamin D may also promote some immune responses by enhancing effector T cell responses including CD8+ cytotoxic function [<xref ref-type="bibr" rid="CR53">53</xref>], and other studies have reported a role for 1,25-(OH)<sub>2</sub>D3 in promoting T cell receptor (TCR) expression and T cell activation [<xref ref-type="bibr" rid="CR60">60</xref>]. Although less well studied, 1,25-(OH)<sub>2</sub>D3 has also been shown to modulate the function of other cytotoxic lymphocytes such as natural killer cells (NK), with apparent effects of NK cell activation [<xref ref-type="bibr" rid="CR61">61</xref>]. Likewise, effects of vitamin D have been described for natural killer T cells (NKT), and NKT cell development is lost in mice lacking the <italic>VDR</italic> gene [<xref ref-type="bibr" rid="CR62">62</xref>]. In contrast to the wide range of data on vitamin D and T cells, there is a scarcity of detailed studies for effects of 1,25-(OH)<sub>2</sub>D3 on B cells, which may include indirect effects via T cell modulation [<xref ref-type="bibr" rid="CR63">63</xref>], and direct B cell effects on class switching [<xref ref-type="bibr" rid="CR64">64</xref>], IL-10 production [<xref ref-type="bibr" rid="CR65">65</xref>] and CCR10 production [<xref ref-type="bibr" rid="CR66">66</xref>].</p></sec><sec id="Sec4"><title>Vitamin D in Autoimmune Disease</title><p id="Par8">Given the proposed role for vitamin D as an immune regulator, it is perhaps unsurprising that vitamin D deficiency has been linked to both allergic [<xref ref-type="bibr" rid="CR67">67</xref>] and autoimmune diseases [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. The increasing incidence/prevalence of MS proportional to distance from the equator, suggests that environmental factors such as sunlight and vitamin D may be involved in disease aetiology [<xref ref-type="bibr" rid="CR70">70</xref>]. This is further underlined by studies from the UK showing that risk of immune-related diseases is significantly influenced by the season of birth as the serum 25-OHD3 levels is associated with this [<xref ref-type="bibr" rid="CR71">71</xref>]. Likewise, genetic variants associated with heritable effects on vitamin D status have also been linked to MS disease onset and progression [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. However, differences between genders [<xref ref-type="bibr" rid="CR74">74</xref>], ethnic groups [<xref ref-type="bibr" rid="CR75">75</xref>] and potentially different subtypes of MS [<xref ref-type="bibr" rid="CR76">76</xref>], make it difficult to decipher the exact role of vitamin D in MS. Furthermore, although vitamin D supplementation has been successful in ameliorating MS symptoms in some studies [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>], this has not been demonstrated consistently [<xref ref-type="bibr" rid="CR81">81</xref>]. Larger randomised controlled trials (RCTs) are now needed to establish whether vitamin D supplementation can reduce risk, severity and/or progression of MS. Similar to MS, vitamin D deficiency is also prevalent in SLE [<xref ref-type="bibr" rid="CR82">82</xref>], where low serum vitamin D has been associated with dysregulation of autophagy [<xref ref-type="bibr" rid="CR83">83</xref>], increased circulating levels of IFNα [<xref ref-type="bibr" rid="CR84">84</xref>], increased CD4+/CD8+ T cells and a reduction in pro-inflammatory cytokines [<xref ref-type="bibr" rid="CR85">85</xref>]. Vitamin D intake has been shown to have variable impact on SLE, with some studies showing no effect on disease severity [<xref ref-type="bibr" rid="CR86">86</xref>–<xref ref-type="bibr" rid="CR88">88</xref>] whilst another study reported decreased disease activity in young adults with SLE [<xref ref-type="bibr" rid="CR89">89</xref>]. As with MS, more research is needed to fully define optimal doses and timing of intervention for vitamin D supplementation.</p><p id="Par9">T1D is another autoimmune disease with reported links to vitamin D status, with vitamin D deficiency correlating with T1D risk severity [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. A prospective, non-blinded non-randomised controlled trial has also shown that T1D patients supplemented with vitamin D and with higher serum 25-OHD3 are more likely to have improved glycemic control [<xref ref-type="bibr" rid="CR92">92</xref>]. T1D has also been linked to single-nucleotide polymorphic variants in the <italic>CYP27B1</italic> [<xref ref-type="bibr" rid="CR93">93</xref>–<xref ref-type="bibr" rid="CR95">95</xref>] and <italic>VDR</italic> [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>] genes. In vivo treatment with the active form of vitamin D, 1,25-(OH)<sub>2</sub>D3, was shown to completely suppress T1D disease in the <italic>NOD</italic> experimental mouse [<xref ref-type="bibr" rid="CR98">98</xref>]. In humans, clinical trials involving supplementation with vitamin D3 or the precursor molecule 1α-hydroxyvitamin D3 in T1D patients have produced mixed results; some studies have reported delay of β-cell destruction in supplemented trial groups compared to non-supplemented groups [<xref ref-type="bibr" rid="CR99">99</xref>–<xref ref-type="bibr" rid="CR101">101</xref>], whilst others found no significant improvements of on β-cell preservation [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR103">103</xref>].</p><p id="Par10">Vitamin D deficiency has also being linked to autoimmune gastrointestinal disorders such as Crohn’s disease, a major form of IBD [<xref ref-type="bibr" rid="CR104">104</xref>–<xref ref-type="bibr" rid="CR107">107</xref>]. The role of vitamin D as a regulator of immune function in IBD has also been studied in vivo in mouse models. Knockout of the mouse genes for VDR (<italic>Vdr</italic>) [<xref ref-type="bibr" rid="CR108">108</xref>] or 1α-hydroxylase (<italic>Cyp27b1</italic>) [<xref ref-type="bibr" rid="CR109">109</xref>] shows increased severity of artificially induced colitis similar to IBD. Other studies have shown that vitamin D-deficient mice have increased severity of induced colitis, with this effect being linked to aberrant innate immune responses within the gastrointestinal tract [<xref ref-type="bibr" rid="CR110">110</xref>]. Furthermore, it has been shown that the VDR, in conjunction with 1,25-(OH)<sub>2</sub>D3, protects against the onset of colitis in mice by maintaining barrier function within the gastrointestinal mucosal epithelium [<xref ref-type="bibr" rid="CR111">111</xref>]. Despite these positive studies, it is still unclear whether vitamin D deficiency is a direct cause of IBD including Crohn’s disease, or whether there is a reverse causation effect.</p></sec><sec id="Sec5"><title>Vitamin D and Rheumatoid Arthritis</title><p id="Par11">Rheumatoid arthritis (RA) is a chronic inflammatory/autoimmune arthritis characterised by synovitis of peripheral joints, with extra-articular manifestations. If untreated, unopposed inflammation leads to joint destruction, loss of function and disability, and RA is also associated with premature mortality secondary, at least in part, to the effects of chronic inflammation on cardiovascular health [<xref ref-type="bibr" rid="CR112">112</xref>]. Like other autoimmune diseases, there is growing interest in the role of vitamin D deficiency in the aetiopathogenesis of RA [<xref ref-type="bibr" rid="CR9">9</xref>]. RA is thought to be triggered by environmental factors [<xref ref-type="bibr" rid="CR113">113</xref>], in patients with an underlying genetic susceptibility [<xref ref-type="bibr" rid="CR114">114</xref>, <xref ref-type="bibr" rid="CR115">115</xref>] leading to dysfunction of innate and adaptive immunity, tipping the balance in preference of autoimmunity over tolerance [<xref ref-type="bibr" rid="CR116">116</xref>]. Whilst smoking is well recognised as a strong environmental risk factor other potential factors include vitamin D [<xref ref-type="bibr" rid="CR9">9</xref>].</p><sec id="Sec6"><title>Vitamin D Status and RA Disease Risk and Progress</title><p id="Par12">In a recent meta-analysis and systematic review, Lin J et al. analysed 24 studies published prior to May 2015 whose focus was the relationship between serum 25-OHD3 and clinical/laboratory indices of RA disease activity. Overall, they reported an inverse relationship between serum 25-OHD3 and RA disease activity [<xref ref-type="bibr" rid="CR117">117</xref>]. However, they also identified important differences between patient subgroups, including a stronger inverse relationship between RA disease activity and serum 25-OHD3 in studies from developing countries, and in low-latitude climates. Since the publication of this meta-analysis, further studies have been conducted. Therefore, to establish a clearer picture of whether vitamin D levels are indeed significantly lower in RA, and are linked to disease activity, all studies of vitamin D levels in RA patients currently listed on Pubmed are summarised in Table <xref rid="Tab1" ref-type="table">1</xref>. The search terms “vitamin D levels” and “rheumatoid arthritis” were used, and no restrictions on study date were applied. In addition, studies included in the meta-analysis (referenced above) were also included. The collected studies listed in Table <xref rid="Tab1" ref-type="table">1</xref> underline the significant heterogeneity between studies and their findings, making it difficult to determine a clear role for vitamin D deficiency in the onset, progression and/or severity of RA. Studies to date have been conducted in over 20 countries, which invariably means that there will be confounding differences in environmental factors including sunlight exposure and diet, and genetic factors. Moreover, the overwhelming majority of the reported studies were observational or cross-sectional by design, and as such can only report on the association between RA disease and vitamin D, rather than a causal role.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of studies comparing serum vitamin D levels with disease activity in RA</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study details (year, lead author)</th><th align="left">Population size and ethnicity</th><th align="left">Disease duration</th><th align="left">Analytical method(s)</th><th align="left">Metabolite(s) measured</th><th align="left">Cut off for vit D def.</th><th align="left">Vit D lower in HC vs. RA</th><th align="left">Association of vitamin D with disease parameter(s)<sup>1</sup></th></tr></thead><tbody><tr><td align="left">1998, Oelzner</td><td align="left">RA = 96, Germany</td><td align="left">Mean 12.2 years (range 6 months–38 years)</td><td align="left">RAI</td><td align="left">1,25(OH)<sub>2</sub> D<sub>3</sub></td><td align="left">Unclear</td><td align="left">n/a</td><td align="left"><p>Neg: disease activity</p><p>Pos; urinary collagen crosslinks</p><p>↑ DA is assoc. neg. Ca balance and ↓ bone formation</p></td></tr><tr><td align="left">2006, Cutolo</td><td align="left">RA = 118, HC = 75, Estonia and Italy</td><td align="left">Not stated</td><td align="left">RAI</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">Neg: DAS-28, however, correlation varied according to time of year and country of origin</td></tr><tr><td align="left">2010, Craig</td><td align="left">RA = 266 (African Americans)</td><td align="left">Mean 31.2 months (SD = 7.3 months)</td><td align="left">Unclear</td><td align="left">25OHD</td><td align="left">< 15 ng/mL</td><td align="left">n/a</td><td align="left">Nil</td></tr><tr><td align="left">2010, Haque</td><td align="left">RA = 62, USA</td><td align="left">Mean 11.6 years (SD = 12.3 years)</td><td align="left">Standardised (Quest + Lab − corp)</td><td align="left">25OHD</td><td align="left">< 30 ng/mL</td><td align="left">n/a</td><td align="left">Neg: DAS28, pain and HAQ in active RA (DAS28 > 2.6) only</td></tr><tr><td align="left">2010, Rossini</td><td align="left">RA = 1191, HC = 1019, Italy</td><td align="left">Mean 11.5 years (SD = 8.7 years)</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left">< 30 ng/mL</td><td align="left">No</td><td align="left">Neg: HAQ disability, DAS28, MADLS, high Steinbrocker functional state</td></tr><tr><td align="left">2011, Braun-Moscovici</td><td align="left">Rheumatic disease = 121 (RA = 85), Israel</td><td align="left">Mean = 9.9 years (SD = 8.5 years)</td><td align="left">NOS</td><td align="left">25OHD</td><td align="left">Unclear</td><td align="left">n/a</td><td align="left">Nil</td></tr><tr><td align="left">2011, Turhanoglu</td><td align="left">RA = 65, HC = 40, Turkey</td><td align="left">Mean = 7.73–7.95 years</td><td align="left">EIA</td><td align="left">25OHD</td><td align="left">Not specified</td><td align="left">No</td><td align="left">Neg: DAS-28, CRP, HAQ</td></tr><tr><td align="left">2012, Kostoglou-Athanassiou</td><td align="left">RA = 44, HC = 44, Greece</td><td align="left">Not stated</td><td align="left">RAI</td><td align="left">25OHD3</td><td align="left">n/a</td><td align="left">Yes</td><td align="left">Neg: DAS-28, CRP, ESR</td></tr><tr><td align="left">2012, Baker</td><td align="left">RA = 499, USA, China</td><td align="left">Not stated</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left"><p>< 50 nmol/L</p><p>(< 30 ng/mL)</p></td><td align="left">Yes</td><td align="left">Nil</td></tr><tr><td align="left">2012, Attar</td><td align="left">RA = 100, HC = 100, Saudi Arabia</td><td align="left">Mean 4.7 years (SD = 5 years)</td><td align="left">LC MS/MS</td><td align="left">25OHD</td><td align="left">< 30 and < 10 ng/mL^</td><td align="left">No</td><td align="left"><p>Neg: DAS28</p><p>^nb study used two definitions for deficiency</p></td></tr><tr><td align="left">2012, Baykal</td><td align="left">RA = 55, HC = 45, Turkey</td><td align="left">Not stated</td><td align="left">Elecsys 25(OH)D reactive kit</td><td align="left">25OHD</td><td align="left">< 30 nmol/L</td><td align="left">Yes</td><td align="left">Nil</td></tr><tr><td align="left">2012, Heidari</td><td align="left">RA = 108, UIA = 39, HC = 239, Iran</td><td align="left">Not stated</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left">< 20 ng/mL</td><td align="left">No</td><td align="left">Correlation of vitamin D with RA disease parameters was not an objective of this study; the study simply compared 25OHD between disease/control</td></tr><tr><td align="left">2013, Atwa</td><td align="left">RA = 55, PsA = 43, HC = 40, Egypt</td><td align="left">Mean 4.93 years (SD = 3.11 years)</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">Yes</td><td align="left">Nil</td></tr><tr><td align="left">2013, Chen</td><td align="left">RA = 110, HC = 110, China</td><td align="left">Mean = 6.51yr, SD = 6.82 yr</td><td align="left">RAI</td><td align="left">25OHD</td><td align="left">Not specified</td><td align="left">n/a</td><td align="left">Neg: DAS28</td></tr><tr><td align="left">2013, Furuya</td><td align="left">RA = 4793, Japanese</td><td align="left">Mean = 12 years</td><td align="left">RAI</td><td align="left">25OHD</td><td align="left">< 20 ng/mL</td><td align="left">n/a</td><td align="left">Neg: Japanese HAQ disability score, NSAID use</td></tr><tr><td align="left">2013, Haga</td><td align="left">RA = 302, Denmark</td><td align="left">Mean = 10.5 years (range 0–50 years)</td><td align="left">HPLC–MS</td><td align="left">25OHD</td><td align="left"><p>< 50 nmol/L</p><p>(< 30 ng/mL)</p></td><td align="left">n/a</td><td align="left">No assoc. overall; however, severe deficiency (< 15 nmol/L 25OHD3) was associated with increased DAS28 > 5.1, CRP, RF and ≥ 3 DMARDs</td></tr><tr><td align="left">2013, Higgins</td><td align="left">RA = 126, New Zealand</td><td align="left">Mean = 12 years (range 1–37 years)</td><td align="left">Immunoassay method NOS</td><td align="left">25OHD</td><td align="left"><p>< 50 nmol/L</p><p>(< 30 ng/mL)</p></td><td align="left">n/a</td><td align="left">Neg: VAS. This parameter of the DAS28 score alone accounted for assoc. with RA</td></tr><tr><td align="left">2013, Sabbagh</td><td align="left">Rheum dx = 56 (RA = 39), non-rheum dx = 60</td><td align="left">Not stated</td><td align="left">NOS</td><td align="left">25OHD</td><td align="left">< 50 nmol/L (< 30 ng/mL)</td><td align="left">Yes</td><td align="left">Neg: DAS28-ESR</td></tr><tr><td align="left">2013, Yazmalar</td><td align="left">RA = 71, AS = 72, OA = 74, HC = 70, Turkey</td><td align="left">Not stated</td><td align="left">HPLC</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">No</td><td align="left">Nil</td></tr><tr><td align="left">2014, Cote</td><td align="left">RA = 120, HC = 1341, USA</td><td align="left">Not stated</td><td align="left">RAI or LC MS/MS</td><td align="left">Vit D</td><td align="left">< 20 ng/mL + < 30 ng/mL</td><td align="left">n/a</td><td align="left">Nil assoc. between vit D and RA onset</td></tr><tr><td align="left">2014, Gheita</td><td align="left">RA = 63, HC = 62, Egypt</td><td align="left">Mean = 5.89 years (SD = 3.67)</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">< 20 ng/mL</td><td align="left">Yes</td><td align="left"><p>Neg: QoL, HAQ II, FMS</p><p><italic>RA </italic>+<italic> FMS had lower vit D than RA alone</italic></p></td></tr><tr><td align="left">2014, Hong</td><td align="left">RA = 130, HC = 80</td><td align="left">Mean 6 years (range 2 months–40 years)</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">Yes</td><td align="left">Neg: SJC, TJC, joint pain, EMS, HAQ, Plt, ESR, IL-17, IL-23</td></tr><tr><td align="left">2014, Hiraki</td><td align="left">Pre-RA = 166, HC = 490</td><td align="left">n/a</td><td align="left">RAI</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">Nil association found between 25OHD and development of RA, except in a small subset of females just prior to RA onset</td></tr><tr><td align="left">2014, Sahebari</td><td align="left">RA = 99, HC = 68, Iran</td><td align="left">Mean = 59 years (SD 5.6 years; range 0.2–20 years)</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left">< 30 nmol/L</td><td align="left">No</td><td align="left">Nil; however, all patient, were on vit D replacement</td></tr><tr><td align="left">2014, Sharma</td><td align="left">RA = 80, HC = 80</td><td align="left">Not stated</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left">< 10 ng/mL</td><td align="left">Yes</td><td align="left">Neg: DAS28</td></tr><tr><td align="left">2015, Cooles</td><td align="left">RA = 73, UA = 40, OA = 58, NIA = 89, other IA = 50, ReA = 14, CrA = 19</td><td align="left">RA—49 years (range 18–88)</td><td align="left">Not stated</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">No</td><td align="left">Nil</td></tr><tr><td align="left">2015, Raczkiewicz</td><td align="left">RA = 97, OA = 28, Poland</td><td align="left"><p>5.8 ± 5.4 years (vit D > 20 ng/dL)</p><p>8.8 ± 9.8 years (vit D < 20 ng/dL)</p></td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">< 20 ng/dL</td><td align="left">n/a</td><td align="left"><p>Neg: DAS28, HAQ, BDI</p><p>Pos: PA, SF-36*</p><p><italic>* remained sig. after multivariate analysis</italic></p></td></tr><tr><td align="left">2015, Matsumoto</td><td align="left">RA = 181, HC = 186, Japan</td><td align="left">Mean = 10.2 years (5.2–20 years)</td><td align="left">RAI</td><td align="left">25OHD</td><td align="left">Not specified</td><td align="left">Yes</td><td align="left">Nil</td></tr><tr><td align="left">2015, Azzeh</td><td align="left">RA = 102, Saudi</td><td align="left">Not stated</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">< 30 ng/mL</td><td align="left">n/a</td><td align="left">Neg: DAS28</td></tr><tr><td align="left">2015, Brance</td><td align="left">RA = 34, HC = 41, Argentina</td><td align="left">Mean = 7.6 years (SD = 1.4 years)</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">< 20 ng/mL (< 50 nmol/L)</td><td align="left">Yes</td><td align="left">Neg: DAS-28</td></tr><tr><td align="left">2015, Cen</td><td align="left">RA = 116, China</td><td align="left">Not stated</td><td align="left">ELISA</td><td align="left">25OHD</td><td align="left"><p>< 50 nmol/L</p><p>(< 30 ng/mL)</p></td><td align="left">Yes</td><td align="left">Nil</td></tr><tr><td align="left">2015, Wang</td><td align="left">Early RA = 154, HC = 60, China</td><td align="left">Disease duration < 1 year</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left"><20 ng/mL</td><td align="left">Yes</td><td align="left">Neg: ACPA, ESR, DAS</td></tr><tr><td align="left">2016, Cecchetti</td><td align="left">RA = 894, HC = 861, multiple countries</td><td align="left">Not available</td><td align="left">NOS</td><td align="left">25OHD</td><td align="left">≤ 10 ng/mL</td><td align="left">Yes</td><td align="left">Neg: DAS28-CRP, SDAI, CDAI</td></tr><tr><td align="left">2016, Pakchotanon</td><td align="left">RA = 239, Thai</td><td align="left">Median 84 months (range 48–132 months)</td><td align="left">CLA</td><td align="left"><p>25OHD<sub>2</sub></p><p>25OHD<sub>3</sub></p></td><td align="left">n/a</td><td align="left">n/a</td><td align="left">Nil</td></tr><tr><td align="left">2016, Zakeri</td><td align="left">RA = 66, Iran</td><td align="left">Not stated</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">n/a</td><td align="left">Neg: DAS-ESR, SJC, TJC, GHS, EMS</td></tr><tr><td align="left">2017, Mateen</td><td align="left">RA = 100, HC = 50</td><td align="left">Not stated</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">n/a</td><td align="left">Yes</td><td align="left">Neg: TNF-α, IL-1β, IL-6, IL-10, IL-17, ROS</td></tr><tr><td align="left">2017, Hajjaj-Hassouni</td><td align="left">RA = 1413, 15 countries</td><td align="left">8.3 years (range 3.6–15.2 years)</td><td align="left">NOS</td><td align="left">25OHD</td><td align="left">≤ 10 ng/mL</td><td align="left">n/a</td><td align="left">Neg: DAS + Corticosteroid dose</td></tr><tr><td align="left">2017, Vojinovic</td><td align="left">RA = 625, HC = 276,13 European countries</td><td align="left">Mean = 11 years (SD = 9 years)</td><td align="left">CLA</td><td align="left">25OHD</td><td align="left">< 20 ng/mL</td><td align="left">Yes</td><td align="left">Neg: DAS28-CRP, RAID, HAQ, SRS/HRS/GRS domains of D-PRO</td></tr><tr><td align="left">2018, Herly</td><td align="left">RA = 160, Denmark</td><td align="left">Median 14.1 weeks (range 6.1–26.6)</td><td align="left"><p>LC MS/MS</p><p>……….</p><p>RAI</p></td><td align="left"><p>25OHD<sub>2</sub></p><p>25OHD<sub>3</sub></p><p>……….</p><p>1,25(OH)<sub>2</sub> D</p></td><td align="left"><p>< 50 nmol/L</p><p>……….</p></td><td align="left"><p>n/a</p><p>……….</p></td><td align="left"><p>Nil</p><p>Nil</p><p>………………………..</p><p>Neg: DAS28-CRP, HAQ, CRP, VAS-pain</p><p>Pos: ACPA</p></td></tr><tr><td align="left">2018, de la Torre Lossa</td><td align="left">RA = 100, Ecuador</td><td align="left">Full article in Spanish</td><td align="left">Full article in Spanish</td><td align="left">25OHD</td><td align="left">Full article in Spanish</td><td align="left">Full article in Spanish</td><td align="left">Nil</td></tr><tr><td align="left">2018, Khoja</td><td align="left">RA = 41, HC = 41</td><td align="left">Not available</td><td align="left">Unclear</td><td align="left">Unclear</td><td align="left">Unclear</td><td align="left">Yes</td><td align="left">Neg: PROs</td></tr></tbody></table><table-wrap-foot><p>References are shown with Supplementary Table 1</p><p><italic>ACPA</italic> anti-citrullinated peptide antibody, <italic>CDAI</italic> clinical disease activity index, <italic>CLA</italic> chemiluminescent assay, <italic>DA</italic> disease activity, <italic>DAS28</italic> disease activity score 28, <italic>ELISA</italic> enzyme-linked immunosorbent assay, <italic>EMS</italic> early morning stiffness, <italic>FMS</italic> fibromyalgia syndrome, <italic>GHS</italic> global health score, <italic>GRS</italic> global risk score (SRS + HRS), <italic>HAQ</italic> health assessment questionnaire, <italic>HRS</italic> habitus risk score, <italic>LC MS/MS</italic> liquid chromatography tandem mass spectrometry, <italic>Neg</italic> negative correlation between vitamin D and outcome measure, <italic>NOS</italic> Not otherwise specified, <italic>OA</italic> osteoarthritis, <italic>Pos</italic> positive correlation between vitamin D and outcome measure, <italic>PROs</italic> patient-reported outcomes, <italic>PsA</italic> psoriatic arthritis, <italic>RA</italic> rheumatoid arthritis, <italic>HC</italic> healthy control, <italic>RAI</italic> Radioimmunoassay, <italic>ROS</italic> reactive oxygen species, <italic>SDAI</italic> simple disease activity index, <italic>SJC</italic> swollen joint count, <italic>SRS</italic> symptom risk score, <italic>TCJ</italic> tender joint count, <italic>VAS</italic> visual analogue score</p></table-wrap-foot></table-wrap></p><p id="Par13">RA is a heterogeneous disease, yet few studies have considered analysing RA subgroups based on antibody status, disease severity or duration. Where subgroups have been defined, this is often based on disease activity score 28 (DAS-28); a composite score that captures different subjective and objective measures of disease activity, hence the potential for skewing of results by one component. One study that did address this reported no correlation between vitamin D levels and DAS-28, with or without the inclusion of the patient global visual analogue scale score (Patient global VAS)—a scale for evaluating the patient’s overall perception of their RA activity. However, patient global VAS on its own did correlate with serum vitamin D levels [<xref ref-type="bibr" rid="CR118">118</xref>]. In 2015, Cooles et al. reported data showing the relationship between serum 25-OHD3 levels and various clinical parameters in early RA (median symptom duration 12 weeks, range 4–104 weeks) [<xref ref-type="bibr" rid="CR119">119</xref>]. They found no clear association between 25-OHD3 and early RA, but in early osteoarthritis (OA) 25-OHD3 was inversely associated with global health visual analogue scale scores (GH-VAS). This suggests that OA, which commonly co-exists with RA, may act as a confounder in interpreting the relationship between vitamin D and RA. These observations are intriguing, and need to be further explored to determine the role, if any, for vitamin D in pain and fatigue associated with RA.</p><p id="Par14">Relatively few studies have assessed the impact of RA treatment regimens on the apparent inverse correlation between serum 25-OHD3 and RA disease activity [<xref ref-type="bibr" rid="CR120">120</xref>–<xref ref-type="bibr" rid="CR122">122</xref>]. Treatment for RA is aimed at reducing disease activity, and therefore comparing serum 25-OHD3 levels with measures of disease activity after the initiation of treatment could mask prior effects of vitamin D deficiency on treatment naïve disease. Since the 1990s, an early and aggressive approach to the management of new RA has been widely used in order to maximise chances of inducing remission [<xref ref-type="bibr" rid="CR123">123</xref>]. Today, this strategy is fully integrated in clinical practice, but its application in the context of low vitamin D, and vitamin D replacement, for treatment naive, newly diagnosed RA patients, is still unclear.</p><p id="Par15">As well as clinical and biochemical differences in subgroups of RA, there are also likely genetic differences which may influence the relative importance of vitamin D in the immunopathogenesis of disease. For example, Dennis et al. identified four distinct synovial tissue gene expression profiles in a cohort of RA patients [<xref ref-type="bibr" rid="CR124">124</xref>]. Although some of these differences in gene expression may be related to the patient’s disease duration or treatment regimen, it seems unlikely that this sufficiently explains all the observed differences, and that distinctly different gene signatures may indeed characterise different subsets of RA. Accordingly, it seems plausible that vitamin D deficiency may play slightly different roles in the aetiopathogenesis and progression of disease in different groups of patients. Ultimately, the role of vitamin D in RA appears far too complex to be understood through simple observational methods.</p><p id="Par16">To date, studies of RA disease and vitamin D have focused on the link between RA and serum levels of the main circulating form of vitamin D, 25-OHD3. However, 25OHD3 is an inactive precursor for 1,25-(OH)<sub>2</sub>D3 and therefore has limited functional relevance for immunomodulation. Consequently, there has been a revival of interest in the role of other vitamin D metabolites both in serum and disease-affected synovial fluid as potentially more informative markers for vitamin D function in RA. Research on this subject began more than 25 years ago with seminal studies of vitamin D metabolism in RA tissues [<xref ref-type="bibr" rid="CR125">125</xref>–<xref ref-type="bibr" rid="CR127">127</xref>]. These reports indicated that concentrations of 25-OHD3 were significantly lower in synovial fluid relative to paired patient blood, but also revealed significant capacity for the generation of 1,25-(OH)<sub>2</sub>D3 by macrophages isolated from synovial fluid [<xref ref-type="bibr" rid="CR127">127</xref>]. In more recent studies, we have measured multiple vitamin D metabolites—the vitamin D ‘metabolome’ in paired serum and synovial fluid from patients with established RA, reactive arthritis and healthy controls using the current gold standard for vitamin D analysis, liquid chromatography–tandem mass spectrometry (LC–MS/MS) [<xref ref-type="bibr" rid="CR128">128</xref>]. These studies showed that for markers such as swollen joint count (SJC), synovial fluid levels of vitamin D metabolites correlated better with RA disease activity than their circulating serum counterparts [<xref ref-type="bibr" rid="CR128">128</xref>].</p><p id="Par17">Another area of contention for vitamin D and RA concerns the definition of vitamin D deficiency itself (Table <xref rid="Tab1" ref-type="table">1</xref>). In the UK, the National Institute of Clinical Excellence (NICE) recommends diagnosis of vitamin D deficiency when serum 25-OHD3 is < 30 ng/mL, and states that for some people 30-50 ng/mL may be insufficient, citing recommendations from the national osteoporosis society guidelines [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]. Hence, there appears to be an ambiguity around whether or not some patients need more vitamin D than others. Current NICE guidance does not define what constitutes adequate vitamin D status in patients of different ages, sex, ethnicities or disease states; for example, patients at risk of RA vs patients with established RA, or in other inflammatory diseases. To date, few studies have attempted to define what adequate supplementation means in RA. A cohort study published in 2012 observed that even supplementation 800-880 IU/day did not achieve adequate repletion of vitamin D (defined as > 20 ng/mL) in 27.7% of RA patients who were vitamin D-deficient, although duration of therapy was not reported [<xref ref-type="bibr" rid="CR131">131</xref>]. This suggests that different levels of vitamin D replacement may be required in different RA patients, depending on pre-supplementation of vitamin D levels, sunlight exposure and skin colour (darker skin absorbs less UV light to make vitamin D). Failure to adequately replete RA patients could also be related to poor treatment compliance or inadequate duration of supplementation. Importantly, inadequate repletion was related to higher HAQ scores for RA patients, implying that inadequate improvement of vitamin D status following supplementation had poorer outcomes [<xref ref-type="bibr" rid="CR131">131</xref>]. Alternatively higher disease activity may simply be associated with less time spent outdoors, indirectly impacting sunlight exposure and skin synthesis of vitamin D. Further RCTs are needed to more clearly define the optimal levels of vitamin D for patients with RA, and how to achieve and maintain these levels. The next section of the review describes the reported supplementation trials for vitamin D and RA.</p></sec><sec id="Sec7"><title>Vitamin D Supplementation Trials in RA</title><p id="Par18">Ultimately, defining vitamin D deficiency in the context of RA is of clinical interest only if replacing vitamin D in RA patients who are deficient is likely to improve disease symptoms, or even prevent the onset of RA in those at risk. To date, vitamin D supplementation trials for RA have varied appreciably in terms of patient numbers, characteristics, disease duration and severity, concomitant medication regimen, type of/duration of supplementation regimen, number of outcomes and period over which these outcomes were measured (Table <xref rid="Tab2" ref-type="table">2</xref>). A recent meta-analysis identified 9 RCTs of vitamin D supplementation for ≥ 3 months in rheumatic diseases, including 5 studies of RA patients [<xref ref-type="bibr" rid="CR132">132</xref>]. In RA, there was a decrease in the rate of disease flare, VAS and DAS-28 with vitamin D supplementation; however, all failed to reach statistical significance. Similar findings have also been reported in previous meta-analyses on this subject [<xref ref-type="bibr" rid="CR133">133</xref>]. Conversely, a meta-analysis conducted in 2012 found that all but one of the 11 studies included in the meta-analysis suggested low vitamin D intake was linked with both increased risk of RA and greater disease activity [<xref ref-type="bibr" rid="CR134">134</xref>]; however, the studies included in that analysis were cohort/association by design, and not RCTs. Challenges associated with identifying whether vitamin D supplementation has a beneficial effect in RCTs to date include inter-study heterogeneity and relatively small sample numbers for a meta-analysis, with only 5 RCTs included, thus emphasising the need for larger RCTs in different subsets of RA patients to fully elucidate the role, if any, for vitamin D supplementation in the management of RA. In addition, there may be differences in vitamin D-binding protein levels, and other genetic variants, which influence the efficacy of vitamin D supplementation [<xref ref-type="bibr" rid="CR135">135</xref>]. Vitamin D supplementation in low/moderate doses is not thought to be harmful to patients, has wider health benefits, is relatively inexpensive and has fewer side effects/interactions compared with many other commonly used treatments for RA, such as non-steroidal anti-inflammatory drugs (NSAIDs), or conventional synthetic or biological disease-modifying anti-rheumatic drugs (DMARDs). Evidence is also emerging that vitamin D may augment certain therapies in RA. In one in vitro study, vitamin D 1,25-(OH)<sub>2</sub>D3 was shown to act synergistically with the biologic drug abatacept to inhibit T cell activation driven by anti-CD3 cross-linking, and promote a pro-regulatory CD28 phenotype [<xref ref-type="bibr" rid="CR136">136</xref>]. The potential for enhancing the effects of biologics with simple, low-risk addition of 1,25-(OH)<sub>2</sub>D3 is interesting, and further work is required to validate this initial in vitro finding.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Vitamin D supplementation trials in rheumatoid arthritis</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">Study participants (no. eligible + DMARD tx)</th><th align="left">Treatment groups/trial design/BL vit D</th><th align="left">Primary and secondary outcome measures</th><th align="left">Summary of key findings</th></tr></thead><tbody><tr><td align="left">Andjelkovic et al. (1999)</td><td align="left">RA = 19 (on MTX ± GC, active dx)</td><td align="left"><p>2 microg/day oral alfacalcidol for 3/12 in 2 groups; mod + highly active RA. Control group = same patients data collected over 3 months prior to suppl</p><p>Open-label trial</p></td><td align="left">ESR, CRP, EMS, Richie index, Lee index at 3 months</td><td align="left"><p>CRP, SJC, TJC, Richie index and Lee index all significantly decreased after 3/12</p><p>RF and CRP were decreased, but this was not statistically significant</p></td></tr><tr><td align="left">Gopinath et al. (2011)</td><td align="left">RA = 121 (on triple DMARDs)</td><td align="left"><p>500 IU 1,25OH2D3 + CaCO3 vs. CaCO3</p><p>Open-label</p><p>25OHD3 < 20 ng/mL at BL</p></td><td align="left">Pain relief assessed by patient VAS at first relief of pain and again at 3/12</td><td align="left">No difference in time achieves first pain relief; however, there was higher pain relief in the vit D group at 3/12 (NNT = 5)</td></tr><tr><td align="left">Salesi et al. (2012)</td><td align="left">RA = 117 (on MTX ± HCQ/CQ, active dx)</td><td align="left"><p>50,000 IU/week for 3 months vs. placebo</p><p>Double-blinded trial</p></td><td align="left">>0.6 or > 1.2 improvement in DAS28 at wk 12</td><td align="left">No improvement in outcome measures reported</td></tr><tr><td align="left">Dehghan et al. 2014</td><td align="left">RA = 80 (remission for 2/12)</td><td align="left"><p>Cholecalciferol 50,000 IU/week versus placebo</p><p>Double-blind RCT</p><p>25OHD levels were < 30 ng/mL at BL</p></td><td align="left">DAS28 as a marker of relapse, over 6/12</td><td align="left">No statistical significant reduction in relapse rate was observed</td></tr><tr><td align="left">Yang J et al. (2015)</td><td align="left">RA = 377 (RA in remission)</td><td align="left"><p>Alfacalcidol 0.25 microg BD for 24 months in vit D def. RA vs. placebo vs. RA with normal vit D levels and no treatment</p><p>Open-label</p><p>Deficiency = 25OHD3 < 30 ng/mL</p></td><td align="left">VAS, SHC, TJC, CRP, ESR and DAS-28 every 2-3/12</td><td align="left">Normal vit D assoc. with ↓recurrence. No difference was observed with or without vit D suppl. In RA with low vit D</td></tr><tr><td align="left">Buondonno et al. (2017)</td><td align="left">Early RA = 39 (Tx naïve), HC = 31</td><td align="left"><p>MTX + GC vs. MTX + GC + 300,000 IU (one-off dose)</p><p>Double-blind RCT</p></td><td align="left">T cell phenotypes, OC precursors, inflammatory cytokines, clinical parameters at 3/12</td><td align="left">Reduced IL-23, incr. GHS reported in the vit D suppl. group</td></tr><tr><td align="left">Chandrashekara et al. (2017)</td><td align="left">RA = 73 (on DMARDs, active dx)</td><td align="left"><p>60, 000 IU/week for 6 weeks then 60,000 IU/month for 3/12</p><p>Open-label</p><p>25OHD3 < 20 ng/mL at BL + DAS28-CRP > 2.6</p></td><td align="left">Improvement in DAS28-CRP, vitamin D status</td><td align="left">↓ DAS28-CRP and ↑ vit D > 20 ng/mL in the tx group</td></tr></tbody></table><table-wrap-foot><p>References are shown with Supplementary Table 2</p><p><italic>BD</italic> twice daily, <italic>BL</italic> baseline, <italic>CQ</italic> chloroquine, <italic>CRP</italic> C-reactive protein, <italic>DAS</italic> disease activity score, <italic>DMARDs</italic> disease-modifying anti-rheumatic drugs, <italic>EMS</italic> early morning stiffness, <italic>ESR</italic> erythrocyte sedimentation rate, <italic>GC</italic> glucocorticoids, <italic>HCQ</italic> hydroxychloroquine, <italic>MTX</italic> methotrexate, <italic>NNT</italic> number needed to treat, <italic>RA</italic> rheumatoid arthritis, <italic>RF</italic> rheumatoid factor, <italic>SJC</italic> swollen joint count, <italic>TJC</italic> tender joint count, <italic>Tx</italic> treatment, <italic>VAS</italic> visual analogue scale</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Cellular Targets for Vitamin D in RA</title><p id="Par19">The pathogenesis of RA involves both innate and adaptive immune activities. Adaptive CD4+ T cells are critical in the pathogenesis of RA. For example, T cells are a source of RANKL, leading to osteoclast activation and subsequent joint destruction in RA [<xref ref-type="bibr" rid="CR137">137</xref>]. However, antigen-presenting cells (APCs) such as DC also contribute to RA by providing the necessary co-stimulatory signals required for CD4+ T cell activation [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]. Not only do APCs activate T cell proliferation, but they also influence T cell phenotype (Th1/Th2/Th17/Treg) and subsequent cytokine profile, and Th1/17 are both known to be relevant to the pathogenesis of RA [<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]. With this in mind, it is clear that the immunomodulatory activities of 1,25-(OH)<sub>2</sub>D3 described earlier in the review (see Fig. <xref rid="Fig1" ref-type="fig">1</xref>) have the potential to influence both the innate and adaptive immune cell types that contribute to the dysregulated immunity associated with RA. In a murine model of RA, tolerogenic DCs (tolDCs) were observed to reduce severity and progression of RA disease by increasing IL-10-producing T cell numbers and reducing Th17 cell counts [<xref ref-type="bibr" rid="CR142">142</xref>]. It is therefore interesting to note that 1,25-(OH)<sub>2</sub>D3 can induce tolDC [<xref ref-type="bibr" rid="CR143">143</xref>], and tolDCs, generated ex vivo using 1,25-(OH)<sub>2</sub>D3 have been proposed as a potential strategy for RA therapy [<xref ref-type="bibr" rid="CR144">144</xref>]. In this instance, 1,25-(OH)<sub>2</sub>D3 was used in combination with the glucocorticoid dexamethasone which is known to promote a tolDC phenotype [<xref ref-type="bibr" rid="CR58">58</xref>].</p><p id="Par20">In addition to enhanced activity of Th1 and Th17 cells, RA disease is also characterised by reduced Treg activity, including decreased Treg numbers [<xref ref-type="bibr" rid="CR145">145</xref>], a reduction in Treg: Th1/Th17 ratio [<xref ref-type="bibr" rid="CR146">146</xref>], altered Treg function [<xref ref-type="bibr" rid="CR147">147</xref>] and differences in Treg number and function in the peripheral blood compared with the synovium [<xref ref-type="bibr" rid="CR148">148</xref>]. However, in some studies, numbers of circulating Treg in RA were similar to those found in healthy controls [<xref ref-type="bibr" rid="CR149">149</xref>] and osteoarthritis patients [<xref ref-type="bibr" rid="CR150">150</xref>]. Tregs are likely to be a key target for vitamin D in RA. In animal models of experimental autoimmune encephalitis (the most widely used mouse model of MS), IBD and T1D, 1,25-(OH)<sub>2</sub>D3 promotes a Treg phenotype and augment IL-10 production, thus inhibiting Th17 responses and ameliorating disease [<xref ref-type="bibr" rid="CR54">54</xref>]. In studies using human Tregs, the 1,25-(OH)<sub>2</sub>D3 analogue TX527 skewed the Treg cell phenotype in favour of migration to sites of inflammation [<xref ref-type="bibr" rid="CR151">151</xref>], whilst also promoting a stable Treg phenotype [<xref ref-type="bibr" rid="CR152">152</xref>]. The growing pool of ex vivo and in vitro evidence linking vitamin D and Treg function now requires replication in vivo, particularly in diseases such as RA.</p><p id="Par21">To date, most studies of the T cell actions of 1,25-(OH)<sub>2</sub>D3 have been based on the analysis of mixed populations of circulating T cells from healthy donors. However, in recent studies, we have shown that T cells from synovial fluid of RA patients’ inflamed joints are relatively insensitive to 1,25-(OH)<sub>2</sub>D3, despite expressing the VDR machinery required for 1,25-(OH)<sub>2</sub>D3 signalling [<xref ref-type="bibr" rid="CR153">153</xref>]. This is due, in part, to decreased 1,25-(OH)<sub>2</sub>D3 responsiveness in the memory T cells that predominate in RA synovial fluid, but also involves tissue-specific effects, with synovial fluid memory T cells showing decreased responses to 1,25-(OH)<sub>2</sub>D3 relative to peripheral blood memory T cells [<xref ref-type="bibr" rid="CR153">153</xref>]. Based on these observations, we have proposed that immunomodulatory responses to vitamin D at tissue sites of inflammation are impaired by target cell insensitivity to 1,25-(OH)<sub>2</sub>D3. If this is the case, then conventional analysis of the effects of vitamin D using circulating blood immune cells can only provide a limited picture of immunomodulation by vitamin D in diseases such as RA. Likewise, to overcome the vitamin D-insensitivity observed in RA patient, inflamed joints may require alternative strategies. This could include the use of higher doses of vitamin D supplements to enhance localised tissue levels of 1,25-(OH)<sub>2</sub>D3, or the use of vitamin D as an adjunct to other RA therapies. With respect to the latter, we have recently shown that 1,25-(OH)<sub>2</sub>D3 can more potently inhibit T cell activation when used in combination with the CD28 co-stimulatory blocker abatacept [<xref ref-type="bibr" rid="CR154">154</xref>].</p><p id="Par22">Beyond the actions of innate and adaptive immune cells, synovial fibroblasts (synoviocytes) also play an important role in the pathogenesis of RA. In studies using the immortalised synoviocyte cell line, MH7A, 1,25-(OH)<sub>2</sub>D3 has been shown to promote synoviocyte apoptosis, which might protect against RA, but only when cells were treated with both tumor necrosis factor α (TNFα) and 1,25-(OH)<sub>2</sub>D3 [<xref ref-type="bibr" rid="CR155">155</xref>]. These observations suggest that TNFα is required for 1,25-(OH)<sub>2</sub>D3 to have anti-inflammatory effects in RA, which is a paradoxical observation given the use of TNFα inhibitors as biological treatment in RA. Conversely, other studies have reported synergistic effects of TNFα inhibition and 1,25-(OH)<sub>2</sub>D3 in suppressing Th17-mediated inflammation [<xref ref-type="bibr" rid="CR156">156</xref>], suggesting a complex interaction between TNFα and 1,25-(OH)<sub>2</sub>D3. Other studies using MH7A cells have shown synergistic effects of interleukin 1β (IL-1β) and 1,25-(OH)<sub>2</sub>D3 in suppressing the production of IL-6 and TNFβ levels, and Th17-inducing cytokines (IL-1β, IL-6 and IL-23) synergistically enhanced the pro-regulatory effect of 1,25-(OH)<sub>2</sub>D3 on T cell phenotype [<xref ref-type="bibr" rid="CR136">136</xref>], further emphasising important interactions between 1,25-(OH)<sub>2</sub>D3 and pro-inflammatory cytokines in RA [<xref ref-type="bibr" rid="CR157">157</xref>]. Collectively, these observations suggest that the beneficial effects of 1,25-(OH)<sub>2</sub>D3 are most potent when the threshold for activation of the immune response is breached, leading to concomitant production of inflammatory cytokines. Therefore, in the setting of inflammation, vitamin D appears to function as a negative-feedback regulator, attenuating the inflammatory immune responses. Vitamin D may also influence the synovial microenvironment by modulating factors that influence joint bone and cartilage damage. In studies using synoviocytes and articular chondrocytes from RA patients, 1,25-(OH)<sub>2</sub>D3 was shown to regulate matric metalloproteinases and prostaglandins, but only in the presence of IL-1β [<xref ref-type="bibr" rid="CR158">158</xref>], suggesting, as outlined earlier, that 1,25-(OH)<sub>2</sub>D3 is only effective as a regulator of synoviocytes in the setting of RA disease inflammation.</p></sec></sec><sec id="Sec9" sec-type="conclusion"><title>Conclusions</title><p id="Par23">Future studies of vitamin D and RA are needed firstly to expand our current understanding of the mechanisms by which 1,25-(OH)<sub>2</sub>D3 is able to regulate key cells associated with RA. In particular, the observation that T cells from the inflamed joints of RA patients are insensitive to 1,25-(OH)<sub>2</sub>D3 [<xref ref-type="bibr" rid="CR153">153</xref>] indicates that RA disease is associated with a corruption of vitamin D signalling that may be fundamentally important for RA disease pathology, and the therapeutic use of vitamin D. A key question that remains to be answered is whether vitamin D has greater benefits in protecting against the onset of RA as opposed to its potential application as a therapy for established RA disease. Thus, future studies to assess the effects of vitamin D supplementation on disease prevention in individuals at risk of RA, and disease development in those at early stages of RA, are required. These studies are likely to be informed by recent meta-analyses for immune effects of vitamin D. Notably, the observation from the analysis of acute respiratory infection trials that vitamin D supplementation was more beneficial in patients with low baseline serum vitamin D, and was more effective when supplementation was used as lower daily or weekly dosing [<xref ref-type="bibr" rid="CR159">159</xref>], provides some important pointers for future studies of vitamin D and RA. Repeated lower doses of vitamin D supplementation would also help to avoid potential adverse effects of higher doses of vitamin D, in particular the reported increased risk of falls in elderly patients receiving a single bolus of higher-dose vitamin D [<xref ref-type="bibr" rid="CR160">160</xref>]. Future studies also need to take into consideration clinical subgroups of patients, including distinguishing between ethnic groups and disease of different durations. The potential for a simple, low-risk and low-cost intervention such as vitamin D as a plausible adjunctive treatment for RA is an exciting notion. Robust evidence to support wider routine use of vitamin D supplementation in RA has the potential to significantly enhance treatment for RA and other autoimmune diseases.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec10"><p>Below is the link to the electronic supplementary material.
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="223_2019_577_MOESM1_ESM.doc"><caption><p>Supplementary material 1 (DOC 123 kb)</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>Funding was provided by Royal Society (Grant No. WM130118), National Institutes of Health Research (Grant No. Birmingham Biomedical Research Centre), Medical Research Council (Grant No. PhD Studentship).</p></notes><notes><title>Compliance with Ethical Standards</title><notes notes-type="COI-statement"><title>Conflict of interest</title><p id="Par50">Stephanie R. Harrison, Danyang Li, Louisa E. Jefery, Karim Raza, and Martin Hewison declare that they have no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakos</surname><given-names>S</given-names></name><name><surname>Ajibade</surname><given-names>D</given-names></name><name><surname>Dhawan</surname><given-names>P</given-names></name><name><surname>Fechner</surname><given-names>A</given-names></name><name><surname>Mady</surname><given-names>L</given-names></name></person-group><article-title>Vitamin D: metabolism</article-title><source>Endocrinol Metab</source><year>2011</year><volume>39</volume><fpage>243</fpage><lpage>253</lpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname><given-names>HF</given-names></name></person-group><article-title>History of the discovery of vitamin D and its active metabolites</article-title><source>BoneKEy Rep</source><year>2014</year><volume>3</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christakos</surname><given-names>S</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Gardner</surname><given-names>DG</given-names></name><name><surname>Wagner</surname><given-names>CL</given-names></name><name><surname>Sergeev</surname><given-names>IN</given-names></name><name><surname>Rutten</surname><given-names>E</given-names></name><name><surname>Pittas</surname><given-names>AG</given-names></name><name><surname>Boland</surname><given-names>R</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Bikle</surname><given-names>DD</given-names></name></person-group><article-title>Vitamin D: beyond bone</article-title><source>Ann N Y Acad Sci</source><year>2013</year><volume>1287</volume><fpage>45</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">23682710</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>C</given-names></name></person-group><article-title>Vitamin D and diabetes: where do we stand?</article-title><source>Diabetes Res Clin Pract</source><year>2015</year><volume>108</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25700626</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzaro</surname><given-names>G</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name></person-group><article-title>Vitamin D and autoimmune thyroid diseases: facts and unresolved questions</article-title><source>Immunol Res</source><year>2015</year><volume>61</volume><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">25407646</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kivity</surname><given-names>S</given-names></name><name><surname>Agmon-Levin</surname><given-names>N</given-names></name><name><surname>Zisappl</surname><given-names>M</given-names></name><name><surname>Shapira</surname><given-names>Y</given-names></name><name><surname>Nagy</surname><given-names>EV</given-names></name><name><surname>Danko</surname><given-names>K</given-names></name><name><surname>Szekanecz</surname><given-names>Z</given-names></name><name><surname>Langevitz</surname><given-names>P</given-names></name><name><surname>Shoenfeld</surname><given-names>Y</given-names></name></person-group><article-title>Vitamin D and autoimmune thyroid diseases</article-title><source>Cell Mol Immunol</source><year>2011</year><volume>8</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">21278761</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantorna</surname><given-names>MT</given-names></name></person-group><article-title>Vitamin D, multiple sclerosis and inflammatory bowel disease</article-title><source>Arch Biochem Biophys</source><year>2012</year><volume>523</volume><fpage>103</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">22085500</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutolo</surname><given-names>M</given-names></name><name><surname>Otsa</surname><given-names>K</given-names></name></person-group><article-title>Review: vitamin D, immunity and lupus</article-title><source>Lupus</source><year>2008</year><volume>17</volume><fpage>6</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">18089676</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D in rheumatoid arthritis-towards clinical application</article-title><source>Nat Rev Rheumatol</source><year>2016</year><volume>12</volume><fpage>201</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">26481434</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>JG</given-names></name><name><surname>Ochalek</surname><given-names>JT</given-names></name><name><surname>Kaufmann</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>G</given-names></name><name><surname>Deluca</surname><given-names>HF</given-names></name></person-group><article-title>CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>15650</fpage><lpage>15655</lpage><pub-id pub-id-type="pmid">24019477</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Zehnder</surname><given-names>D</given-names></name><name><surname>Bland</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name></person-group><article-title>1alpha-Hydroxylase and the action of vitamin D</article-title><source>J Mol Endocrinol</source><year>2000</year><volume>25</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">11013342</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zehnder</surname><given-names>D</given-names></name><name><surname>Bland</surname><given-names>R</given-names></name><name><surname>Williams</surname><given-names>MC</given-names></name><name><surname>McNinch</surname><given-names>RW</given-names></name><name><surname>Howie</surname><given-names>AJ</given-names></name><name><surname>Stewart</surname><given-names>PM</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase</article-title><source>J Clin Endocrinol Metab</source><year>2001</year><volume>86</volume><fpage>888</fpage><lpage>894</lpage><pub-id pub-id-type="pmid">11158062</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>L</given-names></name><name><surname>Hughes</surname><given-names>SV</given-names></name><name><surname>Evans</surname><given-names>KN</given-names></name><name><surname>Bland</surname><given-names>R</given-names></name><name><surname>Eliopoulos</surname><given-names>AG</given-names></name><name><surname>Kilby</surname><given-names>MD</given-names></name><name><surname>Moss</surname><given-names>PA</given-names></name><name><surname>Chakraverty</surname><given-names>R</given-names></name></person-group><article-title>Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>5382</fpage><lpage>5390</lpage><pub-id pub-id-type="pmid">12759412</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreutz</surname><given-names>M</given-names></name><name><surname>Andreesen</surname><given-names>R</given-names></name><name><surname>Krause</surname><given-names>SW</given-names></name><name><surname>Szabo</surname><given-names>A</given-names></name><name><surname>Ritz</surname><given-names>E</given-names></name><name><surname>Reichel</surname><given-names>H</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages</article-title><source>Blood</source><year>1993</year><volume>82</volume><fpage>1300</fpage><lpage>1307</lpage><pub-id pub-id-type="pmid">8394753</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Wood</surname><given-names>AM</given-names></name><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Hou</surname><given-names>TZ</given-names></name><name><surname>Gardner</surname><given-names>D</given-names></name><name><surname>Briggs</surname><given-names>Z</given-names></name><name><surname>Kaur</surname><given-names>S</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name></person-group><article-title>Availability of 25-hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses</article-title><source>J Immunol</source><year>2012</year><volume>189</volume><fpage>5155</fpage><lpage>5164</lpage><pub-id pub-id-type="pmid">23087405</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Burke</surname><given-names>F</given-names></name><name><surname>Evans</surname><given-names>KN</given-names></name><name><surname>Lammas</surname><given-names>DA</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name></person-group><article-title>Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease</article-title><source>J Steroid Biochem Mol Biol</source><year>2007</year><volume>103</volume><fpage>316</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">17368179</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and the intracrinology of innate immunity</article-title><source>Mol Cell Endocrinol</source><year>2010</year><volume>321</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">20156523</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and the intracrinology of innate immunity</article-title><source>Mol Cell Endocrinol</source><year>2010</year><volume>321</volume><fpage>103</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">20156523</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Rafison</surname><given-names>B</given-names></name><name><surname>Witzel</surname><given-names>S</given-names></name><name><surname>Reyes</surname><given-names>RE</given-names></name><name><surname>Shieh</surname><given-names>A</given-names></name><name><surname>Chun</surname><given-names>R</given-names></name><name><surname>Zavala</surname><given-names>K</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>PT</given-names></name></person-group><article-title>Regulation of the extrarenal CYP27B1-hydroxylase</article-title><source>J Steroid Biochem Mol Biol</source><year>2014</year><volume>144</volume><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">24388948</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Peercy</surname><given-names>BE</given-names></name><name><surname>Orwoll</surname><given-names>ES</given-names></name><name><surname>Nielson</surname><given-names>CM</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and DBP: the free hormone hypothesis revisited</article-title><source>J Steroid Biochem Mol Biol</source><year>2014</year><volume>144</volume><issue>Pt A</issue><fpage>132</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">24095930</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lauridsen</surname><given-names>AL</given-names></name><name><surname>Suon</surname><given-names>L</given-names></name><name><surname>Zella</surname><given-names>LA</given-names></name><name><surname>Pike</surname><given-names>JW</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D</article-title><source>J Clin Endocrinol Metab</source><year>2010</year><volume>95</volume><fpage>3368</fpage><lpage>3376</lpage><pub-id pub-id-type="pmid">20427486</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>G</given-names></name><name><surname>Prosser</surname><given-names>DE</given-names></name><name><surname>Kaufmann</surname><given-names>M</given-names></name></person-group><article-title>25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D</article-title><source>Arch Biochem Biophys</source><year>2012</year><volume>523</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">22100522</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlingmann</surname><given-names>KP</given-names></name><name><surname>Kaufmann</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Irwin</surname><given-names>A</given-names></name><name><surname>Goos</surname><given-names>C</given-names></name><name><surname>John</surname><given-names>U</given-names></name><name><surname>Misselwitz</surname><given-names>J</given-names></name><name><surname>Klaus</surname><given-names>G</given-names></name><name><surname>Kuwertz-Broking</surname><given-names>E</given-names></name><name><surname>Fehrenbach</surname><given-names>H</given-names></name><name><surname>Wingen</surname><given-names>AM</given-names></name><name><surname>Guran</surname><given-names>T</given-names></name><name><surname>Hoenderop</surname><given-names>JG</given-names></name><name><surname>Bindels</surname><given-names>RJ</given-names></name><name><surname>Prosser</surname><given-names>DE</given-names></name><name><surname>Jones</surname><given-names>G</given-names></name><name><surname>Konrad</surname><given-names>M</given-names></name></person-group><article-title>Mutations in CYP24A1 and idiopathic infantile hypercalcemia</article-title><source>N Engl J Med</source><year>2011</year><volume>365</volume><fpage>410</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">21675912</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity</article-title><source>Nat Clin Pract Endocrinol Metab</source><year>2008</year><volume>4</volume><fpage>80</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">18212810</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and innate and adaptive immunity</article-title><source>Vitam Horm</source><year>2011</year><volume>86</volume><fpage>23</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">21419266</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Antibacterial effects of vitamin D</article-title><source>Nat Rev</source><year>2011</year><volume>7</volume><fpage>337</fpage><lpage>345</lpage></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name></person-group><article-title>Where is the vitamin D receptor?</article-title><source>Arch Biochem Biophys</source><year>2012</year><volume>523</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">22503810</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouillon</surname><given-names>R</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name><name><surname>Verlinden</surname><given-names>L</given-names></name><name><surname>van Etten</surname><given-names>E</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Luderer</surname><given-names>HF</given-names></name><name><surname>Lieben</surname><given-names>L</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Demay</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and human health: lessons from vitamin D receptor null mice</article-title><source>Endocr Rev</source><year>2008</year><volume>29</volume><fpage>726</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">18694980</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y-G</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name><name><surname>Petrof</surname><given-names>E</given-names></name><name><surname>Claud</surname><given-names>EC</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name></person-group><article-title>Tight junction CLDN2 gene is a direct target of the vitamin D receptor</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>10642</fpage><pub-id pub-id-type="pmid">26212084</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Tian</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Deb</surname><given-names>DK</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Bissonnette</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name></person-group><article-title>Gut epithelial vitamin d receptor regulates microbiota-dependent mucosal inflammation by suppressing intestinal epithelial cell apoptosis</article-title><source>Endocrinology</source><year>2018</year><volume>159</volume><fpage>967</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">29228157</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>TT</given-names></name><name><surname>Dabbas</surname><given-names>B</given-names></name><name><surname>Laperriere</surname><given-names>D</given-names></name><name><surname>Bitton</surname><given-names>AJ</given-names></name><name><surname>Soualhine</surname><given-names>H</given-names></name><name><surname>Tavera-Mendoza</surname><given-names>LE</given-names></name><name><surname>Dionne</surname><given-names>S</given-names></name><name><surname>Servant</surname><given-names>MJ</given-names></name><name><surname>Bitton</surname><given-names>A</given-names></name><name><surname>Seidman</surname><given-names>EG</given-names></name><name><surname>Mader</surname><given-names>S</given-names></name><name><surname>Behr</surname><given-names>MA</given-names></name><name><surname>White</surname><given-names>JH</given-names></name></person-group><article-title>Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>2227</fpage><lpage>2231</lpage><pub-id pub-id-type="pmid">19948723</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacchetta</surname><given-names>J</given-names></name><name><surname>Zaritsky</surname><given-names>JJ</given-names></name><name><surname>Sea</surname><given-names>JL</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lisse</surname><given-names>TS</given-names></name><name><surname>Zavala</surname><given-names>K</given-names></name><name><surname>Nayak</surname><given-names>A</given-names></name><name><surname>Wesseling-Perry</surname><given-names>K</given-names></name><name><surname>Westerman</surname><given-names>M</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Salusky</surname><given-names>IB</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Suppression of iron-regulatory hepcidin by vitamin D</article-title><source>J Am Soc Nephrol</source><year>2014</year><volume>25</volume><fpage>564</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">24204002</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Stenger</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Wenzel</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>BH</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Ochoa</surname><given-names>MT</given-names></name><name><surname>Schauber</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Meinken</surname><given-names>C</given-names></name><name><surname>Kamen</surname><given-names>DL</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Bals</surname><given-names>R</given-names></name><name><surname>Steinmeyer</surname><given-names>A</given-names></name><name><surname>Zugel</surname><given-names>U</given-names></name><name><surname>Gallo</surname><given-names>RL</given-names></name><name><surname>Eisenberg</surname><given-names>D</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name></person-group><article-title>Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response</article-title><source>Science</source><year>2006</year><volume>311</volume><fpage>1770</fpage><lpage>1773</lpage><pub-id pub-id-type="pmid">16497887</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>PT</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>VP</given-names></name><name><surname>Dempsey</surname><given-names>PW</given-names></name><name><surname>Kanchanapoomi</surname><given-names>M</given-names></name><name><surname>Wheelwright</surname><given-names>M</given-names></name><name><surname>Vazirnia</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Steinmeyer</surname><given-names>A</given-names></name><name><surname>Zugel</surname><given-names>U</given-names></name><name><surname>Hollis</surname><given-names>BW</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Modlin</surname><given-names>RL</given-names></name></person-group><article-title>Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses</article-title><source>PLoS ONE</source><year>2009</year><volume>4</volume><fpage>e5810</fpage><pub-id pub-id-type="pmid">19503839</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Kwon</surname><given-names>E</given-names></name><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Song</surname><given-names>GG</given-names></name><name><surname>Sohn</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>JD</given-names></name></person-group><article-title>Regulation of TREM-1 expression by 1,25-dihydroxyvitamin D3 in human monocytes/macrophages</article-title><source>Immunol Lett</source><year>2013</year><volume>154</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">24012964</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadeghi</surname><given-names>K</given-names></name><name><surname>Wessner</surname><given-names>B</given-names></name><name><surname>Laggner</surname><given-names>U</given-names></name><name><surname>Ploder</surname><given-names>M</given-names></name><name><surname>Tamandl</surname><given-names>D</given-names></name><name><surname>Friedl</surname><given-names>J</given-names></name><name><surname>Zugel</surname><given-names>U</given-names></name><name><surname>Steinmeyer</surname><given-names>A</given-names></name><name><surname>Pollak</surname><given-names>A</given-names></name><name><surname>Roth</surname><given-names>E</given-names></name><name><surname>Boltz-Nitulescu</surname><given-names>G</given-names></name><name><surname>Spittler</surname><given-names>A</given-names></name></person-group><article-title>Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns</article-title><source>Eur J Immunol</source><year>2006</year><volume>36</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">16402404</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>V</given-names></name><name><surname>Saccone</surname><given-names>DS</given-names></name><name><surname>Tugizimana</surname><given-names>F</given-names></name><name><surname>Asani</surname><given-names>FF</given-names></name><name><surname>Jeffery</surname><given-names>TJ</given-names></name><name><surname>Bornman</surname><given-names>L</given-names></name></person-group><article-title>Methylation of the Vitamin D Receptor (VDR) gene, together with genetic variation, race, and environment influence the signaling efficacy of the toll-like receptor 2/1-VDR pathway</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">28149297</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritsche</surname><given-names>J</given-names></name><name><surname>Mondal</surname><given-names>K</given-names></name><name><surname>Ehrnsperger</surname><given-names>A</given-names></name><name><surname>Andreesen</surname><given-names>R</given-names></name><name><surname>Kreutz</surname><given-names>M</given-names></name></person-group><article-title>Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells</article-title><source>Blood</source><year>2003</year><volume>102</volume><fpage>3314</fpage><lpage>3316</lpage><pub-id pub-id-type="pmid">12855575</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dionne</surname><given-names>S</given-names></name><name><surname>Duchatelier</surname><given-names>CF</given-names></name><name><surname>Seidman</surname><given-names>EG</given-names></name></person-group><article-title>The influence of vitamin D on M1 and M2 macrophages in patients with Crohn’s disease</article-title><source>Innate Immun</source><year>2017</year><volume>23</volume><fpage>557</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">28770666</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Zehnder</surname><given-names>D</given-names></name><name><surname>Chakraverty</surname><given-names>R</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name></person-group><article-title>Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase</article-title><source>Mol Cell Endocrinol</source><year>2004</year><volume>215</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">15026172</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penna</surname><given-names>G</given-names></name><name><surname>Adorini</surname><given-names>L</given-names></name></person-group><article-title>1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation</article-title><source>J Immunol (Baltimore, Md.: 1950)</source><year>2000</year><volume>164</volume><fpage>2405</fpage><lpage>2411</lpage></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Halteren</surname><given-names>AG</given-names></name><name><surname>Tysma</surname><given-names>OM</given-names></name><name><surname>van Etten</surname><given-names>E</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Roep</surname><given-names>BO</given-names></name></person-group><article-title>1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis</article-title><source>J Autoimmun</source><year>2004</year><volume>23</volume><fpage>233</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">15501394</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>AW</given-names></name><name><surname>Holmstrøm</surname><given-names>K</given-names></name><name><surname>Jensen</surname><given-names>SS</given-names></name><name><surname>Fuchs</surname><given-names>D</given-names></name><name><surname>Rasmussen</surname><given-names>S</given-names></name><name><surname>Kvistborg</surname><given-names>P</given-names></name><name><surname>Claesson</surname><given-names>MH</given-names></name><name><surname>Zocca</surname><given-names>MB</given-names></name></person-group><article-title>Phenotypic and functional markers for 1α,25-dihydroxyvitamin D3-modified regulatory dendritic cells</article-title><source>Clin Exp Immunol</source><year>2009</year><volume>157</volume><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">19659770</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>MD</given-names></name><name><surname>Lutz</surname><given-names>W</given-names></name><name><surname>Phan</surname><given-names>VA</given-names></name><name><surname>Bachman</surname><given-names>LA</given-names></name><name><surname>McKean</surname><given-names>DJ</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name></person-group><article-title>Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>6800</fpage><lpage>6805</lpage><pub-id pub-id-type="pmid">11371626</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willheim</surname><given-names>M</given-names></name><name><surname>Thien</surname><given-names>R</given-names></name><name><surname>Schrattbauer</surname><given-names>K</given-names></name><name><surname>Bajna</surname><given-names>E</given-names></name><name><surname>Holub</surname><given-names>M</given-names></name><name><surname>Gruber</surname><given-names>R</given-names></name><name><surname>Baier</surname><given-names>K</given-names></name><name><surname>Pietschmann</surname><given-names>P</given-names></name><name><surname>Reinisch</surname><given-names>W</given-names></name><name><surname>Scheiner</surname><given-names>O</given-names></name><name><surname>Peterlik</surname><given-names>M</given-names></name></person-group><article-title>Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes</article-title><source>J Clin Endocrinol Metab</source><year>1999</year><volume>84</volume><fpage>3739</fpage><lpage>3744</lpage><pub-id pub-id-type="pmid">10523023</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartels</surname><given-names>LE</given-names></name><name><surname>Jørgensen</surname><given-names>SP</given-names></name><name><surname>Agnholt</surname><given-names>J</given-names></name><name><surname>Kelsen</surname><given-names>J</given-names></name><name><surname>Hvas</surname><given-names>CL</given-names></name><name><surname>Dahlerup</surname><given-names>JF</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn’s disease</article-title><source>Int Immunopharmacol</source><year>2007</year><volume>7</volume><fpage>1755</fpage><lpage>1764</lpage><pub-id pub-id-type="pmid">17996686</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penna</surname><given-names>G</given-names></name><name><surname>Adorini</surname><given-names>L</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>2405</fpage><lpage>2411</lpage><pub-id pub-id-type="pmid">10679076</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piemonti</surname><given-names>L</given-names></name><name><surname>Monti</surname><given-names>P</given-names></name><name><surname>Sironi</surname><given-names>M</given-names></name><name><surname>Fraticelli</surname><given-names>P</given-names></name><name><surname>Leone</surname><given-names>BE</given-names></name><name><surname>Dal Cin</surname><given-names>E</given-names></name><name><surname>Allavena</surname><given-names>P</given-names></name><name><surname>Di Carlo</surname><given-names>V</given-names></name></person-group><article-title>Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells</article-title><source>J Immunol (Baltimore, Md.: 1950)</source><year>2000</year><volume>164</volume><fpage>4443</fpage><lpage>4451</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szeles</surname><given-names>L</given-names></name><name><surname>Keresztes</surname><given-names>G</given-names></name><name><surname>Torocsik</surname><given-names>D</given-names></name><name><surname>Balajthy</surname><given-names>Z</given-names></name><name><surname>Krenacs</surname><given-names>L</given-names></name><name><surname>Poliska</surname><given-names>S</given-names></name><name><surname>Steinmeyer</surname><given-names>A</given-names></name><name><surname>Zuegel</surname><given-names>U</given-names></name><name><surname>Pruenster</surname><given-names>M</given-names></name><name><surname>Rot</surname><given-names>A</given-names></name><name><surname>Nagy</surname><given-names>L</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype</article-title><source>J Immunol (Baltimore, Md.: 1950)</source><year>2009</year><volume>182</volume><fpage>2074</fpage><lpage>2083</lpage></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhalla</surname><given-names>AK</given-names></name><name><surname>Amento</surname><given-names>EP</given-names></name><name><surname>Clemens</surname><given-names>TL</given-names></name><name><surname>Holick</surname><given-names>MF</given-names></name><name><surname>Krane</surname><given-names>SM</given-names></name></person-group><article-title>Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation</article-title><source>J Clin Endocrinol Metab</source><year>1983</year><volume>57</volume><fpage>1308</fpage><lpage>1310</lpage><pub-id pub-id-type="pmid">6313738</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provvedini</surname><given-names>DM</given-names></name><name><surname>Tsoukas</surname><given-names>CD</given-names></name><name><surname>Deftos</surname><given-names>LJ</given-names></name><name><surname>Manolagas</surname><given-names>SC</given-names></name></person-group><article-title>1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production</article-title><source>J Immunol</source><year>1986</year><volume>136</volume><fpage>2734</fpage><lpage>2740</lpage><pub-id pub-id-type="pmid">3007606</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D and immune function: an overview</article-title><source>Proc Nutr Soc</source><year>2012</year><volume>71</volume><fpage>50</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">21849106</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarkar</surname><given-names>S</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Studzinski</surname><given-names>GP</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Kalia</surname><given-names>V</given-names></name></person-group><article-title>Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer</article-title><source>Crit Rev Clin Lab Sci</source><year>2016</year><volume>53</volume><fpage>132</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">26479950</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantorna</surname><given-names>MT</given-names></name><name><surname>Snyder</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>Y-D</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name></person-group><article-title>Vitamin D and 1,25(OH)2D regulation of T cells</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>3011</fpage><lpage>3021</lpage><pub-id pub-id-type="pmid">25912039</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>S</given-names></name><name><surname>Pantalena</surname><given-names>LC</given-names></name><name><surname>Liu</surname><given-names>XK</given-names></name><name><surname>Gaffen</surname><given-names>SL</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Rohowsky-Kochan</surname><given-names>C</given-names></name><name><surname>Ichiyama</surname><given-names>K</given-names></name><name><surname>Yoshimura</surname><given-names>A</given-names></name><name><surname>Steinman</surname><given-names>L</given-names></name><name><surname>Christakos</surname><given-names>S</given-names></name><name><surname>Youssef</surname><given-names>S</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A</article-title><source>Mol Cell Biol</source><year>2011</year><volume>31</volume><fpage>3653</fpage><lpage>3669</lpage><pub-id pub-id-type="pmid">21746882</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantorna</surname><given-names>MT</given-names></name><name><surname>Nashold</surname><given-names>FE</given-names></name><name><surname>Chun</surname><given-names>TY</given-names></name><name><surname>Hayes</surname><given-names>CE</given-names></name></person-group><article-title>Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway</article-title><source>J Immunol</source><year>1996</year><volume>156</volume><fpage>2674</fpage><lpage>2679</lpage><pub-id pub-id-type="pmid">8609382</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boonstra</surname><given-names>A</given-names></name><name><surname>Barrat</surname><given-names>FJ</given-names></name><name><surname>Crain</surname><given-names>C</given-names></name><name><surname>Heath</surname><given-names>VL</given-names></name><name><surname>Savelkoul</surname><given-names>HF</given-names></name><name><surname>O’Garra</surname><given-names>A</given-names></name></person-group><article-title>1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells</article-title><source>J Immunol</source><year>2001</year><volume>167</volume><fpage>4974</fpage><lpage>4980</lpage><pub-id pub-id-type="pmid">11673504</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrat</surname><given-names>FJ</given-names></name><name><surname>Cua</surname><given-names>DJ</given-names></name><name><surname>Boonstra</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>DF</given-names></name><name><surname>Crain</surname><given-names>C</given-names></name><name><surname>Savelkoul</surname><given-names>HF</given-names></name><name><surname>de Waal-Malefyt</surname><given-names>R</given-names></name><name><surname>Coffman</surname><given-names>RL</given-names></name><name><surname>Hawrylowicz</surname><given-names>CM</given-names></name><name><surname>O’Garra</surname><given-names>A</given-names></name></person-group><article-title>In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines</article-title><source>J Exp Med</source><year>2002</year><volume>195</volume><fpage>603</fpage><lpage>616</lpage><pub-id pub-id-type="pmid">11877483</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Burke</surname><given-names>F</given-names></name><name><surname>Mura</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Walker</surname><given-names>LS</given-names></name><name><surname>Lammas</surname><given-names>DA</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>5458</fpage><lpage>5467</lpage><pub-id pub-id-type="pmid">19843932</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Essen</surname><given-names>MR</given-names></name><name><surname>Kongsbak</surname><given-names>M</given-names></name><name><surname>Schjerling</surname><given-names>P</given-names></name><name><surname>Olgaard</surname><given-names>K</given-names></name><name><surname>Odum</surname><given-names>N</given-names></name><name><surname>Geisler</surname><given-names>C</given-names></name></person-group><article-title>Vitamin D controls T cell antigen receptor signaling and activation of human T cells</article-title><source>Nat Immunol</source><year>2010</year><volume>11</volume><fpage>344</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">20208539</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino</surname><given-names>F</given-names></name><name><surname>Alvarez-Mon</surname><given-names>M</given-names></name><name><surname>de la Hera</surname><given-names>A</given-names></name><name><surname>Ales</surname><given-names>JE</given-names></name><name><surname>Bonilla</surname><given-names>F</given-names></name><name><surname>Durantez</surname><given-names>A</given-names></name></person-group><article-title>Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3</article-title><source>Cell Immunol</source><year>1989</year><volume>118</volume><fpage>328</fpage><lpage>336</lpage><pub-id pub-id-type="pmid">2783392</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Cantorna</surname><given-names>MT</given-names></name></person-group><article-title>The vitamin D receptor is required for iNKT cell development</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>5207</fpage><lpage>5212</lpage><pub-id pub-id-type="pmid">18364394</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>K</given-names></name><name><surname>Heilmann</surname><given-names>C</given-names></name><name><surname>Poulsen</surname><given-names>LK</given-names></name><name><surname>Barington</surname><given-names>T</given-names></name><name><surname>Bendtzen</surname><given-names>K</given-names></name></person-group><article-title>The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro</article-title><source>Immunopharmacology</source><year>1991</year><volume>21</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">1880018</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Sims</surname><given-names>GP</given-names></name><name><surname>Chen</surname><given-names>XX</given-names></name><name><surname>Gu</surname><given-names>YY</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lipsky</surname><given-names>PE</given-names></name></person-group><article-title>Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>1634</fpage><lpage>1647</lpage><pub-id pub-id-type="pmid">17641030</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heine</surname><given-names>G</given-names></name><name><surname>Niesner</surname><given-names>U</given-names></name><name><surname>Chang</surname><given-names>HD</given-names></name><name><surname>Steinmeyer</surname><given-names>A</given-names></name><name><surname>Zugel</surname><given-names>U</given-names></name><name><surname>Zuberbier</surname><given-names>T</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Worm</surname><given-names>M</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells</article-title><source>Eur J Immunol</source><year>2008</year><volume>38</volume><fpage>2210</fpage><lpage>2218</lpage><pub-id pub-id-type="pmid">18651709</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirakawa</surname><given-names>AK</given-names></name><name><surname>Nagakubo</surname><given-names>D</given-names></name><name><surname>Hieshima</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 induces CCR16 expression in terminally differentiating human B cells</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>2786</fpage><lpage>2795</lpage><pub-id pub-id-type="pmid">18292499</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hufnaql</surname><given-names>K</given-names></name><name><surname>Jensen-Jarolim</surname><given-names>E</given-names></name></person-group><article-title>Vitamin A and D in allergy: from experimental animal models and cellular studies to human disease</article-title><source>Allergo J Int</source><year>2018</year><volume>27</volume><fpage>72</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">29707474</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anaya</surname><given-names>JM</given-names></name><name><surname>Restrepo-Jiménez</surname><given-names>P</given-names></name><name><surname>Ramírez-Santana</surname><given-names>C</given-names></name></person-group><article-title>The autoimmune ecology: an update</article-title><source>Curr Opin Rheumatol</source><year>2018</year><volume>30</volume><fpage>350</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">29438164</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikiphorou</surname><given-names>E</given-names></name><name><surname>Uksila</surname><given-names>J</given-names></name><name><surname>Sokka</surname><given-names>T</given-names></name></person-group><article-title>A cross-sectional study of vitamin D levels in a large cohort of patients with rheumatic diseases</article-title><source>Clin Rheumatol</source><year>2018</year><volume>37</volume><fpage>803</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">29116541</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>R</given-names></name><name><surname>Rodney Harris</surname><given-names>R</given-names></name></person-group><article-title>On the nature of evidence and ‘proving’ causality: smoking and lung cancer vs. sun exposure, vitamin D and multiple sclerosis</article-title><source>Int J Environ Res Public Health</source><year>2018</year><volume>15</volume><fpage>1726</fpage></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Disanto</surname><given-names>G</given-names></name><name><surname>Chaplin</surname><given-names>G</given-names></name><name><surname>Morahan</surname><given-names>JM</given-names></name><name><surname>Giovannoni</surname><given-names>G</given-names></name><name><surname>Hypponen</surname><given-names>E</given-names></name><name><surname>Ebers</surname><given-names>GC</given-names></name><name><surname>Ramagopalan</surname><given-names>SV</given-names></name></person-group><article-title>Month of birth, vitamin D and risk of immune-mediated disease: a case control study</article-title><source>BMC Med</source><year>2012</year><volume>10</volume><fpage>69</fpage><pub-id pub-id-type="pmid">22764877</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harroud</surname><given-names>A</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name></person-group><article-title>Mendelian randomization in multiple sclerosis: a causal role for vitamin D and obesity?</article-title><source>Mult Scler</source><year>2018</year><volume>24</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">29307294</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokry</surname><given-names>LE</given-names></name><name><surname>Ross</surname><given-names>S</given-names></name><name><surname>Ahmad</surname><given-names>OS</given-names></name><name><surname>Forgetta</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><name><surname>Goltzman</surname><given-names>D</given-names></name><name><surname>Leong</surname><given-names>A</given-names></name><name><surname>Greenwood</surname><given-names>CM</given-names></name><name><surname>Thanassoulis</surname><given-names>G</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name></person-group><article-title>Vitamin D and risk of multiple sclerosis: a mendelian randomization study</article-title><source>PLoS Med</source><year>2015</year><volume>12</volume><fpage>e1001866</fpage><pub-id pub-id-type="pmid">26305103</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krementsov</surname><given-names>DN</given-names></name><name><surname>Asarian</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>Q</given-names></name><name><surname>McGill</surname><given-names>MM</given-names></name><name><surname>Teuscher</surname><given-names>C</given-names></name></person-group><article-title>Sex-specific gene-by-vitamin D interactions regulate susceptibility to central nervous system autoimmunity</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">29403488</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamisli</surname><given-names>O</given-names></name><name><surname>Acar</surname><given-names>C</given-names></name><name><surname>Sozen</surname><given-names>M</given-names></name><name><surname>Tecellioglu</surname><given-names>M</given-names></name><name><surname>Yücel</surname><given-names>FE</given-names></name><name><surname>Vaizoglu</surname><given-names>D</given-names></name><name><surname>Özcan</surname><given-names>C</given-names></name></person-group><article-title>The association between vitamin D receptor polymorphisms and multiple sclerosis in a Turkish population</article-title><source>Mult Scler Relat Disord</source><year>2018</year><volume>20</volume><fpage>78</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">29331875</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Křenek</surname><given-names>P</given-names></name><name><surname>Benešová</surname><given-names>Y</given-names></name><name><surname>Bienertová-Vašků</surname><given-names>J</given-names></name><name><surname>Vašků</surname><given-names>A</given-names></name></person-group><article-title>The impact of five VDR polymorphisms on multiple sclerosis risk and progression: a case–control and genotype-phenotype study</article-title><source>J Mol Neurosci</source><year>2018</year><volume>64</volume><fpage>559</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">29589202</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouchaki</surname><given-names>E</given-names></name><name><surname>Afarini</surname><given-names>M</given-names></name><name><surname>Abolhassani</surname><given-names>J</given-names></name><name><surname>Mirhosseini</surname><given-names>N</given-names></name><name><surname>Bahmani</surname><given-names>F</given-names></name><name><surname>Masoud</surname><given-names>SA</given-names></name><name><surname>Asemi</surname><given-names>Z</given-names></name></person-group><article-title>High-dose ω-3 fatty acid plus vitamin D3 supplementation affects clinical symptoms and metabolic status of patients with multiple sclerosis: a randomized controlled clinical trial</article-title><source>J Nutr</source><year>2018</year><volume>148</volume><fpage>1380</fpage><lpage>1386</lpage><pub-id pub-id-type="pmid">29982544</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolf</surname><given-names>L</given-names></name><name><surname>Muris</surname><given-names>AG</given-names></name><name><surname>Theunissen</surname><given-names>R</given-names></name><name><surname>Hupperts</surname><given-names>R</given-names></name><name><surname>Damoiseaux</surname><given-names>J</given-names></name><name><surname>Smolders</surname><given-names>J</given-names></name></person-group><article-title>Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: attenuation of progressive disturbances?</article-title><source>J Neuroimmunol</source><year>2018</year><volume>314</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">29153546</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miclea</surname><given-names>A</given-names></name><name><surname>Miclea</surname><given-names>M</given-names></name><name><surname>Pistor</surname><given-names>M</given-names></name><name><surname>Hoepner</surname><given-names>A</given-names></name><name><surname>Chan</surname><given-names>A</given-names></name><name><surname>Hoepner</surname><given-names>R</given-names></name></person-group><article-title>Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity</article-title><source>Brain Behav</source><year>2017</year><volume>7</volume><fpage>e00761</fpage><pub-id pub-id-type="pmid">28828221</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosjo</surname><given-names>E</given-names></name><name><surname>Lossius</surname><given-names>A</given-names></name><name><surname>Abdelmagid</surname><given-names>N</given-names></name><name><surname>Lindstrom</surname><given-names>JC</given-names></name><name><surname>Kampman</surname><given-names>MT</given-names></name><name><surname>Jorgensen</surname><given-names>L</given-names></name><name><surname>Sundstrom</surname><given-names>P</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><name><surname>Steffensen</surname><given-names>LH</given-names></name><name><surname>Torkildsen</surname><given-names>O</given-names></name><name><surname>Holmoy</surname><given-names>T</given-names></name></person-group><article-title>Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis</article-title><source>Mult Scler</source><year>2017</year><volume>23</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">27325604</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosjo</surname><given-names>E</given-names></name><name><surname>Steffensen</surname><given-names>LH</given-names></name><name><surname>Jorgensen</surname><given-names>L</given-names></name><name><surname>Lindstrom</surname><given-names>JC</given-names></name><name><surname>Saltyte Benth</surname><given-names>J</given-names></name><name><surname>Michelsen</surname><given-names>AE</given-names></name><name><surname>Aukrust</surname><given-names>P</given-names></name><name><surname>Ueland</surname><given-names>T</given-names></name><name><surname>Kampman</surname><given-names>MT</given-names></name><name><surname>Torkildsen</surname><given-names>O</given-names></name><name><surname>Holmoy</surname><given-names>T</given-names></name></person-group><article-title>Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis</article-title><source>J Neurol</source><year>2015</year><volume>262</volume><fpage>2713</fpage><lpage>2721</lpage><pub-id pub-id-type="pmid">26429571</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name></person-group><article-title>Association between Vitamin D level and/or deficiency, and systemic lupus erythematosus: a meta-analysis</article-title><source>Cell Mol Biol</source><year>2018</year><volume>64</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">29412807</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Duan</surname><given-names>X-H</given-names></name><name><surname>Wu</surname><given-names>Z-Z</given-names></name><name><surname>Gao</surname><given-names>C-C</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Zheng</surname><given-names>Z-H</given-names></name></person-group><article-title>Severe vitamin D deficiency affects the expression of autophagy related genes in PBMCs and T-cell subsets in active systemic lupus erythematosus</article-title><source>Am J Clin Exp Immunol</source><year>2017</year><volume>6</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">28695056</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel Galil</surname><given-names>SM</given-names></name><name><surname>El-Shafey</surname><given-names>AM</given-names></name><name><surname>Abdul-Makoud</surname><given-names>RS</given-names></name><name><surname>El-Boshy</surname><given-names>M</given-names></name></person-group><article-title>Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus</article-title><source>Lupus</source><year>2018</year><volume>27</volume><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">28659049</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahin</surname><given-names>D</given-names></name><name><surname>El-Farahaty</surname><given-names>RM</given-names></name><name><surname>Houssen</surname><given-names>ME</given-names></name><name><surname>Machaly</surname><given-names>SA</given-names></name><name><surname>Sallam</surname><given-names>M</given-names></name><name><surname>ElSaid</surname><given-names>TO</given-names></name><name><surname>Neseem</surname><given-names>NO</given-names></name></person-group><article-title>Serum 25-OH vitamin D level in treatment-naive systemic lupus erythematosus patients: relation to disease activity, IL-23 and IL-17</article-title><source>Lupus</source><year>2017</year><volume>26</volume><fpage>917</fpage><lpage>926</lpage><pub-id pub-id-type="pmid">27927883</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aranow</surname><given-names>C</given-names></name><name><surname>Kamen</surname><given-names>DL</given-names></name><name><surname>Dall’Era</surname><given-names>M</given-names></name><name><surname>Massarotti</surname><given-names>EM</given-names></name><name><surname>Mackay</surname><given-names>MC</given-names></name><name><surname>Koumpouras</surname><given-names>F</given-names></name><name><surname>Coca</surname><given-names>A</given-names></name><name><surname>Chatham</surname><given-names>WW</given-names></name><name><surname>Clowse</surname><given-names>ME</given-names></name><name><surname>Criscione-Schreiber</surname><given-names>LG</given-names></name><name><surname>Callahan</surname><given-names>S</given-names></name><name><surname>Goldmuntz</surname><given-names>EA</given-names></name><name><surname>Keyes-Elstein</surname><given-names>L</given-names></name><name><surname>Oswald</surname><given-names>M</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name></person-group><article-title>Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus</article-title><source>Arthritis Rheumatol</source><year>2015</year><volume>67</volume><fpage>1848</fpage><lpage>1857</lpage><pub-id pub-id-type="pmid">25777546</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karimzadeh</surname><given-names>H</given-names></name><name><surname>Shirzadi</surname><given-names>M</given-names></name><name><surname>Karimifar</surname><given-names>M</given-names></name></person-group><article-title>The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: a randomized clinical trial</article-title><source>J Res Med Sci</source><year>2017</year><volume>22</volume><fpage>4</fpage><pub-id pub-id-type="pmid">28400826</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costenbader</surname><given-names>KH</given-names></name><name><surname>Feskanich</surname><given-names>D</given-names></name><name><surname>Holmes</surname><given-names>M</given-names></name><name><surname>Karlson</surname><given-names>EW</given-names></name><name><surname>Benito-Garcia</surname><given-names>E</given-names></name></person-group><article-title>Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women</article-title><source>Ann Rheum Dis</source><year>2008</year><volume>67</volume><fpage>530</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">17666449</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>GL</given-names></name><name><surname>Paupitz</surname><given-names>J</given-names></name><name><surname>Aikawa</surname><given-names>NE</given-names></name><name><surname>Takayama</surname><given-names>L</given-names></name><name><surname>Bonfa</surname><given-names>E</given-names></name><name><surname>Pereira</surname><given-names>RM</given-names></name></person-group><article-title>Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial</article-title><source>Arthritis Care Res (Hoboken)</source><year>2016</year><volume>68</volume><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">25988278</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zella</surname><given-names>JB</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name></person-group><article-title>Vitamin D and autoimmune diabetes</article-title><source>J Cell Biochem</source><year>2003</year><volume>88</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">12520517</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name></person-group><article-title>Vitamin D and type 1 diabetes mellitus: state of the art</article-title><source>Trends Endocrinol Metab</source><year>2005</year><volume>16</volume><fpage>261</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">15996876</pub-id></element-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aljabri</surname><given-names>KS</given-names></name><name><surname>Bokhari</surname><given-names>SA</given-names></name><name><surname>Khan</surname><given-names>MJ</given-names></name></person-group><article-title>Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency</article-title><source>Ann Saudi Med</source><year>2010</year><volume>30</volume><fpage>454</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">21060157</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Zeitels</surname><given-names>L</given-names></name><name><surname>Smyth</surname><given-names>DJ</given-names></name><name><surname>Yang</surname><given-names>JH</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Hypponen</surname><given-names>E</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name><name><surname>Ramos-Lopez</surname><given-names>E</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name><name><surname>Nejentsev</surname><given-names>S</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes</article-title><source>Diabetes</source><year>2007</year><volume>56</volume><fpage>2616</fpage><lpage>2621</lpage><pub-id pub-id-type="pmid">17606874</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>JD</given-names></name><name><surname>Smyth</surname><given-names>DJ</given-names></name><name><surname>Walker</surname><given-names>NM</given-names></name><name><surname>Stevens</surname><given-names>H</given-names></name><name><surname>Burren</surname><given-names>OS</given-names></name><name><surname>Wallace</surname><given-names>C</given-names></name><name><surname>Greissl</surname><given-names>C</given-names></name><name><surname>Ramos-Lopez</surname><given-names>E</given-names></name><name><surname>Hypponen</surname><given-names>E</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Ouwehand</surname><given-names>WH</given-names></name><name><surname>Wang</surname><given-names>TJ</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes</article-title><source>Diabetes</source><year>2011</year><volume>60</volume><fpage>1624</fpage><lpage>1631</lpage><pub-id pub-id-type="pmid">21441443</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>ER</given-names></name><name><surname>Regulla</surname><given-names>K</given-names></name><name><surname>Pani</surname><given-names>MA</given-names></name><name><surname>Krause</surname><given-names>M</given-names></name><name><surname>Usadel</surname><given-names>KH</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name></person-group><article-title>CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans</article-title><source>J Steroid Biochem Mol Biol</source><year>2004</year><volume>89–90</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">15225764</pub-id></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Lopez</surname><given-names>E</given-names></name><name><surname>Jansen</surname><given-names>T</given-names></name><name><surname>Ivaskevicius</surname><given-names>V</given-names></name><name><surname>Kahles</surname><given-names>H</given-names></name><name><surname>Klepzig</surname><given-names>C</given-names></name><name><surname>Oldenburg</surname><given-names>J</given-names></name><name><surname>Badenhoop</surname><given-names>K</given-names></name></person-group><article-title>Protection from type 1 diabetes by vitamin D receptor haplotypes</article-title><source>Ann N Y Acad Sci</source><year>2006</year><volume>1079</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">17130574</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramagopalan</surname><given-names>SV</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Berlanga</surname><given-names>AJ</given-names></name><name><surname>Maugeri</surname><given-names>NJ</given-names></name><name><surname>Lincoln</surname><given-names>MR</given-names></name><name><surname>Burrell</surname><given-names>A</given-names></name><name><surname>Handunnetthi</surname><given-names>L</given-names></name><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Disanto</surname><given-names>G</given-names></name><name><surname>Orton</surname><given-names>SM</given-names></name><name><surname>Watson</surname><given-names>CT</given-names></name><name><surname>Morahan</surname><given-names>JM</given-names></name><name><surname>Giovannoni</surname><given-names>G</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Ebers</surname><given-names>GC</given-names></name><name><surname>Knight</surname><given-names>JC</given-names></name></person-group><article-title>A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution</article-title><source>Genome Res</source><year>2010</year><volume>20</volume><fpage>1352</fpage><lpage>1360</lpage><pub-id pub-id-type="pmid">20736230</pub-id></element-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>C</given-names></name><name><surname>Waer</surname><given-names>M</given-names></name><name><surname>Laureys</surname><given-names>J</given-names></name><name><surname>Rutgeerts</surname><given-names>O</given-names></name><name><surname>Bouillon</surname><given-names>R</given-names></name></person-group><article-title>Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3</article-title><source>Diabetologia</source><year>1994</year><volume>37</volume><fpage>552</fpage><lpage>558</lpage><pub-id pub-id-type="pmid">7926338</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liao</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Lei</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name></person-group><article-title>Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA)</article-title><source>Diabetes/Metab Res Rev</source><year>2009</year><volume>25</volume><fpage>411</fpage><lpage>416</lpage></element-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabbay</surname><given-names>MA</given-names></name><name><surname>Sato</surname><given-names>MN</given-names></name><name><surname>Finazzo</surname><given-names>C</given-names></name><name><surname>Duarte</surname><given-names>AJ</given-names></name><name><surname>Dib</surname><given-names>SA</given-names></name></person-group><article-title>Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual beta-cell function in new-onset type 1 diabetes mellitus</article-title><source>Arch Pediatr Adolesc Med</source><year>2012</year><volume>166</volume><fpage>601</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">22751874</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ataie-Jafari</surname><given-names>A</given-names></name><name><surname>Loke</surname><given-names>SC</given-names></name><name><surname>Rahmat</surname><given-names>AB</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name><name><surname>Abbasi</surname><given-names>F</given-names></name><name><surname>Leow</surname><given-names>MK</given-names></name><name><surname>Yassin</surname><given-names>Z</given-names></name></person-group><article-title>A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes</article-title><source>Clini Nutr (Edinburgh, Scotland)</source><year>2013</year><volume>32</volume><fpage>911</fpage><lpage>917</lpage></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bizzarri</surname><given-names>C</given-names></name><name><surname>Pitocco</surname><given-names>D</given-names></name><name><surname>Napoli</surname><given-names>N</given-names></name><name><surname>Di Stasio</surname><given-names>E</given-names></name><name><surname>Maggi</surname><given-names>D</given-names></name><name><surname>Manfrini</surname><given-names>S</given-names></name><name><surname>Suraci</surname><given-names>C</given-names></name><name><surname>Cavallo</surname><given-names>MG</given-names></name><name><surname>Cappa</surname><given-names>M</given-names></name><name><surname>Ghirlanda</surname><given-names>G</given-names></name><name><surname>Pozzilli</surname><given-names>P</given-names></name></person-group><article-title>No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>1962</fpage><lpage>1963</lpage><pub-id pub-id-type="pmid">20805274</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>M</given-names></name><name><surname>Kaupper</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>K</given-names></name><name><surname>Foersch</surname><given-names>J</given-names></name><name><surname>Bonifacio</surname><given-names>E</given-names></name><name><surname>Ziegler</surname><given-names>AG</given-names></name></person-group><article-title>No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>1443</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">20357369</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ananthakrishnan</surname><given-names>AN</given-names></name></person-group><article-title>Vitamin D and inflammatory bowel disease</article-title><source>Gastroenterol Hepatol</source><year>2016</year><volume>12</volume><fpage>513</fpage><lpage>515</lpage></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ham</surname><given-names>M</given-names></name><name><surname>Longhi</surname><given-names>MS</given-names></name><name><surname>Lahiff</surname><given-names>C</given-names></name><name><surname>Cheifetz</surname><given-names>A</given-names></name><name><surname>Robson</surname><given-names>S</given-names></name><name><surname>Moss</surname><given-names>AC</given-names></name></person-group><article-title>Vitamin D levels in adults with Crohn’s disease are responsive to disease activity and treatment</article-title><source>Inflamm Bowel Dis</source><year>2014</year><volume>20</volume><fpage>856</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">24681654</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jørgensen</surname><given-names>SP</given-names></name><name><surname>Hvas</surname><given-names>CL</given-names></name><name><surname>Agnholt</surname><given-names>J</given-names></name><name><surname>Christensen</surname><given-names>LA</given-names></name><name><surname>Heickendorff</surname><given-names>L</given-names></name><name><surname>Dahlerup</surname><given-names>JF</given-names></name></person-group><article-title>Active Crohn’s disease is associated with low vitamin D levels</article-title><source>J Crohn’s Colitis</source><year>2013</year><volume>7</volume><fpage>e407</fpage><lpage>e413</lpage><pub-id pub-id-type="pmid">23403039</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohammad</surname><given-names>MS</given-names></name><name><surname>Mayberry</surname><given-names>J</given-names></name></person-group><article-title>PWE-103 vitamin D deficiency in crohns disease and ulcerative colitis</article-title><source>Gut</source><year>2013</year><volume>62</volume><fpage>A172</fpage><lpage>A172</lpage></element-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froicu</surname><given-names>M</given-names></name><name><surname>Weaver</surname><given-names>V</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>McDowell</surname><given-names>MA</given-names></name><name><surname>Welsh</surname><given-names>JE</given-names></name><name><surname>Cantorna</surname><given-names>MT</given-names></name></person-group><article-title>A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases</article-title><source>Mol Endocrinol</source><year>2003</year><volume>17</volume><fpage>2386</fpage><lpage>2392</lpage><pub-id pub-id-type="pmid">14500760</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Nguyen</surname><given-names>L</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Lagishetty</surname><given-names>V</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Hollis</surname><given-names>B</given-names></name><name><surname>DeLuca</surname><given-names>HF</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation</article-title><source>Endocrinology</source><year>2008</year><volume>149</volume><fpage>4799</fpage><lpage>4808</lpage><pub-id pub-id-type="pmid">18535110</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagishetty</surname><given-names>V</given-names></name><name><surname>Misharin</surname><given-names>AV</given-names></name><name><surname>Liu</surname><given-names>NQ</given-names></name><name><surname>Lisse</surname><given-names>TS</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>McLachlan</surname><given-names>SM</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis</article-title><source>Endocrinology</source><year>2010</year><volume>151</volume><fpage>2423</fpage><lpage>2432</lpage><pub-id pub-id-type="pmid">20392825</pub-id></element-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Golan</surname><given-names>MA</given-names></name><name><surname>Annunziata</surname><given-names>ML</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Dougherty</surname><given-names>U</given-names></name><name><surname>Kong</surname><given-names>J</given-names></name><name><surname>Musch</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Pekow</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>C</given-names></name><name><surname>Bissonnette</surname><given-names>M</given-names></name><name><surname>Hanauer</surname><given-names>SB</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name></person-group><article-title>Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis</article-title><source>J Clin Investig</source><year>2013</year><volume>123</volume><fpage>3983</fpage><lpage>3996</lpage><pub-id pub-id-type="pmid">23945234</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>England</surname><given-names>BR</given-names></name><name><surname>Thiele</surname><given-names>GM</given-names></name><name><surname>Anderson</surname><given-names>DR</given-names></name><name><surname>Mikuls</surname><given-names>TR</given-names></name></person-group><article-title>Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications</article-title><source>BMJ</source><year>2018</year><volume>361</volume><fpage>k1036</fpage><lpage>k1036</lpage><pub-id pub-id-type="pmid">29685876</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobon</surname><given-names>GJ</given-names></name><name><surname>Youinou</surname><given-names>P</given-names></name><name><surname>Saraux</surname><given-names>A</given-names></name></person-group><article-title>The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis</article-title><source>Autoimmun Rev</source><year>2010</year><volume>9</volume><fpage>A288</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">19944780</pub-id></element-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Bang</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Cho</surname><given-names>SK</given-names></name><name><surname>Choi</surname><given-names>CB</given-names></name><name><surname>Sung</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>TH</given-names></name><name><surname>Jun</surname><given-names>JB</given-names></name><name><surname>Yoo</surname><given-names>DH</given-names></name><name><surname>Kang</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Suh</surname><given-names>CH</given-names></name><name><surname>Shim</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Chung</surname><given-names>WT</given-names></name><name><surname>Choe</surname><given-names>JY</given-names></name><name><surname>Shin</surname><given-names>HD</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Han</surname><given-names>BG</given-names></name><name><surname>Nath</surname><given-names>SK</given-names></name><name><surname>Eyre</surname><given-names>S</given-names></name><name><surname>Bowes</surname><given-names>J</given-names></name><name><surname>Pappas</surname><given-names>DA</given-names></name><name><surname>Kremer</surname><given-names>JM</given-names></name><name><surname>Gonzalez-Gay</surname><given-names>MA</given-names></name><name><surname>Rodriguez-Rodriguez</surname><given-names>L</given-names></name><name><surname>Arlestig</surname><given-names>L</given-names></name><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Diogo</surname><given-names>D</given-names></name><name><surname>Liao</surname><given-names>KP</given-names></name><name><surname>Karlson</surname><given-names>EW</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Rantapaa-Dahlqvist</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Klareskog</surname><given-names>L</given-names></name><name><surname>Padyukov</surname><given-names>L</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name><name><surname>Worthington</surname><given-names>J</given-names></name><name><surname>Greenberg</surname><given-names>JD</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Bae</surname><given-names>SC</given-names></name></person-group><article-title>High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci</article-title><source>Ann Rheum Dis</source><year>2015</year><volume>74</volume><fpage>e13</fpage><pub-id pub-id-type="pmid">24532676</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarwood</surname><given-names>A</given-names></name><name><surname>Huizinga</surname><given-names>TW</given-names></name><name><surname>Worthington</surname><given-names>J</given-names></name></person-group><article-title>The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA</article-title><source>Rheumatology</source><year>2014</year><volume>55</volume><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25239882</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracy</surname><given-names>A</given-names></name><name><surname>Buckley</surname><given-names>CD</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name></person-group><article-title>Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?</article-title><source>Semin Immunopathol</source><year>2017</year><volume>39</volume><fpage>423</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">28337522</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Davies</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0146351</fpage><pub-id pub-id-type="pmid">26751969</pub-id></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>MK</given-names></name><name><surname>Mackie</surname><given-names>SL</given-names></name><name><surname>Thalayasingam</surname><given-names>N</given-names></name><name><surname>Bingham</surname><given-names>SJ</given-names></name><name><surname>Hamilton</surname><given-names>J</given-names></name><name><surname>Kelly</surname><given-names>CA</given-names></name></person-group><article-title>The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis</article-title><source>Clin Rheumatol</source><year>2013</year><volume>32</volume><fpage>863</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">23340834</pub-id></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooles</surname><given-names>FA</given-names></name><name><surname>Pratt</surname><given-names>AG</given-names></name><name><surname>Lendrem</surname><given-names>DW</given-names></name><name><surname>Ng</surname><given-names>WF</given-names></name><name><surname>Aspray</surname><given-names>TJ</given-names></name><name><surname>Isaacs</surname><given-names>JD</given-names></name></person-group><article-title>Retrospective analysis of the role of serum vitamin D in early rheumatic disease</article-title><source>Rheumatology</source><year>2015</year><volume>54</volume><fpage>374</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">25406355</pub-id></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Franco</surname><given-names>M</given-names></name><name><surname>Barchetta</surname><given-names>I</given-names></name><name><surname>Iannuccelli</surname><given-names>C</given-names></name><name><surname>Gerardi</surname><given-names>MC</given-names></name><name><surname>Frisenda</surname><given-names>S</given-names></name><name><surname>Ceccarelli</surname><given-names>F</given-names></name><name><surname>Valesini</surname><given-names>G</given-names></name><name><surname>Cavallo</surname><given-names>MG</given-names></name></person-group><article-title>Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: a 12 month follow-up study</article-title><source>BMC Musculoskelet Disord</source><year>2015</year><volume>16</volume><fpage>53</fpage><pub-id pub-id-type="pmid">25887374</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuya</surname><given-names>T</given-names></name><name><surname>Hosoi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>E</given-names></name><name><surname>Nakajima</surname><given-names>A</given-names></name><name><surname>Taniguchi</surname><given-names>A</given-names></name><name><surname>Momohara</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>H</given-names></name></person-group><article-title>Prevalence of and factors associated with vitamin D deficiency in 4793 Japanese patients with rheumatoid arthritis</article-title><source>Clin Rheumatol</source><year>2013</year><volume>32</volume><fpage>1081</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">23423442</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haga</surname><given-names>HJ</given-names></name><name><surname>Schmedes</surname><given-names>A</given-names></name><name><surname>Naderi</surname><given-names>Y</given-names></name><name><surname>Moreno</surname><given-names>AM</given-names></name><name><surname>Peen</surname><given-names>E</given-names></name></person-group><article-title>Severe deficiency of 25-hydroxyvitamin D(3) (25-OH-D(3)) is associated with high disease activity of rheumatoid arthritis</article-title><source>Clin Rheumatol</source><year>2013</year><volume>32</volume><fpage>629</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">23318705</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emery</surname><given-names>P</given-names></name><name><surname>Salmon</surname><given-names>M</given-names></name></person-group><article-title>Early rheumatoid arthritis: time to aim for remission?</article-title><source>Ann Rheum Dis</source><year>1995</year><volume>54</volume><fpage>944</fpage><lpage>947</lpage><pub-id pub-id-type="pmid">8546524</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jr</surname><given-names>GD</given-names></name><name><surname>Holweg</surname><given-names>CTJ</given-names></name><name><surname>Kummerfeld</surname><given-names>SK</given-names></name><name><surname>Choy</surname><given-names>DF</given-names></name><name><surname>Setiadi</surname><given-names>AF</given-names></name><name><surname>Hackney</surname><given-names>JA</given-names></name><name><surname>Haverty</surname><given-names>PM</given-names></name><name><surname>Gilbert</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>WY</given-names></name><name><surname>Diehl</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>A</given-names></name><name><surname>Musselman</surname><given-names>D</given-names></name><name><surname>Klearman</surname><given-names>M</given-names></name><name><surname>Gabay</surname><given-names>C</given-names></name><name><surname>Kavanaugh</surname><given-names>A</given-names></name><name><surname>Endres</surname><given-names>J</given-names></name><name><surname>Fox</surname><given-names>DA</given-names></name><name><surname>Martin</surname><given-names>F</given-names></name><name><surname>Townsend</surname><given-names>MJ</given-names></name></person-group><article-title>Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics</article-title><source>Arthritis Res Ther</source><year>2014</year><volume>16</volume><fpage>1</fpage><lpage>18</lpage></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>ME</given-names></name><name><surname>Denton</surname><given-names>J</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Mawer</surname><given-names>EB</given-names></name></person-group><article-title>Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases</article-title><source>Ann Rheum Dis</source><year>1989</year><volume>48</volume><fpage>723</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">2802793</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mawer</surname><given-names>EB</given-names></name><name><surname>Hayes</surname><given-names>ME</given-names></name><name><surname>Still</surname><given-names>PE</given-names></name><name><surname>Davies</surname><given-names>M</given-names></name><name><surname>Lumb</surname><given-names>GA</given-names></name><name><surname>Holt</surname><given-names>PJ</given-names></name></person-group><article-title>Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis</article-title><source>J Bone Miner Res</source><year>1991</year><volume>6</volume><fpage>733</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">1950677</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname><given-names>ME</given-names></name><name><surname>Bayley</surname><given-names>D</given-names></name><name><surname>Still</surname><given-names>P</given-names></name><name><surname>Palit</surname><given-names>J</given-names></name><name><surname>Denton</surname><given-names>J</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Cooper</surname><given-names>RG</given-names></name><name><surname>Mawer</surname><given-names>EB</given-names></name></person-group><article-title>Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis</article-title><source>Ann Rheum Dis</source><year>1992</year><volume>51</volume><fpage>220</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">1550407</pub-id></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Jeffery</surname><given-names>L</given-names></name><name><surname>Jenkinson</surname><given-names>C</given-names></name><name><surname>Harrison</surname><given-names>SR</given-names></name><name><surname>Chun</surname><given-names>RF</given-names></name><name><surname>Adams</surname><given-names>JS</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name></person-group><article-title>Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis</article-title><source>J Steroid Biochem Mol Biol</source><year>2018</year><volume>187</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="other">National Institute of Clinical Excellence - Clincal Knowledge S (2016) Vitamin D deficiency in adults—treatment and prevention</mixed-citation></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="other">National Osteoporosis S (2013) Vitamin D and bone health: a practical clinical guideline for patient management</mixed-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varenna</surname><given-names>M</given-names></name><name><surname>Manara</surname><given-names>M</given-names></name><name><surname>Cantatore</surname><given-names>FP</given-names></name><name><surname>Del Puente</surname><given-names>A</given-names></name><name><surname>Di Munno</surname><given-names>O</given-names></name><name><surname>Malavolta</surname><given-names>N</given-names></name><name><surname>Minisola</surname><given-names>G</given-names></name><name><surname>Adami</surname><given-names>S</given-names></name><name><surname>Sinigaglia</surname><given-names>L</given-names></name><name><surname>Rossini</surname><given-names>M</given-names></name></person-group><article-title>Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis</article-title><source>Clin Exp Rheumatol</source><year>2012</year><volume>30</volume><fpage>714</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">22766134</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>AS</given-names></name><name><surname>Freitas</surname><given-names>TQ</given-names></name><name><surname>Bernardo</surname><given-names>WM</given-names></name><name><surname>Pereira</surname><given-names>RMR</given-names></name></person-group><article-title>Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases</article-title><source>Medicine</source><year>2017</year><volume>96</volume><fpage>e7024</fpage><lpage>e7024</lpage><pub-id pub-id-type="pmid">28591033</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allan</surname><given-names>GM</given-names></name><name><surname>Cranston</surname><given-names>L</given-names></name><name><surname>Lindblad</surname><given-names>A</given-names></name><name><surname>McCormack</surname><given-names>J</given-names></name><name><surname>Kolber</surname><given-names>MR</given-names></name><name><surname>Garrison</surname><given-names>S</given-names></name><name><surname>Korownyk</surname><given-names>C</given-names></name></person-group><article-title>Vitamin D: a narrative review examining the evidence for ten beliefs</article-title><source>J Gen Intern Med</source><year>2016</year><volume>31</volume><fpage>780</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">26951286</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>GG</given-names></name><name><surname>Bae</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name></person-group><article-title>Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis</article-title><source>Clin Rheumatol</source><year>2012</year><volume>31</volume><fpage>1733</fpage><lpage>1739</lpage><pub-id pub-id-type="pmid">22941259</pub-id></element-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>EL</given-names></name><name><surname>Rees</surname><given-names>JR</given-names></name><name><surname>Peacock</surname><given-names>JL</given-names></name><name><surname>Mott</surname><given-names>LA</given-names></name><name><surname>Amos</surname><given-names>CI</given-names></name><name><surname>Bostick</surname><given-names>RM</given-names></name><name><surname>Figueiredo</surname><given-names>JC</given-names></name><name><surname>Ahnen</surname><given-names>DJ</given-names></name><name><surname>Bresalier</surname><given-names>RS</given-names></name><name><surname>Burke</surname><given-names>CA</given-names></name><name><surname>Baron</surname><given-names>JA</given-names></name></person-group><article-title>Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial</article-title><source>J Clin Endocrinol Metab</source><year>2014</year><volume>99</volume><fpage>E2133</fpage><lpage>2137</lpage><pub-id pub-id-type="pmid">25070320</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Qureshi</surname><given-names>OS</given-names></name><name><surname>Gardner</surname><given-names>D</given-names></name><name><surname>Hou</surname><given-names>TZ</given-names></name><name><surname>Briggs</surname><given-names>Z</given-names></name><name><surname>Soskic</surname><given-names>B</given-names></name><name><surname>Baker</surname><given-names>J</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name></person-group><article-title>Vitamin D antagonises the suppressive effect of inflammatory cytokines on CTLA-4 expression and regulatory function</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0131539</fpage><pub-id pub-id-type="pmid">26134669</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danks</surname><given-names>L</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Guerrini</surname><given-names>MM</given-names></name><name><surname>Sawa</surname><given-names>S</given-names></name><name><surname>Armaka</surname><given-names>M</given-names></name><name><surname>Kollias</surname><given-names>G</given-names></name><name><surname>Nakashima</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group><article-title>RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation</article-title><source>Ann Rheum Dis</source><year>2016</year><volume>75</volume><fpage>1187</fpage><lpage>1195</lpage><pub-id pub-id-type="pmid">26025971</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Fernandez</surname><given-names>JL</given-names></name></person-group><article-title>Antigen presentation by dendritic cells in rheumatoid arthritis</article-title><source>Curr Top Med Chem</source><year>2013</year><volume>13</volume><fpage>712</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">23574520</pub-id></element-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klareskog</surname><given-names>L</given-names></name></person-group><article-title>Antigen presentation in joints in the pathogenesis of arthritis</article-title><source>Br J Rheumatol</source><year>1991</year><volume>30</volume><issue>Suppl 1</issue><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">1991242</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nistala</surname><given-names>K</given-names></name><name><surname>Adams</surname><given-names>S</given-names></name><name><surname>Cambrook</surname><given-names>H</given-names></name><name><surname>Ursu</surname><given-names>S</given-names></name><name><surname>Olivito</surname><given-names>B</given-names></name><name><surname>de Jager</surname><given-names>W</given-names></name><name><surname>Evans</surname><given-names>JG</given-names></name><name><surname>Cimaz</surname><given-names>R</given-names></name><name><surname>Bajaj-Elliott</surname><given-names>M</given-names></name><name><surname>Wedderburn</surname><given-names>LR</given-names></name></person-group><article-title>Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>14751</fpage><lpage>14756</lpage><pub-id pub-id-type="pmid">20679229</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Hamburg</surname><given-names>JP</given-names></name><name><surname>Asmawidjaja</surname><given-names>PS</given-names></name><name><surname>Davelaar</surname><given-names>N</given-names></name><name><surname>Mus</surname><given-names>AM</given-names></name><name><surname>Colin</surname><given-names>EM</given-names></name><name><surname>Hazes</surname><given-names>JM</given-names></name><name><surname>Dolhain</surname><given-names>RJ</given-names></name><name><surname>Lubberts</surname><given-names>E</given-names></name></person-group><article-title>Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production</article-title><source>Arthritis Rheum</source><year>2011</year><volume>63</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">20954258</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoop</surname><given-names>JN</given-names></name><name><surname>Harry</surname><given-names>RA</given-names></name><name><surname>von Delwig</surname><given-names>A</given-names></name><name><surname>Isaacs</surname><given-names>JD</given-names></name><name><surname>Robinson</surname><given-names>JH</given-names></name><name><surname>Hilkens</surname><given-names>CMU</given-names></name></person-group><article-title>Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses</article-title><source>Arthritis Rheum</source><year>2010</year><volume>62</volume><fpage>3656</fpage><lpage>3665</lpage><pub-id pub-id-type="pmid">20862679</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bscheider</surname><given-names>M</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name></person-group><article-title>Vitamin D immunoregulation through dendritic cells</article-title><source>Immunology</source><year>2016</year><volume>148</volume><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">27040466</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>AE</given-names></name><name><surname>Swan</surname><given-names>DJ</given-names></name><name><surname>Wong</surname><given-names>OY</given-names></name><name><surname>Buck</surname><given-names>M</given-names></name><name><surname>Eltherington</surname><given-names>O</given-names></name><name><surname>Harry</surname><given-names>RA</given-names></name><name><surname>Patterson</surname><given-names>AM</given-names></name><name><surname>Pratt</surname><given-names>AG</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Doran</surname><given-names>JP</given-names></name><name><surname>Kirby</surname><given-names>JA</given-names></name><name><surname>Isaacs</surname><given-names>JD</given-names></name><name><surname>Hilkens</surname><given-names>CM</given-names></name></person-group><article-title>Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4(+) T cells partly via transforming growth factor-beta1</article-title><source>Clin Exp Immunol</source><year>2017</year><volume>187</volume><fpage>113</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">27667787</pub-id></element-citation></ref><ref id="CR145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponchel</surname><given-names>F</given-names></name><name><surname>Goëb</surname><given-names>V</given-names></name><name><surname>Parmar</surname><given-names>R</given-names></name><name><surname>El-Sherbiny</surname><given-names>Y</given-names></name><name><surname>Boissinot</surname><given-names>M</given-names></name><name><surname>El Jawhari</surname><given-names>J</given-names></name><name><surname>Burska</surname><given-names>A</given-names></name><name><surname>Vital</surname><given-names>EM</given-names></name><name><surname>Harrison</surname><given-names>S</given-names></name><name><surname>Conaghan</surname><given-names>PG</given-names></name><name><surname>Hensor</surname><given-names>E</given-names></name><name><surname>Emery</surname><given-names>P</given-names></name></person-group><article-title>An immunological biomarker to predict MTX response in early RA</article-title><source>Ann Rheum Dis</source><year>2014</year><volume>73</volume><fpage>2047</fpage><lpage>2053</lpage><pub-id pub-id-type="pmid">23989988</pub-id></element-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langdon</surname><given-names>K</given-names></name><name><surname>Haleagrahara</surname><given-names>N</given-names></name></person-group><article-title>Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis</article-title><source>Int Rev Immunol</source><year>2018</year><volume>37</volume><fpage>206</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">29757670</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Yin</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>TR</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>JR</given-names></name><name><surname>Zheng</surname><given-names>S-G</given-names></name><name><surname>Han</surname><given-names>J</given-names></name></person-group><article-title>The abnormal expression of CCR47 and CCR47 on Tregs in rheumatoid arthritis</article-title><source>Int J Clin Exp Med</source><year>2015</year><volume>8</volume><fpage>15043</fpage><lpage>15053</lpage><pub-id pub-id-type="pmid">26628988</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>N</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>F-P</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z-G</given-names></name></person-group><article-title>Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood</article-title><source>Ann Rheum Dis</source><year>2015</year><volume>74</volume><fpage>1293</fpage><lpage>1301</lpage><pub-id pub-id-type="pmid">24521740</pub-id></element-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooles</surname><given-names>FAH</given-names></name><name><surname>Isaacs</surname><given-names>JD</given-names></name><name><surname>Anderson</surname><given-names>AE</given-names></name></person-group><article-title>Treg cells in rheumatoid arthritis: an update</article-title><source>Curr Rheumatol Rep</source><year>2013</year><volume>15</volume><fpage>352</fpage><pub-id pub-id-type="pmid">23888361</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>B</given-names></name><name><surname>Schnatzer</surname><given-names>P</given-names></name><name><surname>Hagmann</surname><given-names>S</given-names></name><name><surname>Rosshirt</surname><given-names>N</given-names></name><name><surname>Gotterbarm</surname><given-names>T</given-names></name><name><surname>Kretzer</surname><given-names>JP</given-names></name><name><surname>Thomsen</surname><given-names>M</given-names></name><name><surname>Lorenz</surname><given-names>H-M</given-names></name><name><surname>Zeifang</surname><given-names>F</given-names></name><name><surname>Tretter</surname><given-names>T</given-names></name></person-group><article-title>CD4<sup>+</sup>CD25+/high CD127 low/− regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints–analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood</article-title><source>Arthritis Res Ther</source><year>2014</year><volume>16</volume><fpage>R97</fpage><lpage>R97</lpage><pub-id pub-id-type="pmid">24742142</pub-id></element-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeke</surname><given-names>F</given-names></name><name><surname>Korf</surname><given-names>H</given-names></name><name><surname>Overbergh</surname><given-names>L</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Thorrez</surname><given-names>L</given-names></name><name><surname>Van Lommel</surname><given-names>L</given-names></name><name><surname>Waer</surname><given-names>M</given-names></name><name><surname>Schuit</surname><given-names>F</given-names></name><name><surname>Gysemans</surname><given-names>C</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name></person-group><article-title>The vitamin D analog, TX527, promotes a human CD4+ CD25 high CD127 low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>132</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">21131424</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Belle</surname><given-names>TL</given-names></name><name><surname>Vanherwegen</surname><given-names>A-S</given-names></name><name><surname>Feyaerts</surname><given-names>D</given-names></name><name><surname>De Clercq</surname><given-names>P</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Korf</surname><given-names>H</given-names></name><name><surname>Gysemans</surname><given-names>C</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 and Its Analog TX527 Promote a Stable Regulatory T Cell Phenotype in T Cells from Type 1 Diabetes Patients</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e109194</fpage><lpage>e109194</lpage><pub-id pub-id-type="pmid">25279717</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Henley</surname><given-names>P</given-names></name><name><surname>Marium</surname><given-names>N</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name></person-group><article-title>Decreased sensitivity to 1,25-dihydroxyvitamin D3 in T cells from the rheumatoid joint</article-title><source>J Autoimmun</source><year>2018</year><volume>88</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">29066221</pub-id></element-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>DH</given-names></name><name><surname>Jeffery</surname><given-names>LE</given-names></name><name><surname>Soskic</surname><given-names>B</given-names></name><name><surname>Briggs</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>TZ</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Sansom</surname><given-names>DM</given-names></name></person-group><article-title>1,25(OH)2D3 promotes the efficacy of CD28 costimulation blockade by abatacept</article-title><source>J Immunol</source><year>2015</year><volume>195</volume><fpage>2657</fpage><lpage>2665</lpage><pub-id pub-id-type="pmid">26276872</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>B</given-names></name><name><surname>Lv</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Qiao</surname><given-names>W</given-names></name><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Zuo</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Miao</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name></person-group><article-title>1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes</article-title><source>Cell Death Dis</source><year>2016</year><volume>7</volume><fpage>e2423</fpage><pub-id pub-id-type="pmid">27763638</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Hamburg</surname><given-names>JP</given-names></name><name><surname>Asmawidjaja</surname><given-names>PS</given-names></name><name><surname>Davelaar</surname><given-names>N</given-names></name><name><surname>Mus</surname><given-names>AMC</given-names></name><name><surname>Cornelissen</surname><given-names>F</given-names></name><name><surname>van Leeuwen</surname><given-names>JPTM</given-names></name><name><surname>Hazes</surname><given-names>JMW</given-names></name><name><surname>Dolhain</surname><given-names>RJEM</given-names></name><name><surname>Bakx</surname><given-names>PAGM</given-names></name><name><surname>Colin</surname><given-names>EM</given-names></name><name><surname>Lubberts</surname><given-names>E</given-names></name></person-group><article-title>TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation</article-title><source>Ann Rheum Dis</source><year>2012</year><volume>71</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">22219138</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Lv</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Gan</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name></person-group><article-title>Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β-induced RANKL, OPG, TNF α, and IL-6 expression in human rheumatoid synoviocyte MH7A</article-title><source>Clin Dev Immunol</source><year>2013</year><volume>2013</volume><fpage>160123</fpage><pub-id pub-id-type="pmid">24348674</pub-id></element-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tetlow</surname><given-names>LC</given-names></name><name><surname>Woolley</surname><given-names>DE</given-names></name></person-group><article-title>The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion</article-title><source>Arthritis Res</source><year>1999</year><volume>1</volume><fpage>63</fpage><pub-id pub-id-type="pmid">11056661</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martineau</surname><given-names>AR</given-names></name><name><surname>Jolliffe</surname><given-names>DA</given-names></name><name><surname>Hooper</surname><given-names>RL</given-names></name><name><surname>Greenberg</surname><given-names>L</given-names></name><name><surname>Aloia</surname><given-names>JF</given-names></name><name><surname>Bergman</surname><given-names>P</given-names></name><name><surname>Dubnov-Raz</surname><given-names>G</given-names></name><name><surname>Esposito</surname><given-names>S</given-names></name><name><surname>Ganmaa</surname><given-names>D</given-names></name><name><surname>Ginde</surname><given-names>AA</given-names></name><name><surname>Goodall</surname><given-names>EC</given-names></name><name><surname>Grant</surname><given-names>CC</given-names></name><name><surname>Griffiths</surname><given-names>CJ</given-names></name><name><surname>Janssens</surname><given-names>W</given-names></name><name><surname>Laaksi</surname><given-names>I</given-names></name><name><surname>Manaseki-Holland</surname><given-names>S</given-names></name><name><surname>Mauger</surname><given-names>D</given-names></name><name><surname>Murdoch</surname><given-names>DR</given-names></name><name><surname>Neale</surname><given-names>R</given-names></name><name><surname>Rees</surname><given-names>JR</given-names></name><name><surname>Simpson</surname><given-names>S</given-names><suffix>Jr</suffix></name><name><surname>Stelmach</surname><given-names>I</given-names></name><name><surname>Kumar</surname><given-names>GT</given-names></name><name><surname>Urashima</surname><given-names>M</given-names></name><name><surname>Camargo</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group><article-title>Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data</article-title><source>BMJ</source><year>2017</year><volume>356</volume><fpage>i6583</fpage><pub-id pub-id-type="pmid">28202713</pub-id></element-citation></ref><ref id="CR160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>KM</given-names></name><name><surname>Stuart</surname><given-names>AL</given-names></name><name><surname>Williamson</surname><given-names>EJ</given-names></name><name><surname>Simpson</surname><given-names>JA</given-names></name><name><surname>Kotowicz</surname><given-names>MA</given-names></name><name><surname>Young</surname><given-names>D</given-names></name><name><surname>Nicholson</surname><given-names>GC</given-names></name></person-group><article-title>Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial</article-title><source>JAMA</source><year>2010</year><volume>303</volume><fpage>1815</fpage><lpage>1822</lpage><pub-id pub-id-type="pmid">20460620</pub-id></element-citation></ref></ref-list></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000220 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000220 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:6960236
|texte= Vitamin D, Autoimmune Disease and Rheumatoid Arthritis
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:31286174" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |